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Abstract 
Control  of translation is a fundamental source  of regulating gene expression. 
Brain-derived  neurotrophic factor (BDNF) is a critical activity-dependent  modulator  of 
gene expression, which can regulate both transcription and translation. Several functions 
of  BDNF, including the induction  of  dendrite  outgrowth and long-term synaptic 
plasticity,  depend  upon the ability  of  BDNF to regulate  protein synthesis.  Although 
BDNF modestly increases total neuronal protein synthesis, substantial evidence indicates 
that  BDNF induces translation  of  only a smal subset  of expressed  mRNAs and 
demonstrates an extraordinary degree of transcript specificity. The mechanism by which 
BDNF selectively  upregulates the translation  of  only a  discrete  group  of  mRNAs is  of 
intrinsic importance to its trophic function in promoting neuronal growth and plasticity, 
but how BDNF selects only a minority of expressed mRNAs is poorly understood.  My 
thesis  work addressed this  question and led to the finding that  BDNF rapidly elevates 
Dicer, increasing  mature  microRNA (miRNA) levels and inducing mRNA repression. 
BDNF also rapidly induces  Lin28, an RNA  binding  protein, causing selective loss  of 
Lin28-regulated miRNAs and a coresponding upregulation in translation of their target 
mRNAs.  Loss  of  Lin28,  or expression  of a  Lin28-resistant  Let-7  precursor  miRNA, 
inhibits BDNF translation specificity and BDNF-dependent dendrite arborization.  
The finding that Lin28 could be upregulated in mature neurons and was required 
for the specificity  of  BDNF-induced  protein synthesis, led to the second  portion  of  my 
thesis research,  which investigates the  molecular mechanism responsible for rapid 
transcription-independent induction  of  Lin28  by  BDNF. This  portion  of  my  doctoral 
work demonstrated that TAR-RNA-binding protein (TRBP), a critical miRNA biogenesis 
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component and  Dicer  binding  partner, is required for the induction  of  Lin28  by  BDNF 
and revealed that TRBP is a novel Lin28 binding partner. 
My  dissertation sheds light  on  novel  mechanisms of specificity in stimulus-
dependent  gene expression and  ofers a mechanistic  understanding  of  how  neuronal 
protein composition is controled through induction  of  Lin28 in  mature  neurons. In 
addition,  my thesis  work elucidated celular  pathways  underlying  plasticity and 
established molecular links  between  neuronal  pro-growth  pathways and  pluripotency, 
which  may  help  us  understand the  dysregulated translation associated  with cognitive 
disorders and diseases of the central nervous system.  
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Chapter I: Introduction 
 
Translational regulation and synaptic plasticity  
The complement  of  proteins expressed in  neurons fundamentaly shape  brain 
function and are  ultimately the  determining factor in the enduring changes  of synaptic 
responses that underlie learning and memory. The selective strengthening and weakening 
of synapses in response to  neuronal activity is termed synaptic  plasticity.  Stimuli that 
generate  persistent forms  of synaptic  plasticity criticaly regulate  gene expression  by 
acting at the level of transcription, translation, or both. In each case, specificity is a key 
feature in ensuring the corect celular response.   Elements enabling transcriptional 
specificity  have  been  under investigation for  many  years and  key components, such as 
transcription factors, co-activators, and chromatin  modifiers  have  been identified.  In 
contrast, our knowledge of general pathways enabling specificity in protein synthesis is 
lacking and results in failures to understand or predict the mechanisms and consequences 
of  defects in these  pathways.   While dysregulated translation is  known to impair 
cognition and is associated  with  disorders including  Fragile  X syndrome,  Autism 
Spectrum  Disorders, and  Parkinson’s  disease (Bassel and  Waren,  2008;  Gehrke et al., 
2010), the mechanisms by which translation selectivity is normaly specified in neurons 
remain unclear. 
 BDNF is a  potent regulator  of synapse  development,  plasticity, and  neuronal 
survival in the  mammalian  nervous system,  which is  known to  mediate  many  of its 
physiological efects by regulating protein synthesis. Although BDNF leads to a general 
stimulation  of the translational  machinery,  BDNF is a  highly selective regulator  of 
protein synthesis. This extraordinary degree of pro-growth target specificity is critical to 
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the function  of  BDNF in the  nervous system.  Our lab chose to study the  post-
transcriptional mechanisms enabling gene target specificity of BDNF as a model system. 
We set  out to establish a  paradigm for  how specificity in stimulus-dependent  neuronal 
protein synthesis  might  be controled  by investigating the  molecular  mechanism 
underlying the remarkable gene target specificity of BDNF-induced translation. 
 
 




The neurotrophin BDNF is widely expressed in both the developing and mature 
mammalian brain where it serves as a crucial regulator of neuronal survival, growth, and 
activity-dependent synaptic plasticity. Many of the wel-known pro-growth functions of 
BDNF rely  upon its ability to enhance the  production  of ensembles  of  proteins that 
support  neuronal  growth and excitatory synaptic function.   This thesis focuses  on the 
physiological function of BDNF-regulated protein synthesis and how BDNF achieves the 
gene target specificity for  pro-growth  mRNAs that are required for enhanced synaptic 
function and plasticity. Multiple lines of evidence indicate that novel protein synthesis is 
required for long-lasting forms of synaptic  plasticity associated  with learning and 
memory.  The importance  of  BDNF in supporting synaptic  plasticity and  memory 
formation stems, at least in part, from its capacity to regulate protein synthesis.  BDNF 
has been shown to increase total celular translation by signaling through its tropomyosin-
related  kinase  B (TrkB) receptor leading to the activation  of the  PLCγ,  P13K, and the 
MAPK pathways (Huang and Reichardt, 2003). 
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 Multiple forms  of  BDNF-mediated  plasticity  depend  upon the regulation  of 
protein synthesis  by  BDNF.   The enhancement  of  dendritic arborization in response to 
BDNF  has  been shown to require the regulation  of translation (Jaworski et al.,  2005). 
Likewise,  BDNF-dependent structural  plasticity  of  dendritic spines, specificaly spine 
head enlargement,  was also shown to  depend  upon  protein synthesis in rat  brain slices 
(Tanaka et al.,  2008). Additional  protein-synthesis  dependent efects  of  BDNF include 
enhanced abundance  of  GluA1 association  with the  postsynaptic  plasma  membrane 
(Caldeira et al.,  2007a). BDNF also  upregulates  both the abundance and  plasma 
membrane-association of NMDA receptor subunits NR1, NR2A, and NR2B in a protein 
synthesis-dependent manner, and this was shown to corelate with an increase in NMDA 
receptor activity (Caldeira et al.,  2007b).  Multiple reports support a critical role for 
BDNF-regulated protein synthesis in in-vitro assays of long-term use-dependent synaptic 
plasticity. BDNF was shown to enhance the induction of early phase LTP (E-LTP) and 
late-phase  LTP (L-LTP) in  hippocampal slices, and  BDNF-mediated stimulation  of de 
novo protein synthesis is essential for the  maintenance  of  L-LTP (Kang and  Schuman, 
1996; Korte et al., 1995; Pang and Lu, 2004; Paterson et al., 1996; Poo, 2001; Tyler et al., 
2002) These findings are consistent with in-vivo studies showing that secretion of BDNF 
is crucial for the  persistence of long-term  memory storage in the  hippocampus 
(Bekinschtein et al., 2007). 
 
BDNF regulates the translation of a subset of neuronal mRNAs 
While the capacity of BDNF to modestly enhance global celular translation has 
been readily appreciated, accumulated evidence has also revealed that only select proteins 
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are increased in response to BDNF.  Multiple investigations examining smal numbers of 
transcripts suggested that BDNF could induce the translation of plasticity-related proteins 
(such as CaMKIα, Staufen, Arc, Homer2, NR1, GluA1) while leaving the levels of other 
proteins  unafected (Aakalu et al.,  2001; Jourdi et al.,  2009;  Kanhema et al.,  2006; 
Keleher et al.,  2004;  Takei et al.,  2004;  Yin et al.,  2002;  Ying et al.,  2002).   High-
throughput approaches examining  gene target selectivity  on a  more  global scale  have 
helped to elucidate the truly impressive extent  of  gene target specificity in  BDNF-
regulated  protein synthesis.   2D electrophoresis  of radiolabeled  proteins from isolated 
synapses demonstrated that only specific proteins were enhanced by BDNF, while most 
proteins show no change, and a subset of proteins were decreased in response to BDNF 
(Yin et al., 2002). In 2004, Schrat and coleagues provided compeling evidence for the 
transcript selectivity  of  BDNF-induced  protein synthesis  using  polysome  profiling.  In 
this study conducted in cortical  neurons,  BDNF  was shown to induce a transcription-
independent recruitment  of a specific subset  of  mRNAs, less than  4  %  of the total 
expressed transcripts, to  polysomes (Schrat et al.,  2004).  This selective regulation  was 
sensitive to inhibition of mTOR. Intriguingly, BDNF not only upregulates translation of a 
discrete  group  of  mRNAs,  but in some cases  BDNF  mediates the transcription-
independent downregulation of specific transcripts and their coresponding proteins, such 
as the potassium co-transporter KCC2 and potassium channel Kv1.1 (Raab-Graham et al., 
2006;  Rivera et al.,  2002;  Wardle and  Poo,  2003). Using  multidimensional  protein 
identification technology (MudPIT) to analyze several thousand  proteins, the selective 
downregulation of significant numbers of proteins by BDNF, in addition to upregulated 
proteins, was also observed in isolated cortical synapses (synaptoneurosomes) (Liao et al., 
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2007).   Components  of the translational  machinery, including translation factors, 
ribonucleoproteins, ribosomal  proteins, as  wel as  proteins  known to regulate synaptic 
function and dendritic spine morphology were among the protein classes upregulated by 
30 minutes of BDNF treatment (Liao et al., 2007). 
 These investigations ilustrate  not  only the efects  of  BDNF in  promoting the 
synthesis of many proteins that support neuronal growth and synaptic plasticity, but also 
colectively underscore the high degree of selectivity in the regulation of target transcripts 
by BDNF. In the context of BDNF's known roles in the brain, it is perhaps not surprising 
that this growth factor would need to selectively regulate only certain proteins in order to 
achieve a net pro-growth or pro-plasticity function. Nonetheless, this striking specificity 
for  both  up- and  down-regulated  gene targets is a feature  of  BDNF control  of  protein 
synthesis that  has sometimes  been  overlooked in favor  of the simplified  understanding 
that BDNF enhances total celular protein synthesis. 
 
Post-transcriptional regulatory  mechanisms  underlying translational specificity  of 
BDNF  
How  does  BDNF selectively regulate the translation  of  only a  discrete  group  of 
mRNAs? In addition to acting on initiation factors of protein synthesis machinery, BDNF 
also modulates several more selective post-transcriptional regulators of gene expression. 
Multiple modes of exerting transcript selectivity in the post-transcriptional regulation of 
gene expression have been described, including cis-regulatory elements such as internal 
ribosome entry sites (IRES) and cytoplasmic  polyadenylation elements (CPEs), and 
trans-regulatory factors such as  RNA-binding  proteins, and  microRNAs (miRNAs). 
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RNA-binding proteins have been shown to modulate the synthesis of several plasticity-
related  proteins that are also targets  of  BDNF.  The  Cytoplasmic  Polyadenylation 
Element  Binding protein (CPEB) (Huang et al.,  2003;  Huang et al.,  2002) and the 
Fragile-X Mental Retardation Protein (FMRP) (Vanderklish and Edelman, 2005; Zalfa et 
al., 2006) function in both localizing and regulating translation of mRNAs. Cytoplasmic 
polyadenylation, and likewise translation, can be regulated in certain mRNAs that contain 
sequence-specific  binding sites for  CPEB.   CPEB is  phosphorylated in an activity-
dependent manner which enhances translation initiation by promoting the recruitment of 
poly(A)  polymerase and causing the  dissociation  of eIF4E from an inhibitory  protein, 
Maskin.  BDNF  may  promote the activity-dependent  polyadenylation  of several  CPE-
containing neuronal RNAs (Du and Richter, 2005; Wu et al., 1998).  
 The translation  of  mRNAs interacting  with the  RNA-binding  protein  Fragile  X 
mental retardation  protein (FMRP)  may also  undergo activity-dependent regulation 
(Brown et al.,  2001;  Miyashiro et al.,  2003).  BDNF  has  been shown to  downregulate 
FMR1 mRNA expression in cultured hippocampal neurons as wel as to decrease FMRP 
protein levels in the  hippocampus  of transgenic  mice  overexpressing  TrkB receptors in 
vivo (Castren et al.,  2002). In addition,  BDNF treatment  has  been reported to  post-
translationaly regulate  FMRP  by activating calcineurin-mediated  FMRP 
dephosphorylation in  hippocampal  neurons (Wang et al.,  2012).  Dephosphorylation  of 
FMRP has been suggested to activate mRNA translation (Ceman et al., 203; Narayanan 
et al.,  2007).  By  decreasing  FMRP levels and  promoting  dephosphorylation  of  FMRP, 
BDNF may induce the translation of a subset of plasticity-related genes. Indeed, BDNF 
treatment elicits an increase in  protein synthesis from several  mRNAs,  CaMKIα,  Arc, 
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Map1B, and  APP, that are  known to  be targets  of  FMRP (Napoli et al.,  2008).  FMRP 
may also  modulate translation  of  mRNAs through interaction  with the cytoplasmic 
FMRP interacting protein 1 (CYFIP1), which binds to eIF4E and forms a complex with 
FMRP-target  mRNAs (Napoli et al.,  2008).  BDNF stimulation in cultured  primary 
hippocampal  neurons and cortical synaptoneurosomes  was shown to  decrease co-
immunoprecipitation  of  CYFIP1 and eIF4E leading to activation  of target  mRNA 
translation (Napoli et al., 2008).  
 Recent evidence indicates that  miRNAs  may  play an important role in the 
capacity of BDNF to selectively regulate specific mRNA targets. miRNAs are smal 22-
24  nucleotide  non-coding endogenous  RNAs that regulate  post-transcriptional 
translational  by  binding to  partialy complementary sites in target  mRNAs.   Perfect 
complementarity of a miRNA seed sequence (miRNA nucleotides 2-8) for the mRNA has 
been shown to  be a strong  predictor  of  miRNA  binding and functional regulation  of a 
given mRNA target (Bartel, 2009; Grimson et al., 2007; Nielsen et al., 2007). Binding of 
an mRNA by a miRNA can lead to translational repression of the mRNA which may be 
accompanied by degradation of the target mRNA.  
 Hundreds of miRNAs are expressed in the mammalian brain and there is strong 
evidence that  brain-specific  miRNAs are crucial for synaptic  plasticity and  neuronal 
function (Bonev et al.,  2011;  Schrat et al.,  2006;  Yu et al.,  2008).   An initial report 
implicating miRNAs in the regulation of protein synthesis by BDNF involved the brain-
specific  miRNA,  miR-134.   miR-134  was found to  negatively regulate  dendritic spine 
size  by inhibiting the translation  of an  mRNA encoding  Limk1 (Schrat et al.,  2006). 
Limk1 mRNA undergoes enhanced translation in response to BDNF (Schrat et al., 2004), 
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and loss  of  Limk1  protein  produces  deficits in spatial learning and  hippocampal  LTP 
(Meng et al.,  2002;  Sarmiere and  Bamburg,  2002).  BDNF  was shown to relieve 
translational suppression  of  Limk1  by inactivating  miR-134 and  permiting increased 
protein synthesis  of synaptic  Limk1 and spine  growth (Schrat et al.,  2006); the 
mechanism by which BDNF relieved miR-134 dependent suppression was not elucidated. 
This study  highlighted the concept that  BDNF could regulate  gene expression through 
altering the function of a specific miRNA to relieve suppression.  
 Additional evidence for reversal  of  miRNA-mediated silencing in  neurons came 
from  Ashraf and coleagues'  demonstration that loss  of an  RNA-induced silencing 
complex (RISC) component,  Armitage, released translational repression  of a synaptic 
mRNA, CaMKI, in drosophila (Ashraf et al., 2006). MOV10, the mammalian homolog 
of  Armitage,  was subsequently shown to  undergo activity-dependent  proteasomal 
degradation that lead to the relief in translational silencing of a several mRNAs (Banerjee 
et al.,  2009).  While  MOV10  degradation  was never explicitly linked to  BDNF, these 
studies  drew atention to the concept that reversal  of  miRNA-mediated silencing could 
present a  mechanism for the regulation  of synaptic  protein synthesis important for 
neuronal  plasticity and  memory formation.   MOV10  degradation  was found to require 
NMDA receptor activation, and  many studies  have  positively linked  BDNF to  NMDA 
signaling. BDNF increases mRNA and protein levels of NMDA receptor subunits NR1, 
NR2A, and NR2B (Caldeira et al., 2007b) and also enhances the phosphorylation of NR1 
and  NR2B in  hippocampal and cortical  neurons (Lin et al.,  1998) which contributes to 
increased glutamatergic transmission (Alder et al., 2005). BDNF also increases the open 
probability  of  NMDAR channels (Levine et al.,  1998;  Levine and  Kolb,  2000). In 
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contrast to  modulation  of  miR-134, the regulation  of  Armitage  or  MOV10  might  be 
expected to produce more 'global', rather than miRNA-specific, changes in relief of mi-
RNA-mediated repression.   While the efects  of loss  of  MOV10  were  not assayed in a 
high-throughput manner, a candidate-based screen did reveal multiple candidate mRNAs, 
including  CaMKIα and  Lypla1, that  underwent enhanced translation  upon loss  of 
MOV10 (Banerjee et al., 2009). 
 
The role of miRNA biogenesis regulation in BDNF signaling 
 Since the discovery of miRNAs twenty years ago (Lee et al., 1993), nuclear and 
cytoplasmic steps have been elucidated which are necessary for the processing of miRNA 
precursors to  mature functional  miRNAs.   Regulatory  mechanisms that impact and 
control the  biogenesis  of  miRNAs at these steps continue to  be revealed.   Given that 
miRNAs are  predicted to regulate  more than  60%  of  mRNAs, the control  of celular 
miRNA composition  holds significant  potential for  post-transcriptional  gene regulation. 
New insights into the efects of BDNF on post-transcriptional regulators, including RNA-
binding  proteins and  miRNAs,  has shed light  on  mechanisms that contribute to the 
specificity  of  BDNF translational control. The  physiological efects  of  BDNF in 
promoting neuronal  growth, survival, and  plasticity arise from selective regulation  of 
mRNA translation; the investigations of myself and others in our laboratory indicate that 
BDNF can achieve this selectivity through  both  positive and  negative regulation  of the 
production of miRNAs (Figure 1.1). As detailed in the folowing chapters, the translation 
of pro-growth or plasticity-related mRNAs is selectively enhanced by BDNF through the 
induction of an RNA-binding protein, Lin28. My thesis work highlights the importance 
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of  Lin28 and its efects on the  Let-7  miRNA family and suggests that the  Lin28/Let-7 
axis may be essential to the physiological impact of BDNF on brain function. 
 
The Lin28 / Let-7 Axis in post-transcriptional control of pro-growth gene expression 
programs 
There is considerable precedence for a prominent role of Let-7 family miRNAs in 
the repression of genes controling growth, proliferation, and pluripotency. In mammals, 
the celular abundance of mature Let-7 miRNAs can be controled, at least in part, in a 
post-transcriptional manner  by  Lin28 (Newman et al.,  2008;  Viswanathan et al.,  2008). 
Lin28 selectively recognizes and binds to pre-miRNAs that contain a ‘GGAG’ sequence 
motif in their terminal loop; this class of precursors includes the Let-7 miRNAs. Lin28 
then recruits a udridinylase, TUT4, which causes uridylation and blocks processing of the 
Let-7 miRNAs leading to a subsequent decline in mature Let-7 miRNA levels which can 
occur through exonuclease action of Dis3l2 (Chang et al., 2013) (Figure 1.2). Lin28 was 
first  discovered in  C. elegans as a  heterochronic  gene and regulator  of  developmental 
timing (Ambros and  Horvitz,  1984;  Moss et al.,  1997). Recent evidence from  genome-
wide association studies (GWAS) indicates that  Lin28  may retain its  heterochronic 
function in  humans and  play a critical role in coordinating  growth and  development. 
Genetic variation near and within Lin28 (LIN28B loci) has been corelated with human 
age at onset of puberty and height (Ong et al., 2009; Pery et al., 2009). Work from the 
Daley lab further substantiated these findings  with transgenic  mice  overexpressing 
Lin28a,  which exhibited increased  body size and  delayed  onset  of  puberty. Increased 
glucose  metabolism and insulin sensitivity,  phenotypes that recapitulated  human 
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developmental traits identified in  GWAS studies,  were also  observed in  mice 
overexpressing Lin28 (He et al., 2009; Letre et al., 2008; Ong et al., 2009; Sulem et al., 
2009; Zhu et al., 2010). Subsequently, Zhu and coleagues showed that Lin28 regulates 
mammalian  glucose  metabolism in an  mTOR-dependent  manner in  part through 
derepression of metabolic genes, including INSR, IGF1R, and IRS2, which are targets of 
Let-7 miRNAs (Zhu et al., 2011). 
 While  Let-7-independent functions for  Lin28 are  known, the role  of  Lin28 in 
managing growth and metabolism is most wel-established through its regulation of the 
Let-7 family  miRNAs that can coordinately repress  many  pro-growth  genes.   As a 
consequence  of these  broad efects,  Let-7 family  miRNAs are  often classified as tumor 
suppressor  genes.   Lin28,  which  blocks  Let-7  miRNA  production, is  believed to  be 
overexpressed in  up to  15  %  of al cancers (Viswanathan et al.,  2009).   Dysregulated 
reduced expression  of  Let-7  miRNAs is frequently found in lung cancer cel lines and 
patient tumor samples, and  Let-7  miRNA  overexpression  has  been  used to inhibit 
proliferation of lung cancer cels (Takamizawa et al., 2004). Other cancers exhibiting low 
levels of Let-7 miRNAs include glioblastoma multiforme, chronic myelogenous leukemia, 
B cel lymphoma,  breast, colon, esophageal,  ovarian, liver,  kidney,  prostate cancer. 
Several studies  have identified  oncogenes including  Ras,  Myc, and  HMGA2, as  Let-7 
targets providing molecular insight into how aberant reductions in Let-7 miRNAs could 
contribute to tumorigenesis (Calin et al., 2004; Johnson et al., 2007; Johnson et al., 2005; 
Kumar et al., 2008; Shel et al., 2007; Yu et al., 2007a; Yu et al., 2008). In healthy tissue, 
a  major role  of the  Let-7  miRNA family is in the control  of target  genes that regulate 
celular proliferation and diferentiation, as required for proper development. Let-7 levels 
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are  progressively elevated  during  development, across many species, and function to 
promote diferentiation and represses self-renewal by decreasing the expression of target 
genes that induce  proliferation and inhibit  diferentiation such as c-Myc,  Pax6,  Ascl1, 
and the transcription factors HBL-1 and DAF-12 (Abrahante et al., 2003; Grosshans et al., 
2005; Lin et al., 2003; Ramachandran et al., 2010; Sampson et al., 2007) Let-7 levels are 
low  or absent in a  variety  of stem cel  or  progenitor cel  populations  of  normal tissue 
(Thomson et al., 2004; Wulczyn et al., 2007). High Let-7 expression is detected late in 
embryonic development and in adult tissues (Sempere et al., 2004; Thomson et al., 2004). 
It is now firmly established that Let-7 functions as a key developmental timing switch in 
the transition from stem cel to diferentiated cel fate across multiple organisms from C. 
elegans to vertebrates. 
 Why might the reduction in  Let-7 family  miRNAs  by  BDNF  have a  profound 
efect  on the translation  of  neuronal  mRNAs containing  binding sites for  Let-7 family 
miRNAs?  This is an interesting consideration,  particularly  given that  miRNAs are 
sometimes viewed as mediators that serve only to fine-tune gene expression. There are 
several reasons  why targeting  Let-7  miRNA levels  may  be  particularly efective in 
alowing BDNF to promote the synthesis of an ensemble of neuronal proteins with roles 
in growth and synaptic plasticity. Several high-throughput studies have been conducted to 
quantitatively assess  brain region-specific  miRNA expression  paterns, and  by  multiple 
approaches the  Let-7 family  of  miRNAs appears to  be  highly abundant in the adult 
mammalian  brain.  A  miRNA  profiling study  using  deep sequencing (Ilumina  Genome 
analyzer)  of  bilateral rat  hippocampal  CA3 regions reported that the  Let-7 family  of 
miRNAs represent nearly 50% of smal RNA sequences (Shinohara et al., 2011). In the 
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adult  mouse frontal cortex and  hippocampus,  miRNA expression  was  quantitatively 
compared using methods of both miRNA-Seq (Ilumina Genome analyzer) and miRNA 
microaray (Afymetrix) (Juhila et al., 2011). This study found that the Let-7 family of 
miRNAs  was colectively  by far the  most abundant class of  miRNAs in  both the 
hippocampus (59%) and frontal cortex (47%).  Remarkably, individual  members  of the 
Let-7 family represented 7 of the 15 most abundant miRNAs in the hippocampus (Juhila 
et al.,  2011).   These studies exemplify  why  mRNAs containing seed-matched sites for 
Let-7  miRNAs  might  be anticipated to  be repressed  by these  miRNAs  under  basal 
conditions, and to  undergo significantly enhanced translation  when a  BDNF stimulus 
leads to relief from miRNA-mediated repression by a substantial and selective decline in 
the highly abundant Let-7 family miRNAs. 
While a foundation of previous research has iluminated the mechanisms of bulk 
regulation  of  protein synthesis  by  BDNF, the first  portion  of  my  doctoral  work has 
focused on how selectivity of BDNF-induced protein synthesis is achieved. My doctoral 
work demonstrates that mRNA transcript selectivity in protein synthesis can be achieved 
through BDNF-mediated control of miRNA biogenesis, and this project wil be discussed 
in chapter two.  The second  bulk  of  my thesis  work investigates  neurotrophin-induced 
regulation  of  Lin28a in  diferentiated tissue and  unveils  key steps responsible for the 
transcription-independent  upregulation  of  Lin28a in  hippocampal  neurons, and these 
findings are described in chapter three. 
 
Note:  During  my  doctoral research, I  have  worked  within and as a leader  of a team 
investigating  diferent aspects  of  miRNA  biogenesis in  mature  neurons.  Contributions 
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that  have  been  made  by  other team  members are  denoted in each figure legend. I 
participated in the  writing  of  publications and in al intelectual aspects  of the  work 






















Figures and Legends 
Figure 1.1 Model of BDNF regulation of mRNA target specificity mediated through  
 
control of miRNA biogenesis 
 
(Left) Dicer and  TRBP process precursor  miRNAs (pre-miRNAs) in  blue and  Lin28-
regulated pre-miRNAs in red into mature miRNAs. These mature miRNAs then go on to 
repress target  mRNAs. (Right)  BDNF stimulation leads to rapid upregulation  of 
Dicer/TRBP,  which enhances  processing  of  pre-miRNAs into  mature  miRNAs.  This 
leads to increased miRNA biogenesis and gene repression and explains why the majority 
of  mRNAs are excluded from translation in response to  BDNF.  BDNF simultaneously 
elevates  Lin28a levels,  which leads to the specific  downregulation  of  Let-7  miRNAs. 
This selectively enhances the translation of a subset of mRNAs that undergo a relief of 






Figure 1.2 Lin28a blocks the processing of mature Let-7 miRNAs 
Lin28a recognizes and  binds to the  GGAG sequence  motif in the terminal loop  of  pre-
Let-7  miRNAs.  Upon  binding to the  precursor  miRNA loop region,  Lin28a recruits a 
terminal  uridyltransferase that leads to the  uridylation  of the  pre-Let-7  miRNA.  This 
blocks processing by Dicer and prevents the biogenesis of mature Let-7 miRNAs. Dis3L2 








Chapter II: Dual regulation of miRNA biogenesis generates target 
specificity in neurotrophin-induced protein synthesis 
 
Background 
The control  of  gene expression at the level  of translation is  vital to  neuronal 
function and synaptic  plasticity.   Dysregulated translation  has  been linked to cognitive 
disorders, including  Fragile  X syndrome,  Autism, and  Parkinson’s  disease.  The 
regulation  of translation  plays a  key role in the  neuronal response to  multiple stimuli, 
including synaptic activity (Huber et al.,  2000;  Raab-Graham et al.,  2006;  Wang et al., 
2009),  depolarization (Schrat et al.,  2004), retinoic acid (Aoto et al.,  2008), and 
neurotrophins (Aakalu et al.,  2001; Jaworski et al.,  2005;  Schrat et al.,  2004).   While 
most of these stimuli enhance total celular protein synthesis, their responses demonstrate 
marked transcript specificity.   This  has  been  best  defined for the  brain-derived 
neurotrophic factor (BDNF), which is broadly expressed in the mammalian brain, plays 
pivotal roles in neuronal survival, structure, and synapse function. The efects of BDNF 
on  protein synthesis,  while  physiologicaly important, are  quite selective  with an 
estimated 4% or less of expressed mRNAs undergoing enhanced translation (Schrat et al., 
2004;  Yin et al.,  2002) despite a  general enhancement  of cap-dependent initiation and 
elongation  by  BDNF (Takei et al.,  2009).   Mechanisms confering specificity to  post-
transcriptional control  of  gene expression are incompletely  defined.   mRNA regulatory 
elements and  binding  proteins  provide significant examples  of control for specific 
transcripts,  but explanations for concerted changes in  groups  of  mRNAs are largely 
lacking.  While subcelular restriction  of stimulus-dependent signals in  neurons likely 
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imparts some transcript selectivity, target specificity remains inadequately explained 
since hundreds of mRNAs populate discrete celular compartments such as dendrites.  
 We suspected that global regulatory mechanisms for mRNA translation, storage, 
or  degradation  might  be enlisted to impart specificity to  BDNF control of  protein 
synthesis.   RNA  processing  bodies (P-bodies  or  GW-bodies) are  RNA  granules that 
depend upon RNA for their formation (Teixeira et al., 2005), and harbor translationaly 
repressed mRNAs that may be degraded or stored and released for subsequent translation 
(Brengues et al.,  2005).  In this  work,  we  demonstrate that  BDNF induces the rapid 
appearance of P-bodies in neurons, and determine that the function of miRNA biogenesis 
pathways is required for  BDNF-mediated regulation  of translation as  wel as the 
induction  of  P-bodies.   Remarkably,  BDNF induces  widespread changes in  miRNA 
biosynthesis through enhancement of the general miRNA processing enzyme, Dicer, and 
elevation  of levels  of  Lin28a, a  protein that  prevents the  processing  of a subset  of 
miRNAs.   The combined action  of  BDNF  on  Dicer and  Lin28a  mediates target-
specificity of BDNF-induced translation by dictating the profile of neuronal miRNAs that 
target mRNAs for translational repression. 
 
Results 
BDNF increases neuronal P-body number 
To investigate whether changes in RNA processing might be induced by BDNF, 
we first used live cel imaging to examine BDNF efects on neuronal P-body abundance 
as a readout  of  potential  broad efects  on  RNA regulatory  mechanisms.   P-bodies  were 
monitored  by expression  of  GFP-tagged  Dcp1a (GFP-Dcp1a), a  decapping enzyme and 
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specific P-body marker (Anderson and Kedersha, 2006) that colocalized with endogenous 
Dcp1a (Figure 2.2A) and other P-body components, including the RNA-binding protein 
GW182 (neuronal  dendrites,  Figure  2.1A;  Figure 2.2A-F).   BDNF-stimulated 
hippocampal  pyramidal  neurons responded  with a rapid and robust increase in the 
number of both dendritic and somatic P-bodies, compared to mock-stimulated neurons, as 
assessed by live imaging of GFP-Dcp1a (Figure 2.1B-D) or endogenous staining (Figure 
2.2G).   Neurons  were  pre-incubated and imaged in the  presence  of the transcription 
inhibitor, Actinomycin-D, indicating that the rapid increase in P-bodies can be mediated 
post-transcriptionaly. BDNF induces P-body complex formation rather than synthesis of 
components since  protein levels  of endogenous  Dcp1a  or  GW182,  or  GFP-Dcp1a  were 
not altered by BDNF (Figure 2.2H), and BDNF enhanced the total co-localization of two 
tagged  P-body components,  Dcp1a and  Pat1b,  without altering their expression (Figure 
2.2F,I).  Immunoprecipitation  of  GW182  demonstrated that  BDNF increased the 
association of P-body components Argonaute 2 (Ago2) and Dcp1a with GW182 (Figure 
2.1E, F) and, as anticipated since P-bodies require RNA for formation, BDNF induced a 
more than two-fold increase in the total co-immunoprecipitated  RNA (Figure  2.1G).  
Exclusion  of ribosomal  protein  S6 (RPS6)  was used to coroborate immunopurification 
purity (Figure 2.1E).   Colectively, these  data show that the formation  of  P-bodies, 
containing  non-translating  RNA targeted for repression  or  degradation, is increased  by 





Loss of GW182 prevents BDNF regulation of target protein synthesis 
Despite  modestly enhancing total celular translation,  BDNF  modulation  of 
protein synthesis is  highly selective  with increases  or  decreases  only in the levels  of 
specific target proteins. To examine whether RNA-processing or repression might factor 
in this target specificity,  we tested the efect  of loss  of  GW182 function  by either 
knockdown  of  GW182  or  by expression  of a  GFP-tagged  dominant  negative  GW182 
(GFP-DNGW182) (Jakymiw et al.,  2005).   Both  manipulations resulted in the los  of 
visible  P-bodies (Figure  2.4A-C), as  previously reported by Jakymiw and coleagues. 
Loss  of  GW182 function  did  not alter the  modest enhancement  of total translation 
mediated  by  BDNF (Figure  2.3A), and also  did  not interfere  with  BDNF-regulation  of 
another pathway, CREB-dependent transcription (Figure 2.4D).  
 In contrast,  GW182  knockdown  or  DNGW182 expression  both strikingly 
eliminated the  mRNA target specificity  of  BDNF-regulated  protein synthesis.   The 
AMPA glutamate receptor subunit GluA1, calcium calmodulin-dependent protein kinase 
I (CaMKIα), and Homer2 normaly undergo enhanced protein synthesis in response to 
BDNF (Narisawa-Saito et al.,  1999;  Schrat et al.,  2004),  while synthesis  of the 
potassium-chloride co-transporter,  KCC2, is  decreased  by  BDNF (Rivera et al.,  2002). 
GW182  knockdown (Figure  2.3B)  or  DNGW182 expression (Figure  2.3C) in 
hippocampal  neurons elevated the  basal levels  of  proteins  normaly  upregulated  by 
BDNF (GluA1, CaMKIα, and Homer2) and prevented their further induction by BDNF. 
In contrast, the  basal  protein level  of  BDNF-downregulated target (KCC2)  was 
unchanged by loss of GW182 function, but KCC2 protein level was no longer reduced by 
BDNF.   b-tubulin II  was  unchanged  by  BDNF and  used for  normalization.   These 
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experiments were performed in the presence of Actinomycin-D; similar efects were seen 
without Actinomycin-D (Figure 2.5). Efective GW182 knockdown was achieved using 
lentiviral transduction and  verified  by imunobloting for GW182 (serum  18033, 
M.Fritzler, Figure 2B, and Abcam Figure 2.4B) 
 Quantitative real time  PCR (RT-qPCR) showed that  mRNA levels  of  BDNF-
upregulated targets were unchanged by loss of GW182 function (Figure 2.4E), suggesting 
that the  observed changes in  basal  protein levels could result from altered target 
translation. As previously reported, BDNF stimulation reduced mRNA levels of the gene 
(SLC12A5) encoding the down-regulated target, KCC2, in control neurons (Rivera et al., 
2002). In neurons deficient in GW182, however, BDNF no longer significantly reduced 
the level  of  mRNA for  KCC2 (Figure  2.4E).   These results indicated that  GW182 
function is required for  both  baseline translational repression  of  BDNF-upregulated 
targets and for  BDNF-induced  mRNA  degradation  of a  downregulated target.   The 
composite efects implied a role for  GW182 in the  process that alows  BDNF to 
diferentialy regulate specific mRNA targets.  
 
The role  of  miRNA-mediated repression in  BDNF regulation  of target  protein 
synthesis 
Several RNA processing events are associated with P-body formation, including 
multiple  RNA  decay  mechanisms,  mRNA suppression  by  RNA  binding  proteins, and 
RISC-mediated repressive functions.   Previous reports  demonstrated that  P-body 
disruption through targeting of discrete P-body protein components, such as GW182, can 
diferentialy block distinct RNA processing events (Liu et al., 2005a). To test whether 
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functions associated with GW182 in particular were required for translational specificity 
of  BDNF,  we compared the efects  of loss  of  GW182  with loss  of another  P-body 
component,  LSm5.   We focused initialy  on assessing  RISC-mediated functions, in 
contrast to decay pathways, since transcript levels of BDNF-upregulated targets appeared 
unchanged  by loss  of  GW182 (Figure  2.4E).  The functions of  miRNA and siRNA 
pathways  were tested  by a reporter assay consisting  of co-expression  of a  hairpin 
precursor shRNA (shCXCR4) and a luciferase reporter containing  3’UTR  binding sites 
with either perfect (siRNA reporter) or mismatched (miRNA reporter) complementarity 
for the  CXCR4 shRNA (Doench et al.,  2003;  Wang et al.,  2006).   Expression  of either 
reporter  without the shRNA exhibited ful luciferase activity (Figure  2.3D); a control 
reporter lacking  CXCR4  binding sites  was  unafected  by shCXCR4 co-expression 
(Figure 2.6). 
 P-body  disruption  by loss  of  GW182 function  produced a  preferential  miRNA 
pathway  deficit, as shown  by failure  of coexpressed shRNA to repress the  miRNA 
reporter, with no efect on siRNA-dependent inhibition (Figure 2.3D).  Loss of GW182 
has  been  previously reported to impair  miRNA-mediated translational repression 
(Jakymiw et al.,  2005;  Liu et al.,  2005a).  In contrast,  P-body  disruption by  LSm5 
knockdown (Figure 2.4F,G)  did  not significantly alter reporter suppression through 
siRNA  or  miRNA  pathways in comparison to controls (shRNA-1, shRNA-2,  or  GFP; 
Figure 2.3D), indicating that these pathways remain intact. 
 The finding that loss  of  GW182,  but  not  LSm5,  disrupted  miRNA-mediated 
repression,  presented the  opportunity to  probe the importance  of  miRNA function in 
determining the specificity  of  BDNF-regulated translation.  In contrast to the loss  of 
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specificity in BDNF-regulated protein synthesis produced by GW182 deficiency (Figure 
2.3B,C), loss  of  LSm5  did  not alter translation specificity (Figure  2.3E) even though 
LSM5 knockdown also disrupted P-bodes (Figure 2.4F,G). LSm5 knockdown, like loss 
of  GW182, also  did  not afect  BDNF-enhancement  of total celular translation (Figure 
2.4H).   Comparing the efects  of loss  of  GW182  or  LSm5 function suggested the 
involvement  of  miRNA-mediated functions in confering target specificity to  BDNF-
regulated protein synthesis. 
 
Rapid enhancement of mature miRNA biogenesis by BDNF 
To further investigate the role  of  miRNA in the specificity  of  BDNF-regulated 
translation,  we asked  whether  BDNF  might itself afect the  miRNA pathway. 
Intriguingly,  BDNF stimulation  of cels co-expressing the shCXCR4 and  miRNA 
reporter greatly enhanced miRNA-mediated suppression.  Titration of shCXCR4 in this 
assay revealed that a low dose that did not suppress the reporter in the absence of BDNF 
generated maximaly efective suppression after celular stimulation with BDNF (Figure 
2.3F). This efect was independent of new transcription as stimulation was caried out in 
the presence of Actinomycin-D. CXCR4 shRNA resembles endogenous pre-miRNA and 
requires Dicer cleavage to generate mature duplex RNA. We reasoned that BDNF could 
enhance  miRNA-mediated repression in the reporter assay  by two  potential  general 
mechanisms:  first, BDNF might increase the eficacy of the RISC complex or, second, 
BDNF  might increase the  generation  of functional  mature  duplex  miRNA from 
transfected  CXCR4 shRNA.   A  mechanism invoking  BDNF-enhanced  mature  miRNA 
biogenesis was congruent with our earlier findings since elevated levels of miRNA can 
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deliver additional  mRNAs targeted for repression to  P-bodies and increase  P-body 
number (Liu et al., 2005b). 
 We addressed the potential for global regulation of miRNA biogenesis by BDNF 
using miRNA arays that selectively measure mature miRNA, as opposed to pre-miRNA. 
Hippocampal  neurons  were treated  with  BDNF for  30  min in the  presence  of 
Actinomycin-D to assess changes due to processing of existing pre-miRNAs rather than 
new pre-miRNA production. Each aray (TaqMan) contained 375 rodent miRNA targets 
of which 195 were detectable in hippocampus in three independent paired experiments. 
Remarkably,  of  detectable endogenous  miRNAs  with levels significantly altered  by 
BDNF,  89.4%  were increased  more than  2-fold  by  BDNF,  while  only  10.6%  were 
decreased to <  50% (Figure  2.7A, left  panel).  Many  more  miRNA species showed 
smaler, less than 2-fold, postranscriptional changes in abundance in response to BDNF. 
While absolute changes in individual  miRNAs  were  not reproducible  between  paired 
aray experiments, the qualitative efect of a predominantly increased abundance of many 
miRNA species in response to  BDNF  was reproducible  on this  platform as  wel as an 
initial analysis  using  Geniom  miRNA  biochips (Febit Inc.,  data  not included).  An 
expression analysis  of fold change for each  detectable  miRNA species from the arays 
ilustrates an overal trend toward higher miRNA quantities in BDNF compared to mock-
treated primary neurons (Figure 2.7A, right panel). 
 Widespread  post-transcriptional  upregulation  of  mature  miRNA  production 
suggested that BDNF might regulate an essential component of miRNA biogenesis, such 
as the  Dicer  processing complex.   To assess this,  we examined  Dicer  protein levels in 
BDNF-stimulated  neurons.   BDNF elicited a  marked transcription-independent increase 
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in  Dicer levels that  peaked  between  5 – 20 min after stimulation (Figure  2.7B).   The 
binding  of  BDNF to  TrkB receptors triggers signaling  pathways  promoting  growth and 
survival, including activation of PI3K/AKT and MAPK/ERK pathways.  Previous work 
in tumor cel lines revealed that a component of the Dicer complex, HIV-1 TAR RNA-
binding  protein (TRBP), could  undergo  Erk-dependent  phosphorylation and that 
phospho-mimetic  TRBP stabilized and enhanced  Dicer levels (Paroo et al.,  2009); 
mutations resulting in decreased TRBP protein also destabilize Dicer (Melo et al., 2009). 
Accordingly,  we evaluated the efect  of  BDNF  on  TRBP levels and  phosphorylation 
status in neurons. BDNF rapidly induced phospho-ERK and a multiple-banding patern 
of TRBP (Figure 2.7C, upper panel) that was colapsed by phosphatase treatment (Figure 
3C, lower  panel).   Total  TRBP  protein levels  were also rapidly elevated and reached 
significance by 5 min after BDNF (2.61 fold increase +/- 0.86 ). 
 To evaluate a requirement for  Dicer activity and  miRNA  biogenesis in  BDNF-
induced recruitment of non-translating mRNA to P-bodies, we depleted Dicer by RNAi. 
Dicer  knockdown completely  prevented a  BDNF-induced increase in  P-body  numbers 
(Figure 2.7 D, E) in hippocampal pyramidal neurons.  Neurons expressing control non-
target shRNA responded to  BDNF similarly to  wildtype  neurons (Figure  2.7E,  Figure 
2.1D).   The requirement for  Dicer in  BDNF induction  of  P-bodies indicated a role for 
Dicer in targeting some mRNAs to the non-translating pool in response to BDNF. 
 We next asked whether Dicer activation, and by implication an increase in mature 
miRNAs, was suficient to generate P-bodies in neurons. The fluoroquinolone, enoxacin, 
was  previously shown to  promote  pre-miRNA  processing  by the  Dicer/TRBP complex 
while a structuraly similar  derivative,  oxolinic acid,  did  not significantly increase 
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miRNA biogenesis(Shan et al., 2008). Enoxacin, but not equimolar oxolinic acid, rapidly 
and robustly increased P-body numbers in neuronal soma and dendrites (Figure 2.7F). In 
comparison to BDNF, the time course of P-body induction by enoxacin was slightly more 
rapid, consistent with a more direct signaling mechanism. In accordance with a role for 
miRNA in regulating mRNA target selection, but not bulk translation, enoxacin did not 
alter basal or BDNF-induced total protein synthesis (Figure 2.6B). These results defined 
a potential mechanism for regulation of miRNA biogenesis by BDNF and linked BDNF-
upregulation of Dicer activity to rapid changes in mRNA repression.  
 To test  whether  Dicer is also required for the regulation  of  BDNF-target  genes, 
we examined the response of representative up- and down-regulated BDNF targets in the 
presence  or absence  of  Dicer.   Hippocampal  pyramidal  neurons from  mice  with a 
conditional Dicer alele (Dicerflox/flox,  3A8 line) (Andl et al.,  2006) were infected  with 
lentivirus expressing  4-hydroxy tamoxifen (OHT)-inducible  Cre recombinase and 
subsequently  mock- or  BDNF-stimulated  with  or  without  OHT.   Targets that are 
normaly low at  baseline and upregulated by  BDNF, including  GluA1,  CaMKIα, and 
Homer2, were each elevated at baseline in Dicer-deficient neurons, consistent with basal 
de-repression in the absence of Dicer, and failed to be further upregulated by BDNF. A 
representative target  normaly downregulated by  BDNF,  KCC2,  was  non-responsive to 
BDNF in Dicer-deficient neurons (Figure 2.7G). Colectively, these results demonstrate 
that  BDNF lacks specificity for  up- or down-regulated targets in the absence  of  Dicer, 
consistent with a critical role for Dicer in BDNF-induced sequestration of mRNAs in P-
bodies and in the  mechanism  determining the selective regulation  of target  mRNAs  by 
BDNF.  
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BDNF confers selectivity to miRNA biogenesis through Lin28a 
Widespread  upregulation  of  miRNA  production and consequent removal  of 
mRNAs from the translating  pool  by targeted repression  provides a  viable negative 
selection mechanism to account for the low  proportion  of  mRNAs reported to undergo 
BDNF-enhanced translation (Schrat et al.,  2004).   We  next asked  whether the  miRNA 
biogenesis  pathway  might also  be regulated to  generate positive selection of  BDNF-
upregulated targets in  protein synthesis.  By  miRNA aray analysis, a smal  number  of 
miRNAs  were  observed to  decrease in response to  BDNF; the  decreases  were  more 
apparent in some individual experiments than in the colective averaged aray  data. 
Among these  decreased  miRNAs  were several  members  of the  Let-7 family.   miRNA 
biogenesis can be regulated at multiple steps by trans-acting factors, including the Lin28 
RNA-binding proteins (Heo et al., 2009; Newman et al., 2008; Viswanathan et al., 2008) 
which target  Let-7 family  members.   Lin28  binding and subsequent  pre-miRNA 
uridylation suppresses processing of targeted pre-miRNA to mature miRNA (Hagan et al., 
2009;  Heo et al.,  2009), and could  provide a  mechanism for decreasing select  mature 
miRNAs even in the context  of  Dicer elevation.   Consistent  with this  possibility,  we 
found a robust and rapid transcription-independent increase in  Lin28a,  but  not  Lin28b, 
protein in mature neurons by 5 min folowing BDNF exposure (Figure 2.8A).  
Analysis  of the terminal loop region  of the  Let-7,  miR-107, and  miR-143  pre-
miRNAs showed that each has a putative or previously functionaly confirmed ‘GGAG’ 
sequence  motif that can  permit recognition  by  Lin28 (Hagan et al.,  2009;  Heo et al., 
2009). Individual  RT-qPCR assays showed significant and reproducible  BDNF-induced 
decreases in abundance  of al tested  members  of the  Let-7 family, as  wel as  miR-107, 
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and miR-143 (Figure 2.8B), even though not al were reproducibly detected through the 
less sensitive  miRNA arays.   Significant  decreases in each  of these  miRNAs  were 
apparent  by  5  min post-BDNF stimulation (Figure  2.8B).  In accordance  with the 
expected efects  of  Lin28,  Northern  bloting for a member  of the  Let-7 family (Let7-a) 
showed significant decreases in both pre-Let7 and mature Let-7 miRNA levels in BDNF-
treated neurons (Figure 2.8C). A control mature miRNA, miR-17, is modestly increased 
by BDNF, consistent with enhanced Dicer processing (Figure 2.8C). 
If  Lin28  positively selects  BDNF-upregulated targets  by  decreasing specific 
miRNAs, an  mRNA containing functional  binding sites for a  Lin28-downregulated 
miRNA  would  be  predicted to  undergo  BDNF-enhanced translation.   To test this 
prediction,  we compared the response to  BDNF  of luciferase reporters  whose  3’UTR 
contained either wildtype or mutated Let-7 miRNA binding sites, or no miRNA binding 
sites,  under conditions  of transcription  blockade.   As  predicted, the reporter containing 
Let-7  binding sites  was significantly induced  by  BDNF,  while levels  of the control 
reporters  were  unchanged (Figure  2.8D).   This result indicates that  downregulation  of 
Let-7 family members by BDNF is suficient to relieve repression and mediate positive 
target selection for BDNF-enhanced translation.  
To examine the extent to which this mechanism could generalize to known BDNF 
targets,  we evaluated the  presence  of  binding sites for  Lin28-regulated  miRNAs in the 
3’UTRs  of  mRNAs  known to  undergo  upregulated,  downregulated,  or  unchanged 
translation in response to  BDNF.   Positive scores (pink  boxes, (Figure  2.8E)  were 
restricted to sites in  which the  miRNA seed sequence (nucleotides  2 - 7)  paired as a 
perfect  or  G-U  wobble-containing  match; similar  miRNA seed sequence pairing  was 
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previously found important for target recognition (Guo et al.,  2010).   Thirteen 
representative BDNF-upregulated targets were al found to contain two or more sites for 
a  Lin28-regulated  miRNA (example sites in  Figure  2.11),  while targets  known to  be 
downregulated by BDNF (KCC2, KV1.1) (Raab-Graham et al., 2006; Rivera et al., 2002) 
or  unregulated  by  BDNF (eEF1A, eIF4E,  MAP2, β-tubulin II) (Schrat et al.,  2004; 
Wang et al., 2009) did not contain such sites (Figure 2.8E).  
We  next  directly tested the role  of  Lin28a in  BDNF target  mRNA selection. 
Depletion of Lin28a through RNAi, but not expression of a control hairpin, prevented the 
decline in  mature  Let-7  miRNAs in  hippocampal  neurons responding to  BDNF (Figure 
2.9A).   Lin28a  knockdown also  prevented the increased translation  of representative 
mRNA targets normally upregulated by BDNF (Figure 2.9B). In accordance with basal 
mRNA repression by miRNAs that are diminished through Lin28, protein levels of these 
normaly  upregulated targets (CaMKIα,  GluA1, and  Homer2) remained at low  basal 
levels even in the presence of BDNF under Lin28a knockdown conditions (Figure 2.9B, 
left and top right panels). Lin28a knockdown did not prevent the increased association of 
P-body protein and RNA components in response to BDNF (Figure 2.9C), which instead 
requires Dicer (Figure 2.7). 
 Targets  normaly  de-repressed and  upregulated  by  BDNF remained repressed in 
Lin28a-deficient neurons, in contrast with the efects of loss of GW182 (Figure 2.3B,C) 
or Dicer (Figure 2.7G) which both resulted in de-repression of BDNF-induced targets at 
baseline and  occlusion  of further  upregulation  by  BDNF.   Notably, targets  normaly 
downregulated  by  BDNF, represented  by  KCC2 and  KV1.1, remained responsive to 
BDNF in the  presence  of  Lin28a  knockdown.   BDNF efects  on target  mRNA levels 
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were unafected by loss of Lin28a (Figure 2.9B, botom right panel). These findings are 
consistent with translation specificity in response to BDNF being generated by a two-part 
regulation  of the  miRNA biogenesis  pathway:  1)  general  upregulation  of  miRNA 
biogenesis that is required for repression  of  mRNAs  whose  protein  products are 
decreased in response to BDNF, 2) downregulation of select miRNAs whose processing 
is  blocked  by the  BDNF-induced  Lin28a, resulting in  de-repression and enhanced 
translation of mRNAs containing binding sites for Lin28-regulated miRNAs. 
 We further examined the role  of  Lin28a in  BDNF-regulated translation  by 
evaluating its efects  on specific target  mRNA repression in association  with  GW182. 
GW182-associated RNA was immunopurified, as in Figure 1E, under control shRNA and 
Lin28a knockdown conditions and the efects of BDNF on mRNA recruitment to GW182 
were assessed by individual RT-qPCR assays. mRNAs undergoing regulated translation 
were enriched in  overal association  with  GW182 in comparison to a ‘housekeeping’ 
GAPDH mRNA (Figure  2.9D).   Under control shRNA conditions,  BDNF reduced the 
GW182-association of representative mRNAs for targets whose translation is upregulated 
by  BDNF (GluA1,  CaMKIα, and  Homer2); in contrast,  BDNF  promoted the  GW182-
association of representative mRNAs for targets (KCC2 and Kv1.1) whose translation is 
downregulated  by  BDNF (Figure  2.9D).   Translation  of  mRNA for b-tubulin II is 
unchanged by BDNF (Schrat et al., 2004) and was used for normalization; 18s rRNA is 
absent from P-bodies and served as a control for immunopurification purity (Figure 2.9D). 
 As expected if  Lin28 regulates  only selection  of  BDNF-upregulated targets, 
Lin28a  knockdown altered  only the  GW182 enrichment  profile  of  mRNAs for 
representative targets (CaMKIα,  GluA1, and  Homer2) that  undergo  BDNF-enhanced 
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translation (Figure 2.9D). mRNAs for BDNF-upregulated targets remained equivalently 
repressed and associated with GW182 in Lin28a knockdown neurons in the presence or 
absence of BDNF, and protein levels of these targets were no longer enhanced by BDNF. 
In contrast, mRNAs for representative BDNF-downregulated targets (KCC2 and Kv1.1) 
remained enriched in association  with  GW182 at  baseline and their enrichment  was 
equivalently increased by BDNF in both control and Lin28 knockdown neurons (Figure 
2.9D).   A target  not regulated  by  BDNF (GAPDH)  was  not enriched in  GW182-
association at baseline, did not change in response to BDNF, and was also unafected by 
Lin28 loss (Figure  2.9D).   These findings indicate that  Lin28a, induced  by  BDNF, is 
required to suppress the  processing  of specific  pre-miRNAs and selectively  decrease 
levels of these mature miRNAs, concomitant with a general BDNF-induced upregulation 
in the biogenesis of most miRNAs by enhanced Dicer levels. The negative regulation of 
miRNA  biogenesis  by  Lin28  presents a  mechanism for the selection  of  upregulated 
targets in BDNF-induced protein synthesis.  
To further test the  mechanism  by  which  Lin28  mediates induced translation  of 
BDNF-upregulated targets, we constructed a Let-7 pre-miRNA that would be resistant to 
Lin28-mediated degradation through mutation of the pre-miRNA terminal loop residues 
from  GGAG to  GUAU.   This  mutation  prevents  Lin28-induced  uridinylation and 
degradation  of  Let-7  pre-miRNA (Heo et al., 2009),  but  does  not alter the target 
specificity of the Let-7 miRNA. Lentiviral-mediated expression of either wildtype (Let-
7WT) or Lin28-resistant Let-7 (Let-7LR) in hippocampal cultures enhanced mature Let-7 
levels in a  dose-dependent  manner that could be titrated to achieve equivalent and low 
levels  of exogenous  Let-7 expression (Figure  2.10A).   Co-expression  of  Let-7LR with 
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reporters harboring the 3’UTR from either of two BDNF-upregulated targets (GluA1 or 
CaMKIα) completely prevented their induction by BDNF. In contrast, co-expression of 
Let-7LR with a reporter  harboring the  3’UTR from a  BDNF-downregulated target 
(KCC2) had no efect on the BDNF-mediated depression of this reporter (Figure 2.10B). 
These results supported a selective role for Lin28 in mediating the specificity of BDNF 
for its upregulated targets. 
 While alternative mechanisms for selectivity could co-exist, our colective results 
strongly indicate that dual control by BDNF of the miRNA biogenesis pathway through 
Lin28a and Dicer criticaly contributes to determining both up- and down-regulated target 
specificity in  BDNF-mediated  protein synthesis.   These findings  prompted  us to 
investigate the efects  of loss  of  Lin28a  on a  physiological response requiring  BDNF-
regulated protein synthesis. 
 
Loss  of  miRNA-mediated regulation  prevents  BDNF-enhanced  dendrite 
arborization 
Induction of dendrite outgrowth in excitatory neurons both in culture and in-vivo 
is a wel-characterized BDNF function requiring the regulation translation (Jaworski et al., 
2005).  Since inhibiting new translation blocks BDNF-induction of dendrite growth, we 
reasoned that  BDNF-upregulated targets, selected  by  Lin28,  might  be  particularly 
important for this  process.   We tested the  physiological relevance  of selective  mRNA 
translation  by release from  Lin28-targeted  miRNAs  using low-dose  BDNF to stimulate 
proximal dendrite growth in developing hippocampal pyramidal neurons expressing Let-
7LR, or Let-7WT as a control. Based on our previous results (Figures 2.9, 2.10A,B) and 
 33	  
the  distribution  of sites for Lin28-targeted  miRNAs (Figure  2.8E,  2.9),  Let-7LR 
expression could be expected to function as a dominant negative to repress mRNA targets 
despite  BDNF-mediated elevation  of  Lin28.   Analysis  of  dendrite complexity 
(experimental methods), showed that Let-7LR expression prevented BDNF enhancement 
of  dendrite  outgrowth (Figure  2.10C),  without significantly altering  basal  dendrite 
complexity (mock condition) in comparison to control  neurons expressing either  Let-
7WT (Figure 2.10C) or GFP (Figure 2.12B, p = 0.78, one-way ANOVA), or cel soma 
size and total  dendritic length,  which  were also  unaffected  by  BDNF (Figure  2.10D). 
Loss  of  GW182 function,  which would  be expected to inhibit  miRNA-mediated 
repression  by  both  Lin28-regulated and  non-Lin28-regulated  miRNAs, also  prevented 
BDNF-induced  dendrite  growth  without altering  basal  dendrite complexity  or total 
protein synthesis (Figures  2.12,  2.3A).   These experiments  highlight the importance  of 
miRNA-mediated target selection in a  neuronal response to  BDNF requiring the 
induction  of  protein synthesis.   We conclude that  Lin28-induced  degradation  of  pre-
miRNAs is specificaly required for the appropriate specification  of  mRNA targets for 




The capacity to rapidly alter the abundance of efector proteins through regulating 
translation is critical to the biological actions of multiple stimuli. However, the pathways 
that  mediate stimulus-dependent selection  of specific  mRNAs for enhanced translation 
have remained poorly understood. We have defined a novel coordinated mechanism for 
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genome-wide control of translation specificity that involves stimulus-dependent positive 
and negative regulation of miRNA biogenesis (model, Figure 2.13).  We provide direct 
evidence that  BDNF achieves translation target specificity  by elevating levels  of  both 
Dicer and Lin28a proteins in a rapid and transcription-independent manner. The resultant 
action  of  Dicer and  Lin28a  on the celular  profile  of  miRNAs in response to  BDNF 
efectively  determines  which  mRNAs  wil  participate in translation  or  be excluded 
through GW182-associated repression. 
 Our results  provide the folowing insights into specificity for  BDNF  up- and 
down-regulated protein synthesis: First, upregulation of an mRNA’s translation by BDNF 
requires the target  mRNA to  be repressed and enriched in association  with  P-body 
component GW182 under basal conditions. Interference with Dicer or GW182 function 
prevents this  basal repression and therefore  occludes stimulus-dependent induction  of 
translation.   Second, interference  with  Dicer  or  GW182  blocks the  downregulation  of 
target  mRNA translation  by  BDNF.   Third, the  presence  of seed-matched sites for a 
Lin28-regulated miRNA within the 3'UTR are predictive of an upregulated BDNF-target 
mRNA.  Interference with selective Lin28-mediated pre-miRNA degradation blocks the 
induction of targets upregulated by BDNF.  Fourth, the stimulus-induced association of 
an  mRNA  with  GW182 is reciprocaly related to its level  of translation.   BDNF 
diminishes the GW182 association of mRNA for translationaly upregulated targets and 
enhances the GW182 association for downregulated targets. 
 Colective evidence indicates that  GW182 interaction  with  miRNAs and  RISC 
components can trigger the formation  of  P-bodies as sites  where repressed  mRNAs 
accumulate (Eulalio et al., 2007; Liu et al., 2005b). It seems plausible that the miRNA-
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dependent repression induced by BDNF typicaly employs P-bodies, consistent with the 
striking  Dicer-dependent increase in  P-body  number in response to  BDNF.   However, 
loss of visible P-bodies by LSm5 knockdown produced no apparent interference with the 
specificity of BDNF-induced protein synthesis, and our data could also be consistent with 
a model in which the mRNA repression does not occur in P-bodies per se, but elsewhere 
in a GW182- and miRNA-dependent manner. 
 BDNF-induced repression  of  mRNAs involves the rapid  Dicer-dependent 
appearance of P-bodies in neuronal cel soma and dendrites that can occur independently 
of new transcription and, as reported in other cel types (Teixeira et al., 2005) appears to 
result from coalescence  of existing  P-body components.   Consistent  with these results, 
both Dicer and pre-miRNAs are present in dendrites and isolated synapses (Lugli et al., 
2008), suggesting that traficking  might  not  be required for rapid responses;  whether 
BDNF regulates  neuronal  miRNA  biogenesis  on a subcelular level remains to  be 
investigated. 
 Recent work indicates that many miRNAs can turnover more quickly in neurons 
than in other cel types. miRNAs from brain or from hippocampal cultures have variable 
estimated half-lives of 0.5 – 6 hr (Krol et al., 2010; Sethi and Lukiw, 2009), compared 
with half-lives ≥ 24 hr in non-neuronal cels. This property might alow degradation of a 
pre-miRNA species in neurons to rapidly lower the coresponding mature miRNA level, 
as supported  by  our finding  of rapid  Lin28-mediated  decline in  mature  Let-7  miRNAs. 
When  miRNA  precursors are  not  depleted  by  BDNF-induced  Lin28, the available 
precursors (i.e. pri- and pre-miRNAs) appear sufficient to replenish mature Let-7 levels 
even when transcription is blocked for 1 – 2 hr. 
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 miRNAs have been reported to repress target mRNA by inhibition of translation 
or  by  degradation.   We  observed  miRNA-dependent  degradation  of target  mRNA for 
representative mRNA targets that underwent decreased translation in response to BDNF; 
these findings are consistent with studies citing mRNA destabilization as a predominant 
source of miRNA-dependent reductions in protein (Guo et al., 2010; Hendrickson et al., 
2009).   However,  our  data also suggest that  miRNAs can function  by translation 
suppression in  neurons  under  basal conditions.   Specificaly,  BDNF-upregulated targets 
were repressed and associated  with  GW182  prior to  BDNF stimulation.   Disruption  of 
this  basal repression (by  deficiency  of  GW182  or  Dicer) increased  protein  production 
from  BDNF-upregulated targets  with  no  detectable elevation  of their  mRNA levels, 
consistent with reports of miRNA function by inhibition of translation (Chendrimada et 
al., 2007; Mathonnet et al., 2007; Petersen et al., 2006). In addition to its established role 
in tuning  protein levels,  our  data  highlight a role for  miRNA-mediated repression in 
determining the specificity of stimulus-induced protein synthesis through both translation 
inhibition and mRNA degradation. 
 Mammalian Lin28 is reported to be downregulated during development with litle 
or no expression in diferentiated cels such as neurons (Moss and Tang, 2003). Our data 
similarly indicate low  basal  Lin28 expression in  mature  neurons,  but show that  BDNF 
induces rapid transcription-independent  upregulation  of  Lin28a,  which alters levels  of 
Lin28-targeted miRNAs and might also perform additional functions. Lin28 expression 
has been associated with oncogenesis and, in conjunction with other modulators, can also 
induce pluripotent stem cels from diferentiated tissues (Viswanathan et al., 2009; Yu et 
al.,  2007b).   This  underscores the concept that the reprogramming  of  gene expression 
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accompanying  both  neoplastic transformation and induced  pluripotency states  may, at 
least in  part,  be additionaly shared  by the induction  of  plasticity in the adult  nervous 
system.  
 Colectively,  our  data indicate that  miRNA  biogenesis  undergoes  dynamic  post-
transcriptional regulation in  neurons to impart  mRNA selection for  BDNF-dependent 
protein synthesis.   Our findings also reveal a role for  mRNA repression in association 
with the P-body component GW182 in confering specificity to basal as wel as stimulus-
dependent translation through miRNA-dependent regulation. It is likely that other stimuli 
use distinct or overlapping regulatory mechanisms in the miRNA biogenesis pathway to 















Figures and Legends 
Figure 2.1 BDNF increases P-body formation in soma and dendrites of hippocampal 
neurons. 
(A)  Endogenous  GW182 (top  panel, red) colocalizes  with  GFP-Dcp1a (middle  panel, 
green) in neuronal dendrites; overlay (botom panel). (B) P-body formation in dendrites 
of hippocampal  pyramidal  neurons folowing  mock- (top  panels)  or  BDNF-stimulation 
(botom panels, 100 ng/mL).  (C) P-body formation in cel somas folowing mock- (top 
panels)  or  BDNF-stimulation (botom  panels). t  =  min  post-stimulation.  (D) 
Quantification and time course  of  percent change in  GFP-Dcp1a  P-body  numbers in 
neuronal dendrites folowing mock- (open circles) or BDNF-stimulation (closed circles) 
in the presence of Actinomycin D (0.5 µg/ml) to isolate changes due to translation. * = 
p<0.05  by  one-way  ANOVA  with  Bonferoni corection. (E)  Lysates from  mock (-)  or 
BDNF (+,  1  hour) stimulated  neuronal cultures immunoprecipitated (IP)  with  GW182 
antiserum (IP-GW) or isotype-control serum (IP-Ctrl). Input is 20% of IP’d protein. (F) 
Densitometric quantification from 9 independent experiments, as in (E); mock condition 
(open bars) set as 1.0. (G) Total RNA, measured by A260, recovered by GW182 IP from 
equal lysate inputs; mock (open bar) set as 1.0. BDNF increased GW182-associated RNA 
2.62 ± 0.29 fold. Al eror bars represent SEM. * = p<0.05 by unpaired Student’s t-test. 
Scale bars represent 10µm.  
The experiments  performed in A  of this figure were  performed  by  Elizabeth  Eyler and 
also published in her thesis; E-G were performed by Alvin Huang and also published in 









Figure 2.2 Composition of neuronal P-bodies. 
Endogenous Dcp1a (top panel, red) colocalizes with GFP-Dcp1a (middle panel, green) in 
a confocal projection of hippocampal pyramidal neuron dendrites. Botom panel, overlaid 
image. (B)  mChery-tagged  Dcp1a (top  panel, red) colocalizes  with  GFP-tagged  Ago2 
(middle  panel,  green) in a confocal  projection. Botom  panel,  overlaid image. (C) 
Endogenous Rck/p54 (top panel, red) colocalizes with endogenous GW182 (middle panel, 
green) in a confocal projection.  Botom  panel,  overlaid image. (D)  Consistent  with the 
lack of translation in P-bodies, endogenous ribosomal RNA, stained with Y10b (top panel, 
red)  does  not colocalize  with  GFP-tagged  Dcp1a (middle  panel,  green) in dendrites  of 
hippocampal  pyramidal  neurons.  Botom  panel,  overlaid image. Images shown are a 
single confocal slice to  beter appreciate co-localization given the relatively larger 
volume of Y10b staining. Inset: enlarged view of imaged region in dashed box, showing 
Y10b  puncta closely  opposed to  but  not colocalizing  with  GFP-Dcp1a  puncta. (E) 
mChery-tagged  Dcp1a (top  panel, red) does  not colocalize  with  GFP-tagged  Staufen 
(middle  panel,  green) in confocal projections from  dendrites  of  hippocampal  pyramidal 
neurons. Botom panel, overlaid image. Inset: enlarged view of imaged region in dashed 
box, showing GFP-Staufen surounding but not colocalizing with a GFP-Dcp1a puncta. 
(F) EBFP2-tagged  Dcp1a (BFP-Dcp1a; top  panel,  blue) colocalizes  with  YFP-tagged 
Pat1b (YFP-Pat1b;  middle  panel,  green).  Scale  bar represents  10 µm in al images. 
Images are confocal z-stack projections unless otherwise indicated. (G) Immunostaining 
of endogenous  P-bodies  with anti-GW182 antibody shows a high  variability in  basal 
dendritic P-body number that is colectively and on average shifted to greater numbers of 
P-bodies in  BDNF-stimulated  neurons. Scater  plot  of endogenous  P-body  numbers in 
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individual  neuronal  dendrites from distinct  pyramidal  neurons  quantified from  GW182 
immunostaining  75  min after mock- (open circles)  or  BDNF-stimulation (filed circle). 
Bar represents mean. Mean values ± SEM are 11.36 ± 1.21 (mock), 15.48 ± 1.26 (BDNF), 
p < 0.05 by Student’s t-test. (H) Left: Immunoblot showing GFP-Dcp1a and endogenous 
Dcp1a and  GW182  protein levels folowing  45  minutes  mock (-)  or  BDNF (+) 
stimulation.  Right:  Relative  quantification  of  protein levels  normalized to β-tubulin II. 
(I) BDNF rapidly enhances the colocalization of P-body components by increasing their 
recruitment to P-bodies, rather than by altering their synthesis. Top panel: The fraction of 
total fluorescence of two co-expressed P-body markers, YFP-Pat1b and BFP-Dcp1a, that 
co-localized was quantified from hippocampal dendrites imaged before and after BDNF 
stimulation  using the spots function and co-localize spots tool in Imaris software 
(Bitplane).  The fraction of colocalized fluorescence  within a  dendritic segment  was 
calculated for each  P-body component  by first summing the aggregate fluorescence 
values that co-localized with the other P-body marker, then dividing this quantity by the 
value of the total fluorescence intensity  within the  dendrite for that channel, and 
multiplying  by  100.  The  percent  of the total fluorescence that colocalized  was 
significantly increased for both YFP-Pat1b and BFP-Dcp1a by BDNF (hatched bars) but 
not mock (checkered bars) stimulation. Middle panel: The degree of colocalization within 
a  given  P-body is  not changed  by  BDNF stimulation.  While the total amount  of 
fluorescence found in  P-bodies  was increased  by  BDNF for both  YFP-Pat1b and  BFP-
Dcp1a, P-bodies always demonstrated a high degree of co-localization for the two P-body 
markers that  was  not significantly altered  by BDNF.  Percent colocalization  within  P-
bodies  was calculated  by  measuring the amount  of fluorescence  of  YFP-Pat1b  or  BFP 
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Dcp1a that co-localized  within defined  P-body  punctae,  dividing this  by the aggregate 
fluorescence  value  within al  defined  P-body  punctae, and  multiplying  by  100.  Botom 
panel: Total fluorescence of YFP-Pat1b or BFP-Dcp1a within dendritic segments did not 
significantly change during mock (checkered bars) or BDNF (hatched bars) stimulation. 
Eror bars represent SEM. * = p < 0.05 by unpaired Student’s t-test. 
The experiments performed in A-C and E of this figure were done by Elizabeth Eyler and 























Figure  2.3 miRNA-mediated repression is enhanced  by  BDNF  and  associated  with 
BDNF target specificity. 
(A)  Loss  of  GW182 function  by shRNA targeting  GW182 (GW182KD)  or  GFP-
DNGW182 expression does not alter BDNF-enhancement of aggregate protein synthesis 
relative to control (uninfected) cels,  or cels expressing scrambled  GW182 shRNA  or 
GFP alone.   Total  protein synthesis  was  monitored  under  mock (open  bars)  or  BDNF 
(hatched bars, 100 ng/ml, 2 hr) stimulated conditions, and ploted relative to the control 
mock condition set as 1.0 (first open bar). A translation inhibitor (rapamycin, 20 µg/ml) 
demonstrates that observed changes are due to translation. (B) Left: Immunobloting for 
BDNF target proteins in neurons either uninfected or infected with lentivirus expressing 
GW182 shRNA (GW182KD) or a mismatched control shRNA (sh-Control-1). mChery 
is co-expressed from the  virus.   Right:  Protein levels,  normalized to  b-tubulin,  of 
representative  BDNF-upregulated targets  under  mock- (open  bars)  or  BDNF- (hatched 
bars, 100 ng/ml, 2 hr) stimulation in the presence or absence of GW182KD (control mock, 
white  bars, set as  1.0);  n  =  6 independent experiments. (C)  Left: Immunobloting for 
BDNF target proteins in neurons either uninfected or infected with lentivirus expressing 
GFP-DNGW182  or  GFP.   Right:  Protein levels,  normalized to  b-tubulin,  of 
representative BDNF up- or down-regulated targets under mock (open bars) and BDNF 
(hatched bars) stimulated conditions in cels expressing GFP-DNGW182, GFP, or control 
uninfected cels (control  mock,  white  bars, set as  1.0);  n  =  6 independent experiments. 
(D)  miRNA function is inhibited  by  GW182KD and  GFP-DNGW182  but  not  by 
knockdown  of  LSm5 (LSm5KD).  Left: luciferase activities  of siRNA- or  miRNA-
reporter constructs in cels expressing reporter alone (- sh-CXCR4),  or co-expressing 
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reporter and  CXCR4 shRNA (+ sh-CXCR4),  with  or  without  GW182KD,  GFP-
DNGW182,  or  LSm5KD.   Normalized luciferase  values are shown relative to levels 
without sh-CXCR4 (set as  1.0).   Right:  Diagram  of reporter constructs. (E)  LSm5 
knockdown  did  not alter  protein synthesis  of representative  BDNF targets.  Left: 
Immunobloting for  BDNF targets in  neurons expressing control shRNA (sh-Control-2) 
or shRNA against LSm5 (LSm5KD) folowing mock (-) or BDNF (+) stimulation (100 
ng/ml,  2  hr).  Right:  Densitometric  quantification  of  3 independent immunoblots, 
normalized to  GAPDH and  ploted relative to  mock-stimulated controls (sh-Control-2 -
mock). (F) BDNF enhances repression of a miRNA-reporter by a smal RNA hairpin (sh-
CXCR4).   Normalized luciferase  values are shown for  mock (open  bars)  or  BDNF-
stimulated (hatched  bars)  neurons co-expressing the  miRNA reporter and either sh-
Control-2 or a dose-titration of sh-CXCR4. Low-dose sh-CXCR4 repressed the miRNA-
reporter in  BDNF- but  not  mock-stimulated conditions.  Al experiments  done in the 
presence  of  Actinomycin-D.  Eror  bars represent  SEM.  *  =  p<0.05 in comparison to 
reporter alone condition (- sh-CXCR4,  D and  F)  or  mock (open  bars)  by  unpaired 
Student’s t-test.  
The experiments  performed in this figure  were conducted  by  Alvin  Huang and also 












Figure 2.4 Loss of P-bodies in neurons lacking either GW182 or LSm5 leaves other 
celular responses to BDNF intact. 
GW182  was chosen as an initial target for  P-body  disruption since it  may  perform a 
scafolding role in P-bodies and does not possess a known enzymatic activity that could 
be required for  general celular function.  (A)  Cultured  hippocampal  neurons (DIV  14) 
were infected  with replication-incompetent lentivirus expressing  mChery and shRNA 
targeting  GW182,  or a control  non-target shRNA and  mChery. Immunohistochemistry 
for endogenous GW182 indicated efective loss of P-bodies in cels expressing GW182 
shRNA (GW182KD),  but  not in control shRNA infected cels. (B) Immunoblot 
demonstrating efective knockdown of GW182 using a rabbit polyclonal antibody raised 
against GW182 (16 amino acid peptide of TNRC6a absent from other TNRC6 isoforms, 
Abcam ab84403)  with  no cross-reaction to isoforms  TNRC6B and  TNRC6C,  or  Ge-1, 
another  P-body component.  Neurons expressing either shRNA against  GW182 
(GW182KD) or scrambled shRNA (sh-control-1) received mock or BDNF stimulation in 
the  presence  of  Actinomycin-D as  previously  described (Figure  2).   Quantification 
relative to the control mock condition (set as 100 %) of protein levels normalized to β-
tubulin is indicated  under  GW182  bands.  (C) Immunohistochemistry for endogenous 
Dcp1a showed loss  of  P  bodies in  neurons expressing  GFP-DNGW182. (D)  BDNF-
induced activation of the cAMP response element-binding protein (CREB) transcription 
factor remains intact in  neurons expressing  GFP-DNGW182.   A luciferase reporter 
harboring cAMP response-elements (CRE) to monitor CREB activation was expressed in 
neurons with or without DNGW182. Mock (open bars) and BDNF (hatched bars, 100 ng 
/  ml  3.5  hours) stimulation  were  performed in the absence  of a transcription  blocker. 
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Luciferase activity  was  normalized to coexpressed constitutive β-galactosidase activity 
and ploted relative to the mock condition. * = p < 0.05 by unpaired Student’s t-test. (E) 
mRNA abundance in neurons as measured by RT-qPCR with al conditions normalized to 
mock stimulation (open  bars; set as  1.0).  mRNA levels  of  BDNF-upregulated targets 
were unaltered from basal values (mock) by BDNF stimulation (BDNF), or by GW182 
knockdown (GW182KD, left  panel)  or  GFP-DNGW182 expression (right  panel).  The 
BDNF-induced  downregulation  of  KCC2 transcripts  was abolished  by loss  of  GW182 
function (right panel). Al RT-qPCR reactions were normalized to β-tubulin II (neuron-
specific isoform)  values,  which are  unchanged  by  BDNF,  within individual cDNA 
samples to control for consistency  between amplification assays.  Expression  of control 
shRNA (sh-control-1, left panel) or GFP (right panel) serve as controls for GW182KD or 
GFP-DNGW182, respectively. (Al experiments done in the presence of Actinomycin-D 
to isolate changes  due  only to translation.  (F) Immunohistochemical staining for 
endogenous  P-body component  LSm5 (middle,  green) showed extensive colocalization 
with another endogenous  P-body component,  GW182 (top  panel, red;  overlay,  botom 
panel) (G) Immunohistochemistry for endogenous  Dcp1a showed loss  of  P  bodies in 
neurons expressing shRNA against  LSm5 (LSm5KD)  but  not in control-shRNA-
expressing  neurons (sh-Control-2).  GFP expression served to  visualize  neuron 
morphology.  Scale  bars represent  10 µm in al images. (H) Increased total  protein 
synthesis in response to  BDNF is  unaltered after  P-body  disruption  by loss  of  LSm5. 
Total protein synthesis was assayed by measuring 35S incorporation in sh-Control-2 and 
LSm5KD  neurons,  undergoing  mock (- BDNF)  or  BDNF (+  BDNF) stimulation  100 
 49	  
ng/ml for  2  hours, in the  presence  of  Actinomycin-D (0.5 µg/ml,  pre-incubated  10  min 
before stimulation). * = p < 0.05 by unpaired Student’s t-test. 
The experiments  performed in this figure  were conducted  by  Alvin  Huang and also 






Figure 2.5 The transcription inhibitor Actinomycin-D does not alter BDNF-induced 
protein synthesis under the assayed conditions.  
(A) Immunobloting for BDNF targets in cultured neurons treated mock (-) or BDNF (+ ; 
100 ng/ml for 2 hours) stimulation in the absence (- Act-D) or presence of Actinomycin-
D (+  Act-D;  0.5 µg/ml added  10  min  before stimulation).  Arc  demonstrates strong 
transcription-dependent  upregulation  by  BDNF and serves as an indicator for 
Actinomycin-D eficacy.  (B)  Protein levels  of  BDNF targets relative to the  mock-
stimulated condition (open  bars, set as  1.0).  Quantification is  by  densitometry  with 
internal normalization to β-tubulin. Eror bars represent SEM. * = p < 0.05 by unpaired 
Student’s t-test. 
The experiments  performed in this figure  were conducted  by  Alvin  Huang and also 







Figure  2.6 Control experiments supporting involvement  of the  miRNA  pathway in 
BDNF-regulation of protein synthesis.  
(A) Activity of a luciferase reporter lacking binding sites is not afected by expression of 
shRNA targeting  CXCR4.  Luciferase reporter assay was caried  out in  neurons 
expressing a control luciferase reporter free  of any  binding site for shRNA against 
CXCR4 (sh-CXCR4) and treated with mock (- BDNF) or BDNF (+ BDNF) stimulation 
at  100  ng/ml for  2  hours in the  presence  of  Actinomycin-D (0.5 µg/ml, added  20  min 
before stimulation).  (B)  Global activation  of  miRNA  biogenesis  by  Dicer stabilization 
with enoxacin does not significantly alter the quantity of total celular protein synthesis. 
Total  protein synthesis  was assayed  by  measuring 35S incorporation in  neurons, 
undergoing mock or BDNF stimulation (100 ng/ml for 2 hours), with or without enoxacin, 
in the presence  of  Actinomycin-D (0.5 µg/ml, added  20  min  before stimulation). 
Oxalinic acid, a structuraly similar control for enoxacin, also does not alter total celular 
protein synthesis. Eror bars represent SEM. * = p < 0.05 by unpaired Student’s t-test. 
The experiments  performed in this figure  were conducted  by  Alvin  Huang and also 











Figure 2.7 BDNF increases Dicer levels and the biogenesis of mature miRNAs.  
(A) Left: percentage of miRNAs from TaqMan miRNA aray with levels decreased over 
50% (open  bar)  or increased  over  2-fold (black  bar) by  BDNF (30  min.,  plus 
Actinomycin-D) Right: scater  plot of relative  quantities (RQ)  of individual  miRNA 
species (solid circles) folowing BDNF relative to mock-stimulation. Red line = 1.0 or no 
change; each  dot above the line represents a  miRNA species increased  by  BDNF, each 
dot below the line represents a miRNA species decreased by BDNF. Normalization is to 
averaged reference RNAs U6snRNA, and snoRNA202, which are unchanged by BDNF; 
n  =  3 separate  miRNA aray  pairs for  mock and  BDNF conditions. (B) Immunoblot  of 
cultured hippocampal neurons stimulated with BDNF for indicated min in the presence of 
 54	  
Actinomycin-D.  Dicer  peaks  near  20 and  declines  by  60  min. (C)  Top  panel,  BDNF 
enhances  TRBP and  ERK  phosphorylation as shown  by immunoblot for  TRBP and 
phospho-Erk.  Cultured hippocampal neurons were stimulated with BDNF for indicated 
min in the  presence  of  Actinomycin-D.  Botom  panel, lysates incubated  with 
λ-phosphatase (λ-phos) as indicated  demonstrate loss  of  phosphorylated  TRBP (upper 
band). (D) P-body appearance in dendrites of hippocampal pyramidal neurons expressing 
control (sh-control-2, top  panels)  or  Dicer-targeting shRNA (DicerKD,  botom  panels) 
folowing BDNF, t = min post-stimulation. (E) Quantification and time course of P-body 
numbers in Dicer-deficient (DicerKD, boxes) or control (sh-control-2, circles) expressing 
hippocampal  neurons folowing  mock- (open shapes)  or  BDNF-stimulation (closed 
shapes). (F) Quantification and time course of P-body numbers in hippocampal pyramidal 
neurons treated  with enoxacin (15 µM, closed circles)  or  oxolinic acid (15 µM,  open 
circles). (G) The efect  of  Dicer loss  on  BDNF-regulated  protein synthesis.  Top  panel, 
immunobloting for  BDNF target  proteins in  Dicer-wildtype (Dicerflox/flox)  or  Dicer-
deficient (Dicer-/-)  neurons.  CreERT2-expressing cels  were treated  with  4-hydroxy 
tamoxifen (800  nM) to induce recombination for  2.5  days  before  BDNF stimulation. 
Asterisk indicates  non-specific  band.  Botom  panel,  densitometric  quantification  of 
immunoblots. Al eror bars represent SEM. * = p<0.05 by unpaired Student’s t-test. 
The experiments in  A of this figure were  performed  by  Elizabeth  Huang and also 
published in  her thesis; experiments in G  was  performed  by  Alvin  Huang and also 









Figure  2.8 BDNF induces  Lin28, selectively  diminishes  Lin28-regulated  miRNAs, 
and specificaly upregulates a heterologous reporter containing Let-7 binding sites. 
(A) Lin28a (top panel) and Lin28b (lower panel) immunoblots of lysates from cultured 
hippocampal  neurons stimulated  with  BDNF for indicated  min. (B)  Timecourse  of 
BDNF-induced reductions in Lin28-regulated miRNA levels by individual TaqMan RT-
qPCR reactions in mock- (BDNF 0’) or BDNF-stimulated neurons. miRNA levels were 
normalized to  18s rRNA and  ploted relative to each  mock-stimulated condition (set as 
1.0). Al samples underwent equal duration Actinomycin-D incubation prior to harvest. 
(C)  Northern  blot (left) and  quantitation (right)  of  pre- and  mature  miRNA levels  of a 
Lin28-target (Let-7a)  or control  miRNA (miR-17) in  mock  or  BDNF-treated (30  min) 
neurons.  (D) A  binding site for  Let-7  miRNAs in the  3’UTR  of an  mRNA confers 
upregulation  of  protein synthesis in response to  BDNF.   Neurons expressing  Let-7 
reporters containing two functional (Let-7  WT)  or  mutated (Let-7  Mut)  Let-7  miRNA 
binding sites in the 3'UTR of firefly luciferase, or a reporter lacking miRNA binding sites 
were  mock- or  BDNF-stimulated (4  hr).  Luciferase activities are  normalized to co-
expressed constitutive β-galactosidase activity and  ploted relative to  mock-stimulation 
for each reporter. Al eror bars represent SEM. * = p < 0.05 by unpaired Student’s t-test. 
(E) Predicted binding sites for Lin28-targeted miRNA. The presence of a Lin28-targeted 
miRNA  binding site in the  3’UTR  of transcripts for  which translation is  BDNF-
upregulated (green),  BDNF-downregulated (red), and  BDNF-nonregulated (black) as 
predicted  by  TargetScan,  PITA,  Pictar,  MiRanda, and  miRwalk.  Pink  boxes  denote the 
presence of a miRNA binding site in which the miRNA seed sequence (nucleotides 2 – 7) 
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paired as a perfect or G-U wobble-containing match. Gray boxes denote the absence of a 
miRNA binding site. See also Figure 2.11. 
Experiments in B and  D of this figure were  performed  by  Alvin  Huang and also 



























Figure 2.9 Lin28 is required for relief of miRNA-mediated repression and selective 
induction of BDNF-upregulated mRNA targets. 
(A)  Loss  of  Lin28  prevents  BDNF-induced  decreases in mature  Let-7a levels. Mature 
Let-7a levels  were assessed  by  RT-qPCR from  neurons infected  with lentivirus 
expressing either control shRNA (sh-control-2) or shRNA targeting Lin28a (Lin28aKD) 
and  mock- or  BDNF-stimulated for  20  min (no  Actinomycin-D);  normalization  was to 
control  mock  values (open  bar, set as  1.0,  n  =  3). (B)  Efect  of  Lin28a loss  on  BDNF-
regulated  protein synthesis. Immunobloting  of  BDNF targets in control  or  Lin28a-
deficient cels, mock- or BDNF-stimulated (left panel).  Densitometric quantification of 
protein levels (right, top  panel,  n  =  6 each condition).  Total  mRNA levels for  both 
BDNF-upregulated or downregulated targets (right, botom panel). (C) Efect of Lin28a 
KD on BDNF-induced association of protein and RNA P-body components. Lysates were 
immunoprecipitated  with anti-GW182 antibody in control (sh-Control-2)  or  Lin28a-
deficient cels, mock- or BDNF-stimulated. Immunobloting for co-IP’d Ago2 and Dcp1a 
(left  panel) and  densitometric  quantification (right, top  panel,  n  =  3). Total  RNA from 
GW182 IP  of equal lysate inputs from  Lin28a  knockdown (Lin28aKD)  or control (sh-
Control-2)  neurons;  mock (open  bars) set as  1.0.  BDNF-induced increase in  GW182-
associated total RNA remains intact after Lin28a knockdown (right, botom panel). (D) 
Abundance of BDNF mRNA targets associated with GW182 in control (sh-Control-2) or 
Lin28a-deficient cels.  In  Lin28a-deficient  neurons,  mRNAs for  BDNF-upregulated 
targets remain associated  with  GW182 in the  presence  of  BDNF  while the response  of 
mRNAs for BDNF-downregulated targets is unchanged. 18s rRNA is nondetectable, ND. 
Eror bars represent SEM. * = p<0.05 Student's t-test.  
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Experiments in this figure  were  performed  by  Alvin  Huang and also  published in  his 





Figure  2.10 Lin28-mediated  degradation  of  Let-7  precursors is required for 
induction of BDNF-upregulated targets and neuronal outgrowth. 
(A)  Lentiviral-mediated expression  of  wild-type (Let-7WT)  or  Lin28-resistant (Let-7LR) 
Let-7  pre-miRNAs in  neurons  produced  dose-dependent enhancement  of  mature  Let-7a 
miRNA levels assessed by RT-qPCR and shown as fold change relative to infection with 
virus expressing  GFP alone (gray  bar, set as  1.0);  1x  or  2x refers to  viral  dose (B) 
Expression  of  Let-7LR,  but  not  Let-7WT,  blocks specificity  of  BDNF for  upregulated 
targets. Reporter assays in mock- (open bars or BDNF-stimulated (hatched bars) neurons 
with luciferase constructs fused to the 3’UTR from BDNF-upregulated targets (GluA1 or 
CaMKIα)  or a  downregulated target (KCC2). (C)  BDNF-induced  dendrite  outgrowth 
requires  Lin28-mediated  degradation  of  miRNA  precursors.  Dendrite complexity is 
quantitated for  neurons expressing Let-7WT (black circles)  or Let-7LR (red triangles) 
folowing mock- (open shapes) or BDNF- (25 ng / ml, closed shapes) treatment. * = p < 
0.05  by  unpaired  Student’s t-test  or  unpaired  one-way  ANOVA  between Let-7WT and 
Let-7LR in  mock and  BDNF conditions. (D)  Soma size (left  panel) and total  dendritic 
length (right panel) did not significantly difer between Let-7WT and Let-7LR in mock or 
BDNF treatment. Eror bars represent SEM. Al experiments were done in the presence 
of Actinomycin D.  











Figure  2.11 Binding sites for  Lin28-regulated  miRNAs (let-7,  miR-143,  and  miR-
107) in the  3’UTRs  of example  BDNF-upregulated targets,  CaMKIIα and  GluA1.  
The  binding region for the  miRNA seed sequence (nucleotides  2-7  of the miRNA) is 
underlined and in red.  Complementary  base  pairing is  denoted  by  uppercase leters, 
noncomplementary  base  pairing are in lowercase leters, and  G:U  wobbles are in  blue 
font. Base pair position indicates the base in the 3’UTR of the mRNA where the miRNA 
5’ end binds. microRNA seeds having an average phylogenetic conservation score higher 
than 0.8 are denoted by the pound (#) sign. The conservation score is based on alignment 
of the longest 3’UTR for 17 vertebrates, including mammalian, amphibian, bird and fish 
species.  Conservation scores range from  0 to  1,  with  1  being  perfectly conserved and 




















Figure  2.12 Loss  of  P  bodies in  neurons expressing  dominant-negative form  of 
GW182 (DNGW182) inhibits BDNF-induced dendritic arborization. 
(A) Representative images of neurons expressing untagged mChery and either GFP (top 
panels) or GFP-DNGW182 (botom panels) folowing 72 hrs of mock- or BDNF- (25 ng / 
ml) treatment. Images show red channel (mChery) only. Scale bar represents 50 mm. (B) 
Shol analysis representing  dendritic complexity at increasing  distances from the cel 
body for  GFP- (circles)  or  GFP-DNGW182- (triangles) expressing  neurons folowing 
mock- (open shapes) or BDNF- (25 ng / mL, closed shapes) treatment. * = p < 0.05 by 
unpaired  one-way  ANOVA;  Mann-Whitney  U test  modified  Bonferoni corection. (C) 
Total  dendritic length (top  panel) and soma size (botom  panel) are  not significantly 
diferent between control and GFP-DNGW182-expressing neurons folowing mock or 25 
ng /  mL  BDNF treatment.  Eror  bars represent  SEM.  mock,  n=30 cels;  BDNF,  n=27; 
GFP-DNGW182, mock, n=21; GFP-DNGW182, BDNF, n=27. 


























Figure  2.13 Proposed  model for the  determination  of  mRNA target specificity in 
BDNF-mediated translation. 
Left panel: In the absence of BDNF stimulation, both Lin28-targeted precursor miRNAs 
(GGAG, red) and  non-Lin28-targeted  precursor  miRNAs (blue) are  processed into 
mature  miRNAs.   mRNAs targeted for translational repression  or  degradation  by these 
mature miRNAs accumulate in P-bodies. Right panel: BDNF induces both positive and 
negative regulation  of  miRNA  biogenesis.  In the  presence  of  BDNF,  TRBP 
phosphorylation and  Dicer  protein levels increase leading to a  general enhancement  of 
processing  of  precursor  miRNAs (blue) into  mature  miRNAs. Increased abundance  of 
mature miRNAs leads to an increase in targeting of mRNAs for repression and increases 
the number of P-bodies in cels. However, Lin28a protein levels also increase in response 
to  BDNF (far right).  Because  Lin28a selectively prevents processing  of its targeted 
precursor  miRNAs (GGAG, red) into  mature  miRNAs, this  population of  miRNAs is 
diminished and mRNA targets of these miRNAs are no longer eficiently repressed and 
become  more readily available for translation.  The  diferential efects  of  BDNF  on 
distinct  miRNA  populations can explain the selective increase in translation  of  only 
























Hippocampal cultures and stimulation 
Al animal procedures conformed to animal care guidelines approved by the Institutional 
Animal Care and Use Commitee. Dissociated hippocampal cultures were prepared from 
postnatal day 0 (P0) mice as previously described (Mefert et al., 2003). Knockdown was 
by lentiviral-mediated delivery of shRNA to cultures at multiplicity of infection of 5 – 10, 
48 hr before imaging or 4 – 5 days for GW182. Cultures were preincubated 10 – 20 min. 
and  mock- or  BDNF-stimulated (100  ng/ml  BDNF) in the  presence  of  Actinomycin-D 
(0.5 µg/ml), unless indicated otherwise.  
 
RNA analysis 
For RT-qPCR, TaqMan Gene Expression and MicroRNA Assays (Applied Biosystems) 
were performed with quantitation by the standard-curve method and no preamplification, 
RQ was calculated as 2-
DCtBDNF / 2-
DCtmock where DCt = (cycle threshold for miRNA of 
interest) – (cycle threshold for reference control).  
 
Reporter Assays 
The folowing  CXCR4 siRNA/miRNA reporter assay constructs (Addgene)  were  used: 
siRNA reporter (PCD  FL1P,  Plasmid  12567),  miRNA reporter (PCD FL4X,  12565), 
control luciferase reporter (PCD  FL0X,  12563), and  CXCR4 shRNA (pLKO.1  puro 
CXCR4 siRNA-2, 12272) (Wang et al., 2006). Let-7 luciferase reporters with wild-type 
or  mutated  Let-7  miRNA  binding sites  were  gifts from  G.  Hannon (Liu et al.,  2005b). 
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3’UTR reporters were constructed by inserting 3’UTRs from GluA1, CaMKIα or KCC2 
downstream  of luciferase in  pGL3-Control  vector (Promega).  A  Lin28-resistant  Let-7 
pre-miRNA  was  generated  by  mutation  of the conserved  Lin28 “GGAG” recognition 
motif to “GtAt” in the terminal loop of pLV-hsa-let-7a-1 (Biosetia).  
 
Imaging and quantification 
For live cels:  Confocal images  of  hippocampal  pyramidal  neurons (excitatory, 
determined by morphology) in 0.24 – 0.3 mm Z sections were acquired using a 40x, 1.3 
NA, EC Plan Neofluoar (whole cels) or a 100x, 1.4 NA Plan Apochromat oil immersion 
objective (dendrites) on a Yokogawa spinning disk system (Cel Observer, Carl Zeiss) at 
37°C in Tyrodes bufer (in mM: 119 NaCl, 5 KCl, 2 CaCl2, 0.2 MgCl2, 30 Glucose, 25 
Hepes, .01 Glycine, pH 7.4). EBFP2 was excited at 405 nm and emissions colected at 
425 - 475  nm.   GFP  was excited at  488  nm and emissions colected at  500 – 550  nm; 
mChery was excited at 561 nm and emissions colected at 598 - 660 nm. Laser power 
and exposure time  were adjusted to  minimize  phototoxicity and avoid saturation.   Al 
experiments  were from a  minimum  of  3 independent cultures, and  no  more than  3 
neurons per dish; the experimenter was blinded to conditions during analysis.  
 For fixed cels, confocal images were acquired in 0.3 mm (dendrites) or 1.7 mm 
(whole cels for arborization) Z sections on an LSM5 Pascal system (Carl Zeiss) using a 
63x, 1.4 NA Plan Apochromat oil immersion objective and 2X optical zoom (dendrites) 
or using a 25x, 0.80 NA Plan-Neofluor multi-immersion objective and 0.7x – 1x optical 
zoom (for whole cels). GFP was excited at 488 nm and emissions colected at 505 - 530 
nm; mChery was excited at 543 nm and emissions colected above 560 nm. Laser power 
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and exposure time  were adjusted to  minimize  photobleaching and avoid saturation.  Al 
experiments were from a minimum of 3 independent cultures and no more than 3 neurons 
per dish 
 Z-stacks containing the entire neuron or process of interest were analyzed using 
Imaris  7.0.0 (Bitplane) and ImageJ software.   Automated analysis  of  P-body  numbers 
was conducted using Spots detection in Imaris. A quality filter and intensity median filter 
for the red channel  were  used to restrict  detection  of  puncta  within  dendrites  only. 
Colocalization analysis was performed using the Colocalize Spots function. The percent 
colocalization  of  P-body components  was calculated  by subtracting the  number  of 
colocalized  BFP-Dcp1a  or  YFP-Pat1b  puncta from the total  number  of  BFP-Dcp1a  or 
YFP-Pat1b puncta and multiplied by 100.  The percent of colocalized fluorescence was 
calculated for each  P-body component  by first summing the aggregate fluorescence 
values that co-localized  with the  other  P-body  marker in ‘spots’, then  dividing this 
quantity  by the  value  of the total fluorescence intensity  within the  dendrite for that 
channel, and  multiplying  by  100.   The  Surfaces tool in Imaris  was  used to create a 
representation  of the  dendrite in  order to  determine total fluorescence intensity 
coresponding to the  dendrite region alone.  The red channel (soluble  mChery 
expression) was used as the source channel to compute the Surfaces. Total fluorescence 
of a dendritic segment was calculated by summing the intensity fluorescence values of al 
of the Surfaces representing a single dendrite.   Shol analysis was performed using the 
Sholl analysis  plugin in ImageJ (A.  Ghosh lab) from  Z-compressed  projections traced 
semi-automaticaly in NeuronJ. For analysis, dendritic intersections were counted using a 
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circle of 15 µm diameter centered on the cel soma and subsequent circles of increasing 5 
µm diameter increments. 
 
Immunobloting 
Primary cultures of mouse hippocampal neurons (DIV 14~15) were incubated in serum-
reduced  medium (0.5%  B27 supplement) for  2  hours, folowed  by  0.5 µg/ml 
Actinomycin-D for  10~30  min.  Bath application  of  BDNF (100 ng/ml)  was for 
designated periods (5 min ~ 2 hours). The cultures were washed 3 times and harvested on 
ice  with lysis  bufer (50  mM  Hepes,  150  mM  NaCl,  10%  Glycerol,  1  mM  EDTA,  1% 
Triton-X-100,  0.2%  SDS)  plus freshly added  protease inhibitor cocktail (Roche) and 
PMSF.   Protein concentration  was  determined  by  Bradford  Assay.  If required, lysates 
were treated with Lambda Protein Phosphatase according to manufacturer’s instructions 
(New England Biolabs P0753S). Equal amounts of lysate protein were resolved on SDS-
PAGE gels, and electrotransfered to PVDF membrane. Membrane was blocked with 5% 
milk in Tris-bufered saline tween 20 (TBST) and probed with primary antibodies in 5% 
milk  or  BSA in  TBST: GluA1 (Milipore  AB1504),  CaMKIα (Zymed  13-7300), 
Homer2 (gift of P.Worley), KCC2 (Upstate 07-432), Kv1.1 (NeuroMab 73-007), btubulin 
(U.Iowa  DSHB, clone  E-7),  GAPDH (gift  of  S.Snyder),  GW182 (18033  gift  of  M. 
Fritzler or Abcam ab84403), Dcp1a (gift of J. Lykke-Andersen or NeuroMab clone3G4), 
phospho-ERK ½ (Sigma  M 7802),  Dicer (NeuroMab clone  N167/7),  TRBP (Abcam 
ab72110), Lin28a (Cel Signaling A177), Lin28b (gift of E. Moss or Cel Signaling 5422), 




Cultured  neurons  were  pre-incubated in  media containing reduced-serum and 
Actinomycin-D as previously described, folowed by washing and incubation for 10 min 
with  methionine- and cysteine-free  DMEM (Mediatech, Inc.), and 35S labeling in the 
same  DMEM  with the addition  of 35S-methionine/cysteine (35S  Met/Cys  EasyTag  Mix, 
Perkin Elmer) to a final concentration of 100 µCi/ml. Mock- or BDNF stimulation was 
for 2 hours. Cels were washed and lysed with lysis bufer (see immunobloting). Lysates 
were centrifuged and colected supernatants subjected to Bradford assay. To asses newly 
synthesized  proteins,  200-500 µg  of lysates  proteins  were  precipitated  with  10% 
trichloroacetic acid (TCA) for 1 hour on ice in the presence of 0.5% deoxycholate (DOC) 
to remove interfering phenol red. After centrifugation, protein pelets were washed with 
ice-cold 95% ethanol, solubilized in denaturing bufer (50 mM Tris pH 8.3, 5 mM EDTA, 
0.05%  SDS,  6M  urea), and subjected to liquid scintilation counting (Econofluor,  New 
England  Nuclear, Inc.).  35S  Disintegration  per  minute (DPM)  was  used to  quantitate 
protein synthesis after subtraction of background readings 
 
Immunopurification of GW182 
Proteins and mRNAs associated with P-body component GW182 were isolated through 
immunoprecipitation  of  GW182  by  modification of  previously  published  protocols 
(Keene et al., 2006; Moser et al., 2009). Primary cultures of mouse hippocampal neurons 
(DIV  14-15)  were incubated in serum-reduced  medium (0.5%  B27 supplement) for  2 
hours, folowed  by  0.5 µg/ml  Actinomycin-D for  10~30  min. and  mock  or  BDNF-
stimulation for  30~60  min.  Cel lysates  were  harvested in  polysomal lysis  bufer (100 
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mM  KCl,  5mM  MgCl2,  10  mM  HEPES  pH  7.0,  0.5%  NP-40)  with  protease inhibitor 
cocktail and freshly added  20  mM  EDTA,  1mM DTT,  100  U/ml  RNase inhibitor 
(RNaseOut, Invitrogen) and  400  mM  Vanadyl ribonucleoside complexes (SIGMA). 
Lysates  were centrifuged and the supernatants  pre-cleared  by  one-hour incubation  with 
recombinant  protein  G  beads  pre-washed in  NT2  bufer (50  mM  Tris-HCl  pH  7.4,  150 
mM  NaCl,  1  mM  MgCl2,  0.05%  NP-40).   Antibody coating  of  protein  G  beads  was 
caried out with antiserum against GW182 (18033, gift of M. Fritzler) or control isotype-
specific serum in NT2 bufer plus protease inhibitor for 4 hours after blocking with NT2 
bufer plus 5% BSA and 1mg/ml heparin for 1 hour. For immunoprecipitation (IP), equal 
amounts  of lysate  protein (2 - 5  mg)  was incubated  with antibody-coated  beads and 
tumbled for 4 hours at 4oC, folowed by washing.  RNAs were recovered from GW182 
immunoprecipitates by Tri-Reagent as described below.  
 Recovered  RNAs  were resuspended in  nuclease-free  water,  measured for  RNA 
concentration, and immediately reverse transcribed into cDNA  using a combination  of 
random decamers and oligo(dT) primers. RT-qPCR was caried out as described below. 
To examine  proteins co-immunoprecipitated  with  GW182, the  washed IP  beads  were 
incubated in sample  bufer at  95oC for  5  minutes and subjected to  SDS-PAGE 
electrophoresis and immunobloting. 
 
RNA extraction, quantitative PCR for individual mRNA and miRNA species 
Total  RNA from  primary cultures  of  mouse  hippocampal  neurons  was isolated  by  Tri-
Reagent (Molecular  Research  Center, Inc.) according to the  manufacturer’s  protocol. 
Cultures were either homogenized in Tri-Reagent  directly,  or  were first lysed in lysis 
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bufer plus RNase inhibitor (if protein from the same sample was required) folowed by 
Tri-Reagent addition to a portion of lysate. RNA pelets were air-dried and resuspended 
in  nuclease-free  water.  RNA concentration and  quality  were assayed  by 
spectrophotometric measurements at an optical density (OD) 260/280/230 nm.  
 For analysis  of  mRNA abundance:  1 µg  of  RNA  was immediately reverse-
transcribed into cDNA with a TaqMan reverse transcripton kit (Applied Biosystems) and 
a  mixture  of random  decamer and  oligo(dT)  primers in a final  volume  of  30 µl and 
subjected to  TaqMan  Gene  Expression  Assays (Applied  Biosystems) for  GluA1 (assay 
ID:  Mm00433753_m1),  CaMKIα (Mm00437967_m1),  Homer2 (Mm01314936_m1), 
KCC2 (Mm00803929_m1),  Kv1.1 (Mm00439977_s1),GW  182 (Mm00523487_m1), 
GAPDH (Mm99999915_g1), and  b-tubulin-II (Mm00727586_s1).  RT-qPCR  was 
performed using a Stratagene Mx3000P machine and software in 20 µl reactions on a 96-
wel optical plate at 95oC for 5 min, followed by 40 cycles of 95oC for 30 sec, 55 oC for 1 
min and 72 oC for 30 sec. The threshold and threshold cycle (Ct) values were determined 
using  default setings.  Standard curves  were constructed and  used for  quantitation of 
target transcript abundance. In this method, 1:5 dilution series of an independent Standard 
sample are amplified to  generate a curve that relates the initial  quantity  of the specific 
target in the Standard samples to the  Ct.  The standard curve is then  used to  derive  by 
interpolation the initial sample template quantities based on their Ct values. Al derived 
quantities  were further  normalized to  neuron-specific β-tubulin II,  whose translational 
status is  unchanged  by  BDNF (Schrat et al.,  2004). Data  were  ploted as fold change 
relative to mock control. 
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 For individual  microRNA abundance assays (Applied  Biosystems),  100  ng  of 
total isolated  RNA  was  prepared for reverse transcription  with stem-looped  primers 
specific for individual  mature miRNAs in a final  volume  of  15 µl according to 
manufacturer’s  protocol;  4oC for  5  min,  16oC for  30  min,  42oC for  30  min,  85oC for  5 
min. and subjected to  TaqMan  MicroRNA  Assays (Applied  Biosystems) for  Let-7a 
(assay ID:  000377),  Let-7b (002619),  Let-7e (002406),  Let-7f1 (000382),  miR-107 
(000443) and miR-143 (0024).  RT-QPCR was performed using a Stratagene Mx3000P 
machine and software with quantities derived by standard-curve quantitation method, as 
described.  The abundance  of  non-coding  18s rRNA in each sample  was  used as an 
internal control to normalize al miRNA species. 
 
miRNA profiling arrays and analysis 
Murine  hippocampal cultures  were  preincubated for  10-20  minutes  with  0.5 µg /  ml 
Actinomycin  D and either  mock- or  BDNF- (100  ng /  ml) stimulated for  30  minutes 
before harvesting.  
 For  miRNA arays, 1 µg  of total  RNA for each sample  was reverse-transcribed 
with stem-looped  Megaplex  RT  Primers (Applied  Biosystems) in a final  volume  of  7.5 
µL according to manufacturer’s instructions: preincubation at 4oC for 5 min; 16 oC for 2 
min, 42 oC for 1 min, 50 oC for 1 sec, 40 cycles; 85 oC for 5 min. The entire cDNA RT 
product (7.5 µl)  was subjected to  RT-qPCR  on an  Applied  Biosystems 7900HT  Fast 
Real-Time PCR system using Taqman Rodent MicroRNA Aray A. Data were compiled 
in  SDS  RQ  Manager 1.2.1 (Applied  Biosystems) and analyzed in  Data  Assist  2.0 
(Applied Biosystems). Thresholds and cycle threshold (Ct) values were determined using 
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default setings and the maximum alowable Ct value was set at 35.0 inclusive. Data were 
normalized  by arithmetic  mean  using MammU6 (4395470) and snoRNA202 (4380914) 
reference  RNAs as controls.   miRNA aray  data reposited  with the  NCBI  Gene 
Expression  Omnibus (GEO).  Initial experiments  using an alternative  miRNA aray 
platform (Geniom microfluidic miRNA profiling, Febit Inc.) similarly indicated a BDNF-
mediated increase in the majority of detectable mature miRNA species.  
 
Lentivirus preparation  
Lentiviral stocks  were  prepared as  previously  described (Lois et al.,  2002). HEK-293T 
cels were trypsinized and seeded onto 15 cm plates, then grown at 37°C in 1X DMEM 
supplemented with 10% fetal bovine serum, penicilin/streptomycin, and glutamine to a 
confluency of ~65-85% before transfection by calcium phosphate. For each transfection 
reaction, 7.5 µg of the viral construct plus 7.5 µg each of the pMDLg/pRRE, RSV-Rev, 
and VSV-G viral packaging plasmids were mixed with 248 µL 2M CaCl2 and dH2O to a 
final  volume  of  2  mL.  2  mL  of  2X  HBSS (50  mM  Hepes,  280  mM  NaCl,  1.5  mM 
Na2HPO4 pH  7.06-7.1)  was then added to each reaction and  bubbled  vigorously  by 
pipeting  up and  down  ~15-20 times.  The  mixture  was then  dripped  onto cels and the 
dish rocked  back and forth to evenly  distribute the transfection complexes  before 
returning the cels to incubate at 37°C. ~8 hours after transfection, media was aspirated 
and replaced with 15 mL fresh media per dish. Cels were alowed to expand and produce 
virus for  ~40-48  hours and the supernatant colected.  Recovered supernatant  was 
centrifuged for 5 minutes at 900 rpm (150 g) to pelet cel debris and filtered with a 0.45 
µm filter before concentration by ultracentrifugation (25900 rpm in a Beckman-Coulter 
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swinging  bucket  SW32Ti rotor for  90  minutes at  4°C).  Supernatant  was  discarded and 
viral  pelets were resuspended in  100 µL cold  PBS (plus  1  mM  CaCl2 and  0.5  mM 
MgCl2). Virus was aliquoted and frozen at 80°C or used immediately.  
Luciferase Reporter Assays 
The siRNA- or miRNA-reporter constructs harbor one perfectly matched or four bulged 
CXCR4 siRNA target sites, respectively, in the  3’UTR  of firefly luciferase  mRNA.  In 
the presence of CXCR4 shRNA, perfectly matched sequences are cleaved by siRISC and 
bulge-containing sequences are targets for translation suppression by miRISC.  miRNA 
and siRNA pathway function were assayed in cels transiently transfected and expressing 
either the miRNA or siRNA reporters alone (no sh-CXCR4 ), or co-expressing either of 
the reporters and  CXCR4 shRNA  with  or  without  P-body  disruption (sh-Control-1  or 
GW182 KD, GFP or GFP-DNGW182, sh-Control-2 or LSm5 KD).  
 Let-7 luciferase reporters (gift of G. Hannon) harbor a wildtype or a mutant Let-7 
miRNA  binding site.  The  Let-7  miRNA  binding sites are  derived from a short  3’UTR 
segment  of  C. elegans  Lin41  mRNA containing two adjacent  proven  Let-7  miRNA 
biding sites and are cloned into  3’UTR  of firefly luciferase in a  pcDNA  backbone. 
Mutations in seed regions of both Let-7 binding sites were made for a negative control 
reporter, which was documented not regulated by endogenous Let-7 miRNAs. 
 Co-transfection  of the  pCSK-lacZ  vector,  which constitutively expresses  b-
galactosidase and is not regulated by shRNA, served to normalize transfection eficiency 
and extract recovery for each sample in al reporter assays. The DNA amounts used for 
each  wel (24  wel  plate)  were  15  ng  of any luciferase reporter,  85  ng  of β-gal (CSK-
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LacZ), and/or  75 - 300  ng  of  CXCR4 shRNA.  Each reporter experiment included 
extracts from cels transfected with pcDNA3.1 alone as a reference control.  
 44 hours post-transfection, hippocampal cultures were treated with serum-reduced 
media (0.5% B27) and Actinomycin-D (0.5 µg/ml) as previously described, folowed by 
BDNF stimulation 100 ng/ml for 4 hours. Cel lysates were colected in 1X lysis bufer 
(reporter lysis  bufer,  Promega), and luciferase (Promega) and chemiluminescent β-gal 
(Roche) reporter assays caried out according to manufacturer instructions using a plate-
reading luminometer (Perkin  Elmer).  Samples  were compared  by subtracting the 
background activity of the reference control, and then normalizing the luciferase activity 
of each sample to its β-gal activity.   When required, fold change  was calculated  by 
dividing normalized stimulated samples by normalized unstimulated samples. 
 
Plasmids and fluorescently tagged constructs:  
GFP-Dcp1a  was a  generous  gift from J.  Lykke-Andersen (UCSD).  GFP-Staufen  was a 
generous gift from L. DesGroseilers (U. Montreal). YFP-Pat1b was a generous gift from 
G.  Stoecklin (U.  Heidelberg).  BFP-Dcp1a  was  generated  by subcloning  with  EBFP2. 
GFP-hAgo2 (11590) and  GFP-GW182Δ1 (DNGW182, 11592)  were  purchased from 
Addgene.  
 
Cloning of let-7a-1 GGAG mutant 
A let-7a-1  precursor  miRNA  with the conserved  Lin28 “GGAG” recognition  motif 
mutated to “GtAt”  was  generated  by two-step  PCR site-directed  mutagenesis from the 
pLV-hsa-let-7a-1 vector (Biosetia, mir-p001) using the folowing primers:  
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TATAGGATCCTCACACAGGAAACCA (forward, outside; P1) 
TATAGCTAGCGCTGCACTACATCTC (reverse, outside; P2) 
 
CCCACCACTGGTATATAACTATACAATCTACTG (forward, inside; P3) 
TGTATAGTTATATACCAGTGGTGGGTGTGA (reverse, inside; P4) 
 
The P1 and P4 primers and the P2 and P3 primers were paired for the first round of PCR 
reactions.  The  products  of these  PCR reactions  were then included  with the  P1 and  P2 
primers for the second round of PCR reactions to generate the final “GtAt” mutant let-7a-
1 fragment.  This fragment  was then subcloned into the  BamHI and  NheI sites  of the 
parent plv-hsa-let-7a-1 parent vector. 
 
Statistical and bioinformatics analysis 
Student’s t-tests were performed in Excel. Nonparametric unpaired one-way 
ANOVA with post hoc Bonferoni analysis, and Mann-Whitney U tests were 














Appropriate regulation of neuronal and synaptic protein composition in response 
to BDNF is critical for  normal  brain function. Our lab  has found that specificity in 
BDNF-induced translation is achieved through regulation  of the  miRNA  biogenesis 
pathway (Huang et al., 2012). Negative regulation of miRNA biogenesis occurs through 
BDNF-induced  upregulation  of Lin28 that  blocks the  processing a subset  of  precursor 
miRNAs (e.g. Let-7 family miRNAs). This alows for mRNA targets of these miRNAs to 
undergo a relief of translational repression and enhanced translation in response to BDNF. 
We found that regulation of the miRNA biogenesis pathway through induction of Lin28a 
is essential for BDNF to corectly specify the protein synthesis of its upregulated targets. 
Positive regulation of miRNA biogenesis, and enhanced abundance of non-Let-7 family 
miRNAs, also occurs as a result of BDNF-induced increase in Dicer protein levels; this 
can explain  how the  majority  of mRNAs are excluded from translation in response to 
BDNF.  Lin28  has  previously  been considered to  be absent from  diferentiated cels 
making our finding that Lin28 function is critical for the efects of BDNF on plasticity-
related  processes including translation regulation and  dendrite  morphogenesis exciting 
and unexpected. 
This chapter of  my thesis describes  my work to  uncover the mechanism  of 
neurotrophin-induced upregulation  of  Lin28 in  mature  neurons, and is  part  of  ongoing 
work in the lab which wil be submited for publication in the next few months. The goal 
of this  portion  of  my thesis and  ongoing  work,  has  been to elucidate the signaling 
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mechanisms responsible for the rapid and transcription-independent induction of Lin28a 
by BDNF. By focusing on the critical initiating events in this pathway, we hope to reveal 
vital regulatory  points that  may  be essential to the  physiological impact  of  BDNF  on 
brain function. Uncovering this mechanism may have important implications in the field 
of stem cel, cancer, and  developmental  biology, given the critical role  Lin28a  plays in 
these celular contexts. 
 
Lin28 paralogs: Lin28a and Lin28b 
Unlike in C. elegans where a single  Lin28  gene is found,  vertebrates  have a 
Lin28a paralog, Lin28b, which shares ~77% identity with Lin28a at the protein level and 
also functions to block Let-7 miRNA biogenesis. In humans the Lin28a gene encodes a 
209 amino acid (aa) protein while the Lin28b protein is 250 aa. Despite a high degree of 
homology in structure,  Lin28a and  Lin28b exert their efects  on let-7  miRNAs through 
distinct mechanisms primarily due to their diferential subcelular localizations.  Lin28a 
is primarily cytoplasmic whereas Lin28b is predominantly localized to the nucleus due to 
its  nuclear localization signals found in the extended  C terminus region of  Lin28b 
(Piskounova et al.,  2011).    While  Lin28a  blocks the  processing  of pre-Let-7 family 
precursors into mature Let-7 miRNAs, Lin28b acts upstream to block processing of pri-
Let-7 family miRNAs to pre-Let-7 by the DGCR8 and Drosha. Like Lin28a, Lin28b also 
functions as an  oncogene and is associated  with advanced  human  malignancies. 
Interestingly, a number of primary human cancers overexpress either Lin28a or Lin28b. 
As  wel as elucidating the  mechanism  of rapid  BDNF-mediated  Lin28a induction, an 
additional  goal  of this  project is to  provide insight into the  distinct  biological roles  of 
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these paralogs, which may help us understand how their re-activation in diferent cancer 
types is uniquely regulated. 
 
Results 
BDNF induces rapid postranscriptional upregulation of Lin28a protein but has no 
efect on its paralog Lin28b  
To initiate  our investigations into the regulation  of  Lin28a  by  BDNF  we first 
addressed the  question  of  whether transcription is  necessary for  BDNF-induced 
upregulation  of  Lin28a in  hippocampal  neurons.  We treated  hippocampal  neurons  with 
Actinomycin-D to inhibit  new transcription and either  mock-stimulated  or  BDNF-
stimulated for  5,  20,  or  60  minutes.   Lin28a  protein level  was significantly elevated in 
response to  5,  20, and  60  minute-stimulation  with  BDNF in  both the  presence and 
absence of Actinomycin-D (Figure 3.1). There was no statisticaly significant diference 
between Lin28a induction in the presence of Actinomycin-D compared to vehicle control 
condition.  This result indicates that transcription is  not required for the ful efect  of 
BDNF on the rapid induction of Lin28a protein levels during this timecourse of BDNF 
stimulation.  To further test the role  of transcription in rapid  BDNF-mediated  Lin28a 
induction, we used qRT-PCR assays (TaqMan, Applied Biosystems) to evaluate Lin28a 
mRNA levels in  BDNF-stimulated  hippocampal  neurons.  We found that  BDNF  has  no 
significant efect on Lin28a mRNA levels at 5-,20-, and 120-minute time points (Figure 
3.1.B).  These findings colectively indicate that  BDNF acts  post-transcriptionaly to 
induce  Lin28a  protein levels and  prompted  us to investigate  whether  BDNF  might 
regulate Lin28a mRNA translation or Lin28a protein stability. We tested whether BDNF 
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could elevate  Lin28a  protein levels from an exogenous  FLAG-tagged construct 
containing the  Lin28a  protein-coding sequence (FL-Lin28a),  but lacking the regulatory 
Lin28a untranslated regions (5' and 3' UTRs). The response of this protein-coding region 
only construct  was compared to endogenous  Lin28a to independently assess  BDNF 
efects at the level  of  protein  or translation. We found that  BDNF rapidly elevates the 
levels  of  FL-Lin28a at  5-,  20-, and  60-minute time  points in a  manner that is 
indistinguishable from endogenous Lin28a (Figure 3.1.C) This finding demonstrates that 
the initial induction by BDNF requires only the protein-coding region of Lin28a.  
We  previously reported that endogenous  Lin28b  protein level is  not afected  by 
BDNF stimulation (Huang et al.  2012).  Given the curent evidence that  Lin28b  has a 
diferential subcelular localization than  Lin28a,  we  wanted to test  whether  BDNF 
treatment would alter the levels of a Lin28b nuclear localization signal (NLS) mutant that 
localizes to the cytoplasm. To answer this question we expressed either wildtype FLAG-
tagged  Lin28b (Fl-Lin28b)  or a  FLAG-tagged  Lin28bΔNLS and compared this to 
endogenous  Lin28b levels in response to  5,  20,  or  60  minute  BDNF stimulation in the 
presence  of  Actinomycin-D.  Our results show that  BDNF  had no efect  on endogenous 
Lin28b,  Fl-Lin28b,  or Fl-Lin28bΔNLS  protein level (Figure  3.1.D).  This result 
demonstrates that  Lin28a and  Lin28b are subject to  diferential postranscriptional 
regulation by BDNF, and prompted us to further investigate whether BDNF might act at 
the  protein level to selectively induce  Lin28a. Ongoing experiments are addressing the 






BDNF modulates TRBP phosphorylation to stabilize Lin28a  
 
Upon binding to its TrkB receptor BDNF activates multiple signaling pathways, 
including the MAPK/Erk pathway. Work from our lab shows that BDNF enhances both 
Erk and TRBP phosphorylation (Huang et al., 2012), consistent with a recent publication 
finding  Erk-dependent  phosphorylation  of  TRBP in a cel line (Paroo et al.,  2009).  In 
experiments aimed at defining the critical signaling intermediates  mediating  Lin28 
induction  downstream  of  BDNF, we observed that blocking  Erk signaling,  using an 
Erk1/2 inhibitor (U0126) prevents  BDNF-induced upregulation  of  Lin28a in 
hippocampal  neurons (Figure  3.2.A).  Interestingly, a previous report showed that 
expression  of a  phosphomimetic-TRBP  mutant (TRBP SΔD)  not  only enhanced  Dicer 
stabilization and increased levels of many miRNAs, but also selectively decreased levels 
of  Let-7 family  miRNAs  by an  unexplored  mechanism.  An intriguing hypothesis, 
consistent with our own findings, would be that TRBP stabilizes not only Dicer but also 
Lin28a  protein; thereby explaining the  observed reduced  Let-7 levels.  To  determine 
whether TRBP is necessary for BDNF-induced regulation of Lin28a we used lentiviral-
mediated shRNA  knockdown  of  TRBP in  hippocampal  neurons and evaluated  protein 
levels of Lin28a. We found that loss of TRBP results in a significant downregulation of 
Lin28a  protein  under  basal conditions, and  prevents  BDNF-induced  upregulation  of 
Lin28a in hippocampal neurons (Figure 3.2.B).  In contrast, loss of Dicer has no efect on 
basal Lin28a levels (Fig 3.2.C). These results indicate that TRBP is required for Lin28a 
induction and heightened our interest in further investigating the role of TRBP in BDNF-
induced regulation of Lin28a. 
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Phosphorylation of TRBP is critical for the stabilization of Dicer protein (Paroo et 
al. 2009). We hypothesized that BDNF-mediated phosphorylation of TRBP and increase 
in total TRBP levels (Huang et al., 2012) might simultaneously mediate the stabilization 
and induction of both Lin28 and Dicer.  To evaluate the role of TRBP phosphorylation in 
the rapid BDNF-mediated induction  of  Lin28a, we  used a lentivirus  vector  under a 
neuron-specific  promoter (synapsin) to express  wildtype (WT)  TRBP,  phospho-mutant 
(SΔA) TRBP, or phosphomimetic (SΔD) TRBP in  hippocampal  neurons and examined 
the efect on Lin28a protein level.  We found that expression of TRBP SΔD significantly 
elevated Lin28a protein and  occluded induction  by  BDNF.   Compared to expression  of 
TRBP WT, Lin28a levels were lower in neurons expressing TRBP SΔA (Figure 3.2.D). 
However,  BDNF stil  modestly induced  Lin28a in  neurons expressing SΔA  TRBP, 
possibly due to the presence of endogenous TRBP. To circumvent this issue we knocked-
down endogenous TRBP and replaced it with SΔA TRBP; BDNF was no longer able to 
induce Lin28a in neurons that lacked endogenous TRBP and only expressed SΔA TRBP 
(Figure  3.2.E). These exciting results suggest that  TRBP  phosphorylation is necessary 
and suficient for BDNF-mediated post-transcriptional induction of Lin28a. Furthermore, 
we found that expression  of  WT  TRBP,  TRBP SΔA, and  TRBP SΔD elevates  Lin28a 
from baseline compared to a condition where TRBP is not exogenously expressed (Figure 
3.3.A). This data indicates that the presence of TRBP itself is suficient to elevate Lin28a 
protein but that TRBP phosphorylation enhances this efect. Interestingly, Lin28b ΔNLS 
levels  were  not altered  by the expression  of  WT  TRBP,  TRBP SΔA, and  TRBP SΔD 
(Figure  3.3.A),  which  highlights a critical  point  of  diferential regulation  of these two 
paralogs. To further investigate the importance  of  TRBP  phosphorylation  on  Lin28a 
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induction  we expressed  FL-Lin28a and  FL-WT  TRBP, -TRBP -SΔA, and -TRBP SΔD 
and  normalized  FL-Lin28a and  FL-TRBP  protein to GAPDH.  Then  we  ploted the 
amount of FL-Lin28a protein per amount of FL-TRBP protein (Figure 3.3.B). We found 
that expression of al FL-TRBP constructs elevated FL-Lin28a protein, but that the extent 
of this elevation  was the  greatest  when  TRBP SΔD  was expressed.  Next,  we 
hypothesized that since TRBP SΔD is suficient to induce Lin28a levels then we might 
expect that TRBP SΔD is also suficient to cause a reduction in Let-7 miRNA levels. To 
test this  prediction  we expressed either control  virus  or  FSW-FL-TRBP SΔD in 
hippocampal neurons under mock or BDNF stimulation conditions and examined levels 
of Let-7a and Let-7c using TaqMan qRT-PCR. Results showed that expression of TRBP 
SΔD  was suficient to significantly reduce  Let-7 levels in a  manner that  mimicked and 
occluded the efects of BDNF (Figure 3.3.C). This exciting finding suggests that TRBP 
mediates the BDNF-induced increase in Lin28a and resulting decrease in Let-7 levels.  
 
Lin28a, but not Lin28b, exists in a protein complex with TRBP and Dicer 
We  hypothesized that  BDNF  might elevate Lin28a  protein levels by inducing a 
stabilizing change in the  protein-binding  partners associated  with  Lin28a; in particular 
with a  protein complex including  TRBP and  Dicer.  Co-immunoprecipitation (Co-IP) 
experiments revealed the exciting finding that endogenous  Dicer and  Lin28a associate 
with IP’d FL-TRBP, and not with control rabbit IgG (Figure 3.4.A). In the reciprocal IP, 
we found that endogenous TRBP and Dicer co-associated with IP’d FL-Lin28a, and not 
with control mouse IgG (Figure 3.4.B). These results suggest a possible mechanism for 
Lin28a stabilization similar to TRBP-mediated stabilization of Dicer protein. FL-TRBP 
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does not co-IP Lin28b protein, even when Lin28b is localized to the cytoplasm (Figure 
3.4.C), revealing specificity in the regulation of these paralogs. To test whether Lin28a, 
TRBP, and  Dicer  may  be components  of a single  multi-protein complex,  we expressed 
Myc-TRBP and FL-Lin28a in HEK 293T cels and conducted sequential IPs. First, using 
a Myc antibody we puled down Myc-TRBP and detected co-association of endogenous 
Dicer protein and FL-Lin28a.  Next, we IP’d the eluent with anti-FL antibody and puled 
down FL-Lin28a. We detected the presence of both Dicer and Myc-TRBP indicating that 
Lin28a, TRBP, and Dicer can exist in a single complex (Figure 3.4.D).  
 
 
Lin28a and TRBP are regulated by ubiquitin modifications  
 
Since  basal levels  of  Lin28a are low in  mature  neurons,  we  hypothesized that 
Lin28a protein may have a relatively short half-life, generating low basal levels that are 
rapidly elevated  by  Lin28a  binding to  TRBP.  We  next sought to  determine  whether 
Lin28a levels in  mature  hippocampal  neurons are controled at the level  of  protein 
degradation. We examined the efect  of inhibition  of  26S-proteasomal  degradation on 
Lin28a protein level by immunobloting for Lin28a in lysates from cultured hippocampal 
neurons (DIV14) undergoing mock or BDNF stimulation (for 20 min.), in the absence or 
presence  of  MG132 (proteasomal inhibitor).  Inhibition  of proteasomal  degradation 
significantly elevates  Lin28a levels in a rapid  manner that  mimics and occludes further 
induction by BDNF (Figure 3.5.A). In contrast, Lin28b levels, which are unafected by 
BDNF, are also  unafected  by 60  minute MG132 (Figure  3.5.B), further  highlighting 
diferential celular regulatory mechanisms for these Lin28 paralogs. We also examined 
the efects  of  MG132  on  TRBP and  noted a significant elevation  of  TRBP  protein in 
 89	  
neurons treated  with  MG132 for  20  minutes (Figure  3.5.C). Constitutive  proteasomal 
degradation implies that Lin28a, or a protein required to stabilize Lin28a (such as TRBP), 
is  undergoing constitutive  ubiquitination and  proteasomal  degradation.  To  determine 
whether  Lin28a, itself,  might  be  ubiquitinated we  first expressed  FL-Lin28a and  HA-
Ubiquitin Wildtype (HA-Ub  WT) in HEK293T cels and in hippocampal  neurons and 
caried out a stringent IP for Lin28a with anti-Flag antibody folowed by immunobloting 
for HA. We found that in the presence of MG132 (26S proteasome inhibitor) and PR619 
(deubiquitinase inhibitor), HA-Ubiquitin co-precipitated with FL-Lin28a in heterologous 
cels and in  hippocampal  neurons but  not in the control condition (lysates from cels 
expressing  HA-Ub  WT  but  not  FL-Lin28a) (Figure  3.5.D).  Lysates  were treated  with 
denaturing conditions (high salt,  high  detergent) to  determine if  HA-Ub  WT is  directly 
conjugated to Lin28a and rule out the possibility that HA-Ub WT is indirectly associated 
by a protein complex with Lin28a. Disruption of non-covalent interactions by stringent IP 
conditions is confirmed by the absence  of TRBP co-IP  under these conditions (Figure 
3.5.D). This data indicates that Lin28a can be post-translationaly modified by ubiquitin 
and suggests that BDNF signaling could alter the degradation of Lin28a through the 26S 
proteasomal pathway to increase Lin28a protein stability. 
Although  ubiquitin, a  76 aa  protein, is  best  known for targeting  proteins to the 
26S  proteasome for  degradation,  nonproteolytic signaling functions  of  ubiquitin 
modification are also wel known. Substrate proteins are linked to ubiquitin using distinct 
ubiquitin lysine (K) residues (K6,  K11,  K27,  K29,  K33,  K48, and  K63).  Each lysine 
residue can  be further conjugated  by another  ubiquitin to create  polyubiquitin chains. 
Nonproteolytic functions  of  ubiquitin include regulation  of  protein localization and 
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activity, membrane traficking, DNA repair, and chromatin dynamics. Unlike K48-linked 
ubiquitination, K63-linked ubiquitination does not trigger protein degradation but instead 
plays an important role in regulating  protein/protein interactions and  kinase signaling 
activation  (Chen  &  Sun  2009,  Wang et al.  2010).  To investigate  which type(s)  of 
ubiquitin  modification  Lin28a  undergoes,  we  obtained several  HA-tagged  ubiquitin 
constructs including a HA-Ubiquitin K63 (HA-Ub K63) and HA-Ubiquitin K48 (HA-Ub 
K48) (laboratory of Ted Dawson; (Lim et al. 2005). The HA-Ub K63 construct contains 
arginine substitutions  on al lysine residues except the lysine at  position  63 and is 
therefore expected to only alow the proteasome-independent K63 ubiquitin linkage. The 
HA-Ub  K48 construct contains arginine substitutions  on al lysine residues except the 
lysine at  position  48 and is expected to  promote  proteasome-dependent  K48-linked 
ubiquitin chains. In heterologous cels we expressed FL-Lin28a and either HA-Ub, HA-
Ub K63, or HA-Ub K48. Control conditions expressed HA-Ub, HA-Ub K63, or HA-Ub 
K48 alone.  We  used stringent IP conditions (high salt,  high  detergent) to  disrupt  non-
covalent interactions and IP’d lysates  with  Fl-coated  beads.  Upon immunobloting for 
HA  we  noted a ladder  of anti-HA immuoreactivity  present in each  FL IP condition 
consistent with polyubiquitination of WT Ub, K63 Ub, and K48 Ub but not in the control 
conditions (Figure  3.5.E). Interestingly, in the  HA-Ub  K63 condition  we  detected a 
prominent and distinct band above the 37 kD molecular weight marker which we predict 
represents a  K63-ubiquitinated form  of  Lin28a.  These results indicate the  Lin28a is 
subject to  both  proteasomal and  proteasomal-independent  ubiquitination  via  K48 and 
K63 linkages, respectively.   Ongoing experiments are  directed at evaluating  whether 
Lin28 ubiquitination can be altered by BDNF.  
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Since we also observed that MG132 treatment elevates TRBP protein levels, we 
next set  out to  determine if  TRBP itself is also subject to  ubiquitin  modification.  We 
hypothesized that since TRBP phosphorylation serves to stabilize TRBP protein itself, we 
might  observe  decreased  ubiquitination  of TRBP SΔD compared to cels expressing 
TRBP SΔA. To test this hypothesis, we expressed HA- K48 Ub and either FL-WT TRBP, 
-TRBP SΔD, or -TRBP SΔA in HEK 293T cels. In control conditions we expressed HA-
K48  Ub alone.  As  described above,  we  used a stringent IP  protocol to  pul-down  FL-
TRBP (WT, SΔD, and SΔA) and immunobloted for HA to determine whether HA-K48 
Ub conjugates to  FL-TRBP.  Our results show  higher  HA immunoreactivity in  TRBP 
SΔA expressing cels compared to TRBP SΔD and WT TRBP conditions (Figure 3.5.F). 
We  do  not  detect any  HA  bands in control conditions.  These results  demonstrate that 
TRBP  undergoes  K48-linked  ubiquitin  modification and that the  phosphorylation status 
of  TRBP  determines the extent  of this  ubiquitination.  This  data raises the exciting 
possibility that BDNF-induced  TRBP  phosphorylation  might lead to  decreased 
proteasome-mediated  degradation  of  TRBP  protein alowing increased levels  of  TRBP 
that can  bind to and stabilize  Lin28a  protein.  Ongoing  work is seeking to determine 
whether  BDNF stimulation leads to  decreased  TRBP  ubiquitination, and to assess the 
importance of phospho-TRBP in BDNF-mediated neuronal growth responses. 
 
Discussion 
 Our  work  has  uncovered a  novel signaling  mechanism responsible for the rapid 
post-transcriptional upregulation of Lin28a by BDNF. The results from this thesis chapter 
demonstrate that  Lin28a can associate  with a  miRNA  machinery component,  TRBP 
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protein. We also provide the first evidence that TRBP phosphorylation is critical for the 
stabilization of Lin28a. Our studies also show that Lin28a is post-translationaly modified 
by ubiquitin and that TRBP undergoes K48-linked poly-ubiquitination. Interestingly, we 
observed that the  phosphorylation status  of  TRBP  might  determine the  degree  of this 
post-translational modification. Furthermore, we reveal that BDNF has a distinct impact 
on Lin28a and its paralog Lin28b. Both Lin28a and Lin28b are crucial regulators of cel 
growth, developmental timing, and pluripotency and exert their efects by controling the 
abundance  of  Let-7 family  miRNAs.  However,  we find that in the context  of 
neurotrophin signaling Lin28a and Lin28b are subject to diferential post-transcriptional 
regulation. Given the high degree of homology between the two paralogs, future studies 
wil be directed at identifying distinct residues that might confer regulation to Lin28a but 
not Lin28b in BDNF signaling. An additional topic of interest is investigating the efect 
of  TRBP  phosphorylation  on a  physiological efect  of  BDNF such as  dendritic spine 
density.  BDNF-induced spine  density  depends  upon its ability to regulate  new  protein 
synthesis and therefore we suspect that TRBP phosphorylation and subsequent induction 
of Lin28a might be suficient to mediate a physiological efect of BDNF. We expect that 
knowledge from  our studies  wil  have far-reaching implications for further establishing 
the critical role of miRNA biogenesis and its regulation in shaping changes in pro-growth 






Figures and Legends 
Figure 3.1 Lin28a, but not its paralog Lin28b, is regulated by BDNF in a rapid, 
transcription-independent manner. 
(A) (Left)  Protein levels,  normalized to  GAPDH,  of  Lin28a  under  mock (0  min)  or 
BDNF stimulation (5  min,  20  min,  60  min;  100  ng/ml) in the  presence (gray  bars)  or 
absence (white bars) of Actinomycin-D (0.5 µg/ml). (Right) Immunobloting for Lin28a 
protein in neurons undergoing mock or BDNF stimulation for indicated minutes (min) in 
the presence (+) or absence (-) of Actinomycin-D. (B) Quantification of Lin28a mRNA 
level by individual TaqMan qRT-PCR reaction in hippocampal neurons undergoing mock 
or BDNF stimulation (20 min, 60 min,120 min). (C) (Left) Densitometric quantification 
of protein levels of endogenous Lin28a (white bars) or Flag-Lin28a (gray bars) in mock 
(0 min) or BDNF stimulated conditions (5 min, 20 min, 60 min). (Right) Immunobloting 
of endogenous Lin28a or FLAG-Lin28a in hippocampal neurons infected with lentivirus 
expressing FLAG-Lin28a undergoing mock (0 min) or BDNF stimulation (5 min, 20 min, 
60 min). (D) Normalized protein level of endogenous Lin28b (white bars), FLAG-Lin28b 
(gray  bars) in  neurons infected  with lentivirus expressing  FLAG-Lin28b ,  or  FLAG-
Lin28bΔNLS (dark  gray  bars) in  neurons infected  with lentivirus expressing  FLAG-
Lin28bΔNLS.  Neurons  were stimulated  with  BDNF for  0, 5, 20, or  60  min. (Right) 
Immunobloting  of endogenous  Lin28b,  FLAG-Lin28b,  or  FLAG-Lin28bΔNLS in 
hippocampal  neurons.  Al eror  bars represent  SEM.  *p  <  0.05  by  unpaired  Student’s t 
test. 
Experiments in panel D of this figure were performed by Alexandra Amen and wil also 








Figure 3.2 BDNF modulates TRBP phosphorylation to induce Lin28a. 
 
(A) (Left)  Densitometric  quantification  of  Lin28a  protein level in hippocampal  neurons 
treated  with  vehicle (DMSO)  or  Erk  1/2 inhibitor  U0126 for 30  minutes  prior to  mock 
(open bars) or BDNF stimulation for 60 minutes (hatched bars). (Right) Immunoblot of 
Lin28a in vehicle or U0126 conditions in the presence or absence of BDNF. (B) Efect of 
TRBP loss  on  Lin28a  protein level and  BDNF-regulated  Lin28a induction.   Lin28a 
protein levels  were assessed from  neurons infected  with lentivirus expressing either 
control shRNA (NTshRNA)  or shRNA targeting  TRBP (TRBPshRNA) (Left) 
Densitometric  quantification  of  protein levels. (Right) Immunobloting  of  Lin28a and 
TRBP in control or TRBP-deficient neurons under mock or BDNF stimulated conditions. 
(C)  Loss  of  Dicer  has  no efect  on  Lin28a  protein level. (Left)  Quantification  of  Dicer 
and  Lin28a  protein levels in  hippocampal  neurons expressing control shRNA 
(NTshRNA)  or  Dicer-targeting shRNA (Dicer shRNA). (Right) Immunobloting  of 
Lin28a and Dicer in control or Dicer-deficient neurons. (D) (Left) Quantification of FL-
Lin28a  protein level in  hippocampal  neurons infected  with lentivirus expressing either 
WT  TRBP, SΔD TRBP, SΔA  TRBP in the  presence  or absence  of  60  minute  BDNF 
treatment. (Right) Immunobloting  of  FL-TRBP and  FL-Lin28a in  neurons expressing 
SΔA TRBP, SΔD TRBP, or WT TRBP. (E) (Left) Quantification of Lin28a, TRBP, and 
Flag-TRBP SΔA in  hippocampal  neurons infected  with lentivirus expressing either 
control (NTsh; blue bars) or shRNA targeting TRBP (TRBPsh; purple bars) in mock or 
BDNF-stimulated conditions. (Right) Immunobloting for  FL-TRBP,  FL-Lin28a, and 








Figure 3.3 TRBP is suficient to induce Lin28a protein and reduce Let-7 miRNAs. 
(A) (Top  Left) Immunobloting  of  FL-TRBP and  FL-Lin28bΔNLS in  HEK  293T cels 
expressing control empty  vector (PCDNA),  WT  TRBP, SΔA  TRBP,  or SΔD  TRBP. 
(Botom  Left) Immunobloting  of  FL-TRBP and  FL-Lin28a in  HEK  293T cels 
expressing  WT  TRBP, SΔA  TRBP,  or SΔD  TRBP. (Right)  Quantification  of  FLAG-
Lin28a and FLAG- Lin28bΔNLS. (B) HEK 293T cels were transfected with FL-Lin28a 
and  WT  TRBP, SΔA  TRBP,  or SΔD  TRBP.  Scater  plot shows  FL-Lin28a  protein 
concentration  per amount  of  FL-TRBP  protein.  Expression  of  WT  TRBP, SΔA  TRBP, 
and SΔD  TRBP elevated  FL-Lin28a  protein level.  Induction  of  FL-Lin28a  by SΔD 
TRBP was greater compared to WT TRBP and SΔA TRBP conditions. The positive slope 
was greatest in SΔD TRBP-expressing cels and the slope was the lowest for SΔA TRBP-
expressing cels (C) Quantification of Let-7 miRNA levels by individual TaqMan qRT-
PCR reactions in  neurons expressing control  virus (green  bars)  or SΔD TRBP (orange 
bars) undergoing mock or BDNF treatment (60 minutes). miRNA levels were normalized 
to U6 snRNA and ploted relative to each mock-stimulated control virus condition (set as 
1.0). *p < 0.05 and **p < 0.01 by unpaired Student’s t test. Experiments in panel A and 















(A)  Lin28a is a  novel  TRBP  binding  partner.  HEK  293T cel lysates  were IP’d  with 
control rabbit IgG (rIgG)  or anti-FLAG antibody to  pul  down  FL-TRBP. 
Immunobloting for  Dicer and  Lin28a show co-association  with  FL-TRBP  but  not  with 
control IgG. (B)  HEK  293T cel lysates  were IP’d  with control  mouse IgG (mIgG)  or 
anti-FLAG antibody to  pul  down  FL-Lin28a. Immunobloting for  Dicer and  TRBP 
demonstrate co-association in the FL pul down condition but in control IgG condition. 
(C)  HEK  293T cels expressing  FL-Lin28bΔNLS  were IP’d  with anti-FLAG antibody. 
Dicer and TRBP are only present in the input condition but not in the IP’d Flag condition. 
(D) HEK 293T cels expressing Myc-TRBP and FL-Lin28a were first IP’d using an anti-
Myc antibody and co-association  of endogenous  Dicer  protein and  FL-Lin28a  was 
detected.  For the sequential IP the eluent  was IP’d  with anti-FLAG antibody and  both 
Dicer and Myc-TRBP co-associated.  
Experiments in this figure  were  performed  by  Alexandra  Amen and  wil also  be 












(A) (Top)  Densitometric  quantification  of  Lin28a  protein level.  Hippocampal  neurons 
were treated  with  vehicle (DMSO;  gray  bars)  or  10 µM  MG132 (20  min; red  bar) and 
either mock or BDNF stimulated (20 min). (Botom) Immunobloting for Lin28a protein 
in control  or  MG132 treated  neurons,  mock and  BDNF-stimulated. (B) (Top) 
Hippocampal  neurons  were treated  with  vehicle (DMSO;  gray  bars)  or  10 µM  MG132 
(60  min; red  bar) and either  mock  or  BDNF stimulated (60  min). (Botom) 
Immunobloting for  Lin28b  protein in control  or  MG132 treated  neurons,  mock and 
BDNF-stimulated. (C)  Quantification  of  TRBP  protein in  hippocampal  neurons treated 
with  vehicle (DMSO;  gray  bar)  or  10 µM  MG132 (20  min; red  bar). (D) (Left) 
Hippocampal neurons were infected with lentivirus expressing FL-Lin28a and HA-Ub. In 
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the IP control (Ctrl) condition  neurons expressed  only  HA-Ub. In  both conditions anti-
FLAG antibody  was  used to IP  FL-Lin28a  under stringent (high salt,  high  detergent) 
conditions. HA immunoreactivity was detected in only the FL IP condition. (Right) HEK 
293T cels were transfected with FL-Lin28a and HA-Ub and stringent IP was conducted 
to IP FL-Lin28a. (E) HEK 293T cels were transfected with FL-Lin28a and either HA-
UB  WT (WT),  HA- K63  UB (K63),  HA-K48  Ub (K48).  Control (Ctrl) conditions 
expressed  only  HA  WT,  K63,  or  K48.  Stringent IP  was conducted  using anti-FLAG 
antibody. Distinct HA immunoreactivity is detected in each FL IP condition but not in the 
control condition. (F) HEK293T cels were transfected with FL-WT TRBP, -SΔA TRBP, 
or -SΔD  TRBP and  HA-K48  Ub.  Control condition  was transfected  with  HA-K48  Ub 
alone.  FLAG-coated  beads  were  used to IP  FL-TRBP constructs  under stringent 
conditions.  HA  banding  was  more  prominent in SΔA  TRBP condition.  No  HA 








Primary cultures of mouse hippocampal neurons (DIV 14~15) were incubated in serum-
reduced  medium (0.5%  B27 supplement) for  2  hours, folowed  by preincubation  with 
Actinomycin-D (0.5 µg/ml ) for 10~30 min. Bath application of BDNF (100 ng/ml) was 
for designated periods (5 min - 2 hours). The cultures were washed 3 times and harvested 
on ice with lysis bufer (50 mM Hepes, 150 mM NaCl, 10% Glycerol, 1 mM EDTA, 1% 
Triton-X-100,  0.2%  SDS)  plus freshly added  protease inhibitor cocktail (Roche) and 
phosphatase inhibitor (sodium orthovanadate 0.2mM, sodium pyrophosphate 1mM) and 
NEM (50  mM).   Protein concentration  was  determined  by  Bradford  Assay or 
Bicinchoninic (BCA) assay.   Equal amounts  of lysate  protein  were resolved  on  SDS-
PAGE gels, and electrotransfered to PVDF membrane. Membrane was blocked with 5% 
BSA in Tris-bufered saline tween  20 (TBST 0.1%) for  2-4  hours and  probed  with 
primary antibodies in  5%  BSA in  TBST: Lin28a (Cel  Signaling D9F5),  FLAG  M2 
(Sigma  F3165),  HA  (Invitrogen  71-5500),  GAPDH (Milipore  6C5), TRBP (Abcam 
ab72110), Lin28b (Cel  Signaling  5422),  Myc  peptide (Sigma M2435).  For IP 
experiments we used the folowing reagents: 3X Flag peptide (Sigma F4799-4MG), 1X 
Flag  peptide: (Sigma  F3290-4MG),  Control  Mouse IgG (Santa  Cruz sc-2025),  Control 
Rabbit IgG (Santa Cruz sc-2027), Dicer (Sigma SAB4200087). 
Immunoprecipitation 
Stringent IP Protocol for Ubiquitination Assessment 
Stringent Polysomal Lysis Bufer: 100mM KCl, 10 mM HEPES, 4 mM MgCl2, 50 µM 
ZnCl2, 1% Triton-X, 0.25% SDS, 50 mM NEM, 1 mM DTT, PR619 5 µM, pH=7.3 
 104	  
 
Stringent Wash bufer: 1M NaCl, 50 µΜ ZnCl2, 1 mM MgCl2, 50 mM HEPES, 20% 
Glycerol, 50 mM NEM, 1% NP40, 0.1% SDS, pH=7.8 
Procedure: 
1. Block protein G sepharose beads in 1mL Stringent Wash bufer + 5% BSA for 1 
hour. 
2. Centrifuge beads at 2000xg for 25 sec at 4°C, suction of supernatant, and 
resuspend in Stringent Wash bufer +protease inhibitor+phosphatase 
inhibitor+NEM (to 50% slury). 
3. Coat beads with FLAG or MYC antibody (2-4 µg/IP) or control isotype-specific 
serum (IgG) rotating at 4° C overnight. 
4. Prepare beads: 
a. Wash beads  
i. Antibody coated beads from previous day + beads for preclearing 
(overestimate 25µl/sample x 2). Wash with 500 µl chiled 
Stringent Wash bufer (invert, spin 2000g for 25 sec at 4°C, 
suction of bufer with needle and repeat). 
b. Resuspend beads in 2x excess of Stringent Wash bufer plus 
protease/phosphatase inhibitor. Keep on ice until ready to use.  
5. Lysis: 
a. Wash cels 2x with ice-cold PBS + 0.9mM MgCl2 
b. Harvest lysate in Stringent Polysomal Lysis Bufer (900-1000 µl for 10 
cm dishes or 70 µl for 24 wel plates) with protease inhibitor cocktail, 
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phosphatase inhibitors, and freshly added 1mM DTT. Let cels sit in lysis 
bufer on ice 10 min, scrape, and rotate at 4 oC 10 minutes. 
c. Centrifuge lysate at 13.2 x g, 4 oC for 15 minutes. Remove supernatant. 
6. Protein assay (Bradford or BCA) to determine concentration 
7. Lysate pre-clearing: 
a. Pre-clear lysate with protein G sepharose beads pre-washed in Stringent 
Wash bufer Add 37.5 µl 3x bead dilution to lysates. 
b. Incubate 30-45 min rotating at 4 oC, then spin 2000g for 1 minute at 4oC 
and remove cleared lysate to new tube. 
8. Remove 2.5% lysate protein sample for input, add SDS, boil, and freeze to run on 
gel later 
9. Add 45 µl antibody-bound beads to protein lysate (1000-2600 µg) and incubate 
rotating 4 hours at 4 oC 
10. Washes  
a. Wash 3x with 1 mL cold Stringent Wash bufer plus proteasome and 
phosphatase inhibitors rotating 10 min at 4oC. Centrifuge at 2000g, 4oC 
for 25sec. Use vacuum line with needle to suction of supernatant (careful 
not to remove the beads!) 
b. Wash 1x with 1mL cold Stringent Wash bufer WITHOUT 
protease/phosphatase inhibitors and rotate for 5 min at 4oC. Spin for 1 
minute at 2000g 4oC, and remove bufer entirely with vacuum suction.  
11. Boil Elution 
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a. Add 30 µl of Stringent Wash bufer without protease/phosphatase 
inhibitor and 6 µl of 6x SDS PAGE loading bufer. 
b. Boil at 85-90 oC for 10-15 minutes  
c. Spin for 1 minute at 13,000g at room temperature and transfer supernatant 
to a new eppendorf tube to run on SDS PAGE gel 
 
TRBP/Lin28a coIP Protocol (maximized RNA stability) 
Polysomal lysis bufer (PLB): 100mM KCl, 4mM MgCl2, 10mM HEPES (pH 7.3), 
50µM ZnCl, 0.5% NP-40 (add to 10mL: protease inhibitors, phosphatase inhibitors, 
20mM NEM) 
NT2 Bufer: 50mM HEPES (pH=7.8), 150mM NaCl, 1mM MgCl2, 50µM ZnCl, 0.05% 
NP-40 (add to 10mL: protease inhibitors, phosphatase inhibitors, 20mM NEM) 
***For PLB and NT2 bufers use DEPC H20 
 
Day 0: 
1) Block protein G sepharose beads in 1.5mL NT2 bufer + 5% BSA for 1  
hour. 
 i. use 30µl 50% bead slury per sample 
 
2) Centrifuge beads at 2000xg for 25 sec at 4°C, suction of supernatant, and 
resuspend in NT2+protease inhibitor+phosphatase inhibitor+NEM (to 50% slury). 
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3) Coat beads with Flag antibody or control isotype-specific serum (IgG) rotating at 
4° C overnight. 
a. Use about 1µg antibody per 200µg protein sample 
Day1: 
1) Prepare beads: 
a. Wash beads  
i. Wash antibody coated beads from day 0 and beads for preclearing 
(30µL 50% slury per sample) with 1.5mL chiled NT2 (invert, 
spin 2000g for 25 sec at 4°C, suction of bufer with needle). 
i. Repeat wash  
b. Resuspend beads in 2x excess of NT2+protease/phosphatase inhibitor 
(45µL per IP final volume).  
 
Neurons (DIV14) 
2) BDNF stimulation: 
-Incubate primary mouse hippocampal cultures, DIV14, in serum-reduced media 
(1/4 B27) for 2 hrs 
-Dilute stock Actinomycin-D 1:1250 in NBA and add 100µl to each wel. 
Incubate 5 min prior to BDNF/mock stimulation. 
-Add 40µl of 1ng/µl BDNF (diluted in NBA) to a final concentration of 
100ng/mL. Incubate 60 minutes. 
3) Lysis: 
-Wash cels 2x with ice-cold PBS + 0.9mM MgCl2 
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-Harvest lysate in polysomal lysis bufer + protease inhibitor cocktail, 
phosphatase inhibitors, 20mM NEM, and freshly added 1mM DTT. Let cels sit in 
lysis bufer on ice 10 min prior to scraping. 
 -Add 70µL to first wel, and 40µL to subsequent wels. Transfer lysate 
from previous to next wel before scraping. 
-Rotate harvested lysate for 10min at 4°C. 
-Centrifuge lysate at 13.2 x g, 4°C for 15 minutes. Remove supernatant. 
 
HEK293T cels 
2) Ensure 100% confluency of 10cm dishes. No stimulation required. 
 
    3) Lysis: 
-Wash cels 2x with ice-cold PBS + 0.9mM MgCl2 
-Harvest lysate in 1mL polysomal lysis bufer + protease inhibitor cocktail, 
phosphatase inhibitors, 20mM NEM, and freshly added 1mM DTT per dish. Let 
cels sit in lysis bufer on ice 10 min prior to scraping. 
-Rotate harvested lysate for 10min at 4°C. 
-Centrifuge lysate at 13.2 x g, 4°C for 15 minutes. Remove supernatant. 
 
Al cel types 
 
4) Protein assay (Bradford) to determine concentration. 
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    5) Lysate pre-clearing: 
-Pre-clear lysate with protein G sepharose beads pre-washed in NT2 bufer (from 
step 1). Add 45µL 3x bead dilution to lysate sample. 
-Incubate 30 min rotating at 4°C, then spin 2000g for 1 minute at 4°C and remove 
cleared lysate to new tube. 
 
6) Remove a 2.5-10% lysate protein sample (depending on amount to IP), add SDS,  
boil, and freeze to run on gel later. 
 
7) Add 45µL antibody bound beads (now 15µl beads in 33% suspension) to protein 
lysate. 
 -Use p200 tips with ends cut of 
 -Incubate rotating 3-4 hours at 4°C 
 
8) Washes 
-Wash 3x with 1.5µl cold NT2 + protease and phosphatase inhibitors+NEM by 
filing tube, resuspending, and then briefly centrifuging the breads in an eppendorf 
tube. Centrifuge at 2000g, 4°C for 25sec. Use vacuum line to suction of supernatant; 
crush pipete tip with tweezers to decrease tip diameter (careful not to remove the 
beads!). 
  ***For third wash, let rotate at 4°C for 5 minutes before suctioning of 
supernatant. 
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-Wash 1x with 1mL cold NT2 WITHOUT protease/phosphatase inhibitors, and spin 
for 1 minute at 2000g 4°C. Remove bufer entirely with vacuum suction.  
 
10) Elution with flag (or myc) peptide 
-Add 30µl of peptide, diluted in NT2 to 100µg/mL (flag peptide - 1:40 from stock; 
myc peptide – 1:500 from stock) 
-Rotate 30 min-1 hr at ROOM TEMP 
-Spin 10sec at 12000rpm at ROOM TEMP 
-Colect 30µl of eluent 1 
-Repeat steps and colect eluent 2 
-Repeat steps and colect eluent 3 
-Combine eluents (about 90µl) and spin for 10sec at 12000rpm 
-Pipet of 30-45µl of eluent 
-Boil samples with loading dye for SDS-PAGE analysis 
 
TRBP/Lin28a/Dicer sequential IP Protocol 
Polysomal lysis bufer (PLB): 100mM KCl, 4mM MgCl2, 10mM HEPES (pH 7.3), 
50uM ZnCl, 0.5% NP-40 (add to 10mL: protease inhibitors, phosphatase inhibitors, 
20mM NEM) 
NT2 Bufer: 50mM HEPES (pH=7.8), 150mM NaCl, 1mM MgCl2, 50uM ZnCl, 0.05% 
NP-40 (add to 10mL: protease inhibitors, phosphatase inhibitors, 20mM NEM) 
 
***For PLB and NT2 bufers use DEPC H20 
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Day 1: 
1) Transfect 1 10cm dish with 0.25µg/mL flag-Lin28a and 0.5µg/mL myc-
TRBP-WT  
2) Transfect 1 10cm dish with 0.25 µg/mL flag-Lin28a only 
a. Bring up to 30µg total with PCDNA3.1 empty vector 
b. Add 124µL CaCl2 per dish 
c. Bring total volume up to 1mL with ddH2O 
d. Add 1mL 2XHBSS to 1mL DNA/CaCl2 solution. Bubble and add 
drop-wise to plate. 




5) Block protein G sepharose beads in 1.5mL NT2 bufer + 5% BSA for 1  
hour. 
 i. use 30µl 50% bead slury per sample, overestimate by 1 sample = 30µl 
X 3 = 90µL 
 
6) Centrifuge beads at 2000xg for 25 sec at 4°C, suction of supernatant, and 
resuspend in NT2+protease inhibitor+phosphatase inhibitor+NEM (to 50% slury). 
 
7) Coat half (45µL) of the beads with mouse anti-flag antibody, and the other half 
(45µL) of the beads with rabbit anti-myc antibody. 
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4) Prepare beads: 
a. Wash beads  
i. Wash antibody coated beads from day 0 and beads for preclearing 
(30µL 50% slury per sample) with 1.5mL chiled NT2 (invert, 
spin 2000g for 25 sec at 4°C, suction of bufer with needle). 
i. Repeat wash  
b. Resuspend beads in 2x excess of NT2+protease/phosphatase inhibitor. 
 
2) Ensure 100% confluency of 10cm dishes. No stimulation required. 
 
    3) Lysis: 
-Wash cels 2x with ice-cold PBS + 0.9mM MgCl2 
-Harvest lysate in 1mL polysomal lysis bufer + protease inhibitor cocktail, 
phosphatase inhibitors, 20mM NEM, and freshly added 1mM DTT per dish. Let 
cels sit in lysis bufer on ice 10 min prior to scraping. 
-Rotate harvested lysate for 10min at 4°C. 
-Centrifuge lysate at 13.2 x g, 4°C for 15 minutes. Remove supernatant. 
 
8) Protein assay (Bradford) to determine concentration. 
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    5) Lysate pre-clearing: 
-Pre-clear lysate with protein G sepharose beads pre-washed in NT2 bufer (from 
step 1). Add 45µL 3x bead dilution to lysate sample. 
-Incubate 30 min rotating at 4°C, then spin 2000g for 1 minute at 4°C and remove 
cleared lysate to new tube. 
 
6) Remove a 2.5-10% lysate protein sample (depending on amount to IP), add SDS, 
boil, and freeze to run on gel later. 
 
7) IP #1: Add 45µL myc-antibody bound beads (now 15µl beads in 33% suspension) 
to protein lysate. 
 -Use p200 tips with ends cut of 
 -Incubate rotating 3 hours at 4°C 
 
8) Washes 
-Wash 3x with 1.5mL cold NT2 + protease and phosphatase inhibitors+NEM by 
filing tube, resuspending, and then briefly centrifuging the breads in an eppendorf 
tube. Centrifuge at 2000g, 4°C for 25sec. Use vacuum line to suction of supernatant; 
crush pipete tip with tweezers to decrease tip diameter (careful not to remove the 
beads!). 
  ***For third wash, let rotate at 4°C for 5 minutes before suctioning of 
supernatant. 
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-Wash 1x with 1mL cold NT2 WITHOUT protease/phosphatase inhibitors, and spin 
for 1 minute at 2000g 4°C. Remove bufer entirely with vacuum suction.  
 
10) Elution with myc peptide 
-Add 30µl of peptide, diluted in NT2 1:500 from stock 
-Rotate 30 min at 4°C 
-Spin 10sec at 12000rpm at 4°C 
-Colect 30µl of eluent 1 
-Repeat steps and colect eluent 2 
-Repeat steps and colect eluent 3 
-Combine eluents (about 90µl) and spin for 10sec at 12000rpm at 4°C 
-Remove a 10% elution sample (about 9µL, to ensure that 1st IP worked) and bring 
up to 30µL with NT2. Boil samples with loading dye for SDS-PAGE analysis 
 
11) IP #2: Add 45µL flag-antibody bound beads (now 15µl beads in 33% 
suspension) to protein lysate. 
 -Use p200 tips with ends cut of 
 -Incubate rotating 3 hours at 4°C 
 
12) Washes 
-Wash 3x with 1.5ul cold NT2 + protease and phohsphatase inhibitors+NEM by 
filing tube, resuspending, and then briefly centrifuging the breads in an eppendorf 
tube. Centrifuge at 2000g, 4°C for 25sec. Use vacuum line to suction of supernatant; 
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crush pipete tip with tweezers to decrease tip diameter (careful not to remove the 
beads!). 
  ***For third wash, let rotate at 4°C for 5 minutes before suctioning of 
supernatant. 
-Wash 1x with 1mL cold NT2 WITHOUT protease/phosphatase inhibitors, and spin 
for 1 minute at 2000g 4°C. Remove bufer entirely with vacuum suction.  
 
13) Elution – boil of 
-Add 30µL NT2 without inhibitors plus 6µL 6XSDS loading bufer to beads from 
each IP.  
-Boil 10min  
- Spin 10sec at 12000rpm at ROOM TEMP 
-Remove liquid sample from the top of beads (around 35-40µL). Proceed directly to 
western bloting, or freeze overnight. 
 
Plasmids 
Wildtype (WT) TRBP, phospho-mutant (SΔA) TRBP, and phosphomimetic (SΔD) TRBP 
were generous gifts from Dr. Zain Paroo. Flag-Lin28a was a generous gift from Dr. 
Yinqun Huang. HA-Ubiquitin WT, K63, K48 constructs were generous gifts from Dr. 
Ted Dawson. The Richard Gregory laboratory kindly provided Lin28bΔNLS mutant. 





MG132 (Sigma C2211), PR619 (LifeSensors SI9619), U0126 (Cel Signaling 9903S), 
NEM (Sigma 04260) 
 
Lentivirus and Gene Knockdown using shRNA 
TRBP shRNA Infection: 
Reduce culture media to ~300µl and infect for 4 days with: 
o 50µl TRBP shRNA virus 
o 20µl Non-Target shRNA (NT shRNA) virus 
• Add media after 8 hours 
• Change media every 24 hours 
Dicer shRNA Infection: 
• Reduce culture media to ~300ul 
• Infect for 4 days with: 
o 30µl Dicer shRNA virus 
o 10µl Non-Target shRNA (NT shRNA) virus 
• Add media after 8 hours 
• Change media every 24 hours 
 
Quickchange Mutation Protocol to Generate shRNA-resistant TRBP SΔA Construct  
	  
Primer Design: 
• Design two complementary primers: 
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o Contain mutation 
o Mutation flanked by ~15 unmodified nucleotides (25 to 45 total nt) 
o Minimum %GC > 40% 
o Terminate in one or more G/C 
• Tm  > 78
oC ** 




• Size of Vector ~ 9500bp 
• Primer Mix: 196µl + 2µl Forward Primer + 2µl Reverse Primer 
• DNA Mix: 10ng DNA = 0.01µg DNA in 0.5µl → [DNA] = 0.02 µg/ul 
• [FSW-TRBPΔA] = 0.9927µg/µl 
• 0.9927/0.02 = 49.5 → 1:49.5 dilution 
PCR Reaction Master Mixes:  
 
-Mg2+ 
Master Mix: -Mg2+ (Typicaly works beter) 





dH2O 17 5 (4+1) 85 
Mg2+ 0 5 0 
Primer Mix 2.5 5 12.5 
dNTPs 2.0 5 10.0 
Phusion Bufer 2.5 5 12.5 
Phusion Polymerase 0.5 5 2.5 
DNA 0.5   






Master Mix: +Mg2+ 





dH2O 14.5 5 (4+1) 72.5 
Mg2+ 2.5 5 12.5 
Primer Mix 2.5 5 12.5 
dNTPs 2.0 5 10.0 
Phusion Bufer 2.5 5 12.5 
Phusion Polymerase 0.5 5 2.5 
DNA 0.5   
 25  125 
 
-Phusion Polymerase 
Master Mix: -Phusion 





dH2O 15 5 (4+1) 75 
Mg2+ 2.5 5 12.5 
Primer Mix 2.5 5 12.5 
dNTPs 2.0 5 10.0 
Phusion Bufer 2.5 5 12.5 
Phusion Polymerase 0 5 0 
DNA 0.5   






Step Cycles Temp (oC) Time 
1 1 95 5:00 
2 15 95 1:00 
  69 (Tm = +3) 1:00 
  72 10:00 
(1min/kb) 
3 1 72 10:00 









Template Digest:  
 
DPN1 Digest 





PCR Product (2x 
tubes) 
40 
2 tubes per reaction 
per condition 
 
NEB4 (10x) 5 6.5 (6+0.5) 32.5 
DPN1 2 6.5 13 
dH2O 3 6.5 19.5 
 50   
 
• Heat Inactivate 20 min @ 80oC 
• Transform: 3µl DNA digest 
• Plate:  
o 5µl + 75µl LB+ 
o Remaining 
 
** Use:  
• For Primer Design: Tm = 81.5 + 0.41(%GC) – 675/N – %mismatch, GC = percent 
GC, N = primer length (nt) 












Chapter IV: Conclusions and Perspectives 
 
BDNF-induced regulation  of  protein synthesis is crucial for its role in shaping 
synaptic structure, function, and  plasticity.  Dysregulation  of  BDNF signaling is 
implicated in a  variety  of  neurological and  neuropsychiatric  disorders  highlighting the 
necessity to beter understand the mechanisms of BDNF action. A remarkable aspect of 
the  post-transcriptional regulation  of  gene expression  by  BDNF is the  high  degree  of 
transcript specificity.  BDNF  modulates  protein synthesis in an extraordinarily specific 
manner with  both selective enhancement and reduction in the levels  of specific target 
genes.  This tight control  of  protein synthesis enables  BDNF to  modulate synaptic 
function in a  pro-growth  manner.  To  unravel the  molecular  mechanisms that  govern 
BDNF-dependent protein synthesis,  my thesis  work first addressed the folowing 
question:  How  does  BDNF achieve  post-transcriptional  gene target specificity?  We 
discovered that BDNF regulates miRNA biogenesis to generate translation specificity in 
hippocampal  neurons and that  BDNF-mediated  post-transcriptional induction  of  Lin28a 
is essential for the enhanced translation  of a specific set  of  pro-growth and  plasticity-
related  genes.  We also found that  Lin28a function is critical for  BDNF-mediated 
dendritic  outgrowth. In  particular,  we showed that  Lin28a-mediated  downregulation  of 
the Let-7 family of miRNAs was necessary for BDNF-enhanced dendrite growth and for 
relieving translational repression of BDNF target genes important for pro-growth efects 
of  BDNF.  These results  heightened  our interest in investigating the  mechanism 
underlying BDNF-induced regulation of Lin28a. 
The exciting and intriguing results obtained during the first portion of my thesis 
research emphasized the important role  of the  Lin28a/Let-7 axis in  BDNF signaling, 
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which was very unexpected in light of the fact that Lin28a was previously thought to be 
absent from  diferentiated cels.  Our finding that  Lin28a could  be induced  by a 
neurotrophin in mature neurons (the first diferentiated tissue reported to express Lin28a) 
and that its function was crucial for BDNF-dependent translational control led us to pose 
the second  major  question  of  my thesis  work:  what are the  molecular  mechanisms 
responsible for the rapid and  post-transcriptional regulation  of  Lin28a  by  BDNF? 
Answering this question was the goal of the second portion, and chapter 3, of my doctoral 
work.   We revealed that  BDNF-induced  phosphorylation  of  TRBP is  necessary and 
suficient for rapid (significant  by  5  minutes) induction  of  Lin28a  protein levels.  We 
found that  Lin28a  protein can  physicaly associate  with  TRBP in  hippocampal  neurons 
and that this interaction is enhanced when TRBP is phosphorylated in response to BDNF. 
In the absence  of  TRBP,  BDNF is  unable to  mediate rapid induction  of  Lin28a  protein 
levels.  We also  demonstrated that  both  Lin28a and  TRBP  undergo  post-translational 
ubiquitin  modifications.  Ongoing  work is aimed at  determining the  protein  half-life  of 
Lin28a, which we hypothesize wil be short under basal conditions, and whether BDNF 
and TRBP phosphorylation might prolong Lin28a half-life by promoting Lin28a protein 
stabilty.   We are also in the  process  of  determining  whether  BDNF signaling can 
modulate the  ubiquitination status  of  Lin28a and/or  TRBP as a  means  of regulating 
protein turn over.   
Another exciting area  of  our  ongoing and future research is investigating the 
diferential regulation  of the  Lin28  paralogs  by  BDNF.  Mammals  have evolved two 
forms  of  Lin28,  Lin28a and  Lin28b, that share  ~77% identity at the  protein level. 
Although  both  paralogs function to  block  biogenesis  of  Let-7  miRNAs, they  do so 
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through distinct mechanisms. Lin28a exists primarily in the cytoplasm where it inhibits 
pre- to  mature  Let-7  miRNA  processing,  while  Lin28b exists  primarily in the  nucleus 
where it inhibits  pri- to  pre-Let-7  processing.   Our  data showed that  Lin28a,  but  not 
Lin28b, is subject to rapid and  postranscriptional regulation  by  BDNF in  hippocampal 
neurons. Interestingly, TRBP phosphorylation had absolutely no efect on celular Lin28b 
levels, whereas Lin28a protein level was dramaticaly enhanced by the phosphorylation 
of  TRBP.  Furthermore,  unlike  Lin28a,  Lin28b  does  not  bind to  TRBP.  These results 
demonstrate a critical  diference in the regulation  of these  paralogs,  which  were at  one 
point thought to  be functionaly redundant.  Our  work  now emphasizes the  unique 
biological role of these paralogs and suggests that at the protein level they may undergo 
diferent  post-translational  modifications and  participate in  distinct signaling  pathways. 
Given the critical role that Lin28a and Lin28b play in development and growth as wel as 
their role in tumorigenesis, we expect that elucidating the diverse molecular mechanisms 
regulating their function wil have a broad impact on the fields of neuronal plasticity, as 
wel as stem cel and tumor biology.  
BDNF-dependent  protein synthesis  plays a crucial role in  hippocampal-based 
learning and memory processing. For example, both novel object recognition and spatial 
learning are impaired in animals with a hippocampal-specific deletion of BDNF (Heldt et 
al.,  2007).  An exciting future  direction  wil  be to evaluate the efects  of  Lin28a loss in 
hippocampal-based learning.  To accomplish this  goal  we  have  obtained a conditional 
Lin28a mouse line in which exons encoding the gene for Lin28a are flanked by loxP sites 
(Lin28afl/fl) from the laboratory  of  George  Daley.  By crossing the Lin28afl/fl with a 
R26R/CAMKIα-CreERT2 mouse line  we  plan to conditionaly  knockout  Lin28a in 
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forebrain  neurons. Investigations  using this  mouse line  wil alow the findings in this 
thesis to  be extended and  directly assess the importance  of  Lin28a in cognitive 
performance.  Results from these experiments wil be a significant step forward as they 
wil  be the first to test the role in adult  brain  of an evolutionarily conserved axis 
(Lin28/Let-7) known to control growth and developmental timing during embryogenesis.  
Multiple  behavioral tests are  known to  be  hippocampal-dependent and are impaired in 
mice that lack  BDNF signaling.  We expect that loss  of  Lin28a in vivo wil impair 
memory formation and  negatively afect the  performance  of animals  on learning and 
memory tasks.  
Dysregulated translation is associated  with a range  of cognitive  disorders 
including  Fragile  X  Syndrome (FXS), a  neurodevelopmental  disorder and autism 
spectrum  disease associated  with cognitive impairment,  behavioral  disturbance, and 
disrupted  neuronal  network function.  Aberant  BDNF signaling  has also  been linked to 
autism spectrum  disorders.  Our  discovery that  Lin28a  plays a crucial role in regulating 
the rapid efects  of  BDNF-induced  protein synthesis, leads  us to suspect that  Lin28a 
might play a role in the pathophysiology of autism spectrum disorders.  Future work in 
our lab  wil explore the involvement  of  BDNF and the  Lin28/Let-7 axis in the 
pathogenesis of autism spectrum disorders and other instances of disordered synaptic and 
neuronal  growth in the central  nervous system.  The coordination  of a  multitude  of 
growth-related  genes  by the  Lin28/Let-7 axis leads  us to suspect that its  dysregulation 
would  be  very likely to  produce cognitive impairment and  defects in learning and 
memory.  
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Overal my thesis addressed the broader question of how stimulus-dependent gene 
expression is  post-transcriptionaly regulated in the central  nervous system to alow the 
coordinated induction of ensembles of pro-growth proteins.  Regulation of the neuronal 
proteome is required for shaping appropriate synaptic function and is critical for neural 
circuit formation. Our work was the first description of a paradigm for the generation of 
translational specificity in BDNF-induced neuronal protein synthesis. We also established 
a  novel role for  Lin28a in  mature  neurons  by  demonstrating that  Lin28a confers 
specificity to  BDNF-regulation  of translation  by functioning as a critical selector 
molecule that blocks Let-7 miRNAs from being processed and alowing gene targets of 
Let-7 to  undergo enhanced translation.  Without  Lin28a,  BDNF is  unable to  upregulate 
the synthesis  of  growth-promoting targets that are important for  neuronal  plasticity and 
cognition.  Ongoing  work is focused  on  understanding  how  BDNF signaling controls 
Lin28a protein levels and future work wil elucidate the role of Lin28a in vivo. Another 
topic of future interest wil be to determine whether other activity-dependent stimuli may 
exert their efects  on  gene expression through a similar  paradigm in  which a  unique 
selector molecule coordinates the expression of an entire suite of proteins. Since a single 
miRNA can regulate the expression of hundreds of transcripts, this makes miRNAs and 
miRNA regulators, such as RNA binding proteins, atractive candidates for coordinating 
complex biological responses. The insights provided in this thesis reveal the critical role 
of miRNA biogenesis regulation in BDNF signaling and pave the way for future studies 








Aakalu,  G.,  Smith,  W.B.,  Nguyen,  N., Jiang,  C., and  Schuman,  E.M. (2001).  Dynamic 
visualization of local protein synthesis in hippocampal neurons. Neuron 30, 489-502. 
Abrahante, J.E.,  Daul,  A.L.,  Li,  M.,  Volk,  M.L.,  Tennessen, J.M.,  Miler,  E.A., and 
Rougvie,  A.E. (2003).  The  Caenorhabditis elegans  hunchback-like  gene lin-57/hbl-1 
controls developmental time and is regulated by microRNAs. Developmental cel 4, 625-
637. 
Alder, J., Thakker-Varia, S., Crozier, R.A., Shaheen, A., Plummer, M.R., and Black, I.B. 
(2005). Early presynaptic and late postsynaptic components contribute independently to 
brain-derived neurotrophic factor-induced synaptic plasticity. J Neurosci 25, 3080-3085. 
Ambros,  V., and  Horvitz,  H.R. (1984).  Heterochronic  mutants  of the  nematode 
Caenorhabditis elegans. Science 226, 409-416. 
Anderson, P., and Kedersha, N. (2006). RNA granules. J Cel Biol 172, 803-808. 
Andl, T., Murchison, E.P., Liu, F., Zhang, Y., Yunta-Gonzalez, M., Tobias, J.W., Andl, 
C.D.,  Seykora, J.T.,  Hannon,  G.J., and  Milar,  S.E. (2006).  The  miRNA-processing 
enzyme dicer is essential for the morphogenesis and maintenance of hair folicles. Cur 
Biol 16, 1041-1049. 
Aoto, J., Nam, C.I., Poon, M.M., Ting, P., and Chen, L. (2008). Synaptic signaling by al-
trans retinoic acid in homeostatic synaptic plasticity. Neuron 60, 308-320. 
Ashraf,  S.I.,  McLoon,  A.L.,  Sclarsic,  S.M., and  Kunes,  S. (2006).  Synaptic  protein 
synthesis associated with memory is regulated by the RISC pathway in Drosophila. Cel 
124, 191-205. 
Banerjee, S., Neveu, P., and Kosik, K.S. (2009). A coordinated local translational control 
point at the synapse involving relief from silencing and MOV10 degradation. Neuron 64, 
871-884. 
Bartel,  D.P. (2009).  MicroRNAs: target recognition and regulatory functions.  Cel 136, 
215-233. 
Bassel,  G.J., and  Waren,  S.T. (2008).  Fragile  X syndrome: loss  of local  mRNA 
regulation alters synaptic development and function. Neuron 60, 201-214. 
Bekinschtein, P., Cammarota, M., Igaz, L.M., Bevilaqua, L.R., Izquierdo, I., and Medina, 
J.H. (2007).  Persistence  of long-term  memory storage requires a late  protein synthesis- 
and BDNF- dependent phase in the hippocampus. Neuron 53, 261-277. 
Bonev, B., Pisco, A., and Papalopulu, N. (2011). MicroRNA-9 reveals regional diversity 
of neural progenitors along the anterior-posterior axis. Developmental cel 20, 19-32. 
Brengues,  M.,  Teixeira,  D., and  Parker,  R. (2005).  Movement  of eukaryotic  mRNAs 
between polysomes and cytoplasmic processing bodies. Science 310, 486-489. 
Brown, V., Jin, P., Ceman, S., Darnel, J.C., O'Donnel, W.T., Tenenbaum, S.A., Jin, X., 
Feng,  Y.,  Wilkinson,  K.D.,  Keene, J.D., et  al. (2001).  Microaray identification  of 
 126	  
FMRP-associated  brain  mRNAs and altered  mRNA translational  profiles in fragile  X 
syndrome. Cel 107, 477-487. 
Caldeira,  M.V.,  Melo,  C.V.,  Pereira,  D.B.,  Carvalho, R.,  Coreia,  S.S.,  Backos,  D.S., 
Carvalho,  A.L.,  Esteban, J.A., and  Duarte,  C.B. (2007a).  Brain-derived  neurotrophic 
factor regulates the expression and synaptic  delivery  of alpha-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid receptor subunits in hippocampal neurons. The Journal 
of biological chemistry 282, 12619-12628. 
Caldeira,  M.V.,  Melo,  C.V.,  Pereira,  D.B.,  Carvalho,  R.F.,  Carvalho,  A.L., and  Duarte, 
C.B. (2007b). BDNF regulates the expression and trafic of NMDA receptors in cultured 
hippocampal neurons. Mol Cel Neurosci 35, 208-219. 
Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, 
M.,  Ratan,  S.,  Bulrich,  F.,  Negrini,  M., et  al. (2004).  Human  microRNA  genes are 
frequently located at fragile sites and  genomic regions involved in cancers.  Proc  Natl 
Acad Sci U S A 101, 2999-3004. 
Castren, M., Lampinen, K.E., Mietinen, R., Koponen, E., Sipola, I., Bakker, C.E., Oostra, 
B.A., and  Castren,  E. (2002).  BDNF regulates the expression  of fragile  X  mental 
retardation protein mRNA in the hippocampus. Neurobiology of disease 11, 221-229. 
Ceman,  S.,  O'Donnel,  W.T.,  Reed,  M.,  Paton,  S.,  Pohl, J., and  Waren,  S.T. (2003). 
Phosphorylation influences the translation state  of  FMRP-associated  polyribosomes. 
Human molecular genetics 12, 3295-3305. 
Chang,  H.M.,  Triboulet,  R.,  Thornton, J.E., and  Gregory,  R.I. (2013).  A role for the 
Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway. Nature 497, 244-248. 
Chendrimada,  T.P.,  Finn,  K.J., Ji,  X.,  Bailat,  D.,  Gregory, R.I.,  Liebhaber,  S.A., 
Pasquineli,  A.E., and  Shiekhatar,  R. (2007).  MicroRNA silencing through  RISC 
recruitment of eIF6. Nature 447, 823-828. 
Doench, J.G., Petersen, C.P., and Sharp, P.A. (2003). siRNAs can function as miRNAs. 
Genes Dev 17, 438-442. 
Du, L., and Richter, J.D. (2005). Activity-dependent polyadenylation in neurons. RNA 11, 
1340-1347. 
Eulalio,  A.,  Behm-Ansmant, I.,  Schweizer,  D., and Izauralde,  E. (2007).  P-body 
formation is a consequence,  not the cause,  of  RNA-mediated  gene silencing.  Mol  Cel 
Biol 27, 3970-3981. 
Gehrke,  S., Imai,  Y.,  Sokol,  N., and  Lu,  B. (2010).  Pathogenic  LRRK2  negatively 
regulates microRNA-mediated translational repression. Nature 466, 637-641. 
Grimson, A., Farh, K.K., Johnston, W.K., Garet-Engele, P., Lim, L.P., and Bartel, D.P. 
(2007). MicroRNA targeting specificity in mammals: determinants beyond seed pairing. 
Molecular cel 27, 91-105. 
Grosshans,  H., Johnson,  T.,  Reinert,  K.L.,  Gerstein,  M., and  Slack,  F.J. (2005).  The 
temporal paterning microRNA let-7 regulates several transcription factors at the larval to 
adult transition in C. elegans. Developmental cel 8, 321-330. 
 127	  
Guo, H., Ingolia, N.T., Weissman, J.S., and Bartel, D.P. (2010). Mammalian microRNAs 
predominantly act to decrease target mRNA levels. Nature 466, 835-840. 
Hagan, J.P.,  Piskounova,  E., and  Gregory,  R.I. (2009).  Lin28 recruits the  TUTase 
Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cels. Nat Struct Mol Biol 
16, 1021-1025. 
He, C., Kraft, P., Chen, C., Buring, J.E., Pare, G., Hankinson, S.E., Chanock, S.J., Ridker, 
P.M., Hunter, D.J., and Chasman, D.I. (2009). Genome-wide association studies identify 
loci associated with age at menarche and age at natural menopause. Nature genetics 41, 
724-728. 
Heldt, S.A., Stanek, L., Chhatwal, J.P., and Ressler, K.J. (2007). Hippocampus-specific 
deletion  of  BDNF in adult  mice impairs spatial  memory and extinction  of aversive 
memories. Mol Psychiatry 12, 656-670. 
Hendrickson, D.G., Hogan, D.J., McCulough, H.L., Myers, J.W., Herschlag, D., Ferel, 
J.E., and Brown, P.O. (2009). Concordant regulation of translation and mRNA abundance 
for hundreds of targets of a human microRNA. PLoS Biol 7, e1000238. 
Heo, I., Joo, C., Kim, Y.K., Ha, M., Yoon, M.J., Cho, J., Yeom, K.H., Han, J., and Kim, 
V.N. (2009). TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-
microRNA uridylation. Cel 138, 696-708. 
Huang,  E.J., and  Reichardt,  L.F. (2003).  Trk receptors: roles in  neuronal signal 
transduction. Annu Rev Biochem 72, 609-642. 
Huang,  Y.S.,  Carson, J.H.,  Barbarese,  E., and  Richter, J.D. (2003).  Facilitation  of 
dendritic mRNA transport by CPEB. Genes & development 17, 638-653. 
Huang, Y.S., Jung, M.Y., Sarkissian, M., and Richter, J.D. (2002). N-methyl-D-aspartate 
receptor signaling results in  Aurora  kinase-catalyzed  CPEB  phosphorylation and alpha 
CaMKI mRNA polyadenylation at synapses. The EMBO journal 21, 2139-2148. 
Huang, Y.W., Ruiz, C.R., Eyler, E.C., Lin, K., and Mefert, M.K. (2012). Dual regulation 
of  miRNA  biogenesis  generates target specificity in  neurotrophin-induced  protein 
synthesis. Cel 148, 933-946. 
Huber,  K.M.,  Kayser,  M.S., and  Bear,  M.F. (2000).  Role for rapid  dendritic  protein 
synthesis in  hippocampal  mGluR-dependent long-term  depression.  Science 288,  1254-
1257. 
Jakymiw, A., Lian, S., Eystathioy, T., Li, S., Satoh, M., Hamel, J.C., Fritzler, M.J., and 
Chan, E.K. (2005). Disruption of GW bodies impairs mammalian RNA interference. Nat 
Cel Biol 7, 1267-1274. 
Jaworski, J.,  Spangler,  S.,  Seeburg,  D.P.,  Hoogenraad,  C.C., and  Sheng,  M. (2005). 
Control  of  dendritic arborization  by the  phosphoinositide-3'-kinase-Akt-mammalian 
target of rapamycin pathway. J Neurosci 25, 11300-11312. 
Johnson,  C.D.,  Esquela-Kerscher,  A.,  Stefani,  G.,  Byrom,  M.,  Kelnar,  K.,  Ovcharenko, 
D.,  Wilson,  M.,  Wang,  X.,  Shelton, J.,  Shingara, J., et al. (2007).  The let-7  microRNA 
represses cel proliferation pathways in human cels. Cancer research 67, 7713-7722. 
 128	  
Johnson, S.M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, 
E.,  Reinert,  K.L.,  Brown,  D., and  Slack,  F.J. (2005).  RAS is regulated  by the let-7 
microRNA family. Cel 120, 635-647. 
Jourdi, H., Hsu, Y.T., Zhou, M., Qin, Q., Bi, X., and Baudry, M. (2009). Positive AMPA 
receptor  modulation rapidly stimulates  BDNF release and increases  dendritic  mRNA 
translation. J Neurosci 29, 8688-8697. 
Juhila, J., Sipila, T., Icay, K., Nicorici, D., Elonen, P., Kalio, A., Korpelainen, E., Greco, 
D., and  Hovata, I. (2011).  MicroRNA expression  profiling reveals  miRNA families 
regulating specific  biological  pathways in  mouse frontal cortex and  hippocampus.  PloS 
one 6, e21495. 
Kang,  H., and  Schuman,  E.M. (1996).  A requirement for local  protein synthesis in 
neurotrophin-induced hippocampal synaptic plasticity. Science 273, 1402-1406. 
Kanhema, T., Dagestad, G., Panja, D., Tiron, A., Messaoudi, E., Havik, B., Ying, S.W., 
Nairn,  A.C.,  Sonenberg,  N., and  Bramham,  C.R. (2006).  Dual regulation  of translation 
initiation and peptide chain elongation during BDNF-induced LTP in vivo: evidence for 
compartment-specific translation control. Journal of neurochemistry 99, 1328-1337. 
Keene, J.D.,  Komisarow, J.M., and  Friedersdorf,  M.B. (2006).  RIP-Chip: the isolation 
and identification of mRNAs, microRNAs and protein components of ribonucleoprotein 
complexes from cel extracts. Nat Protoc 1, 302-307. 
Keleher,  R.J.,  3rd,  Govindarajan,  A., Jung,  H.Y.,  Kang,  H., and  Tonegawa,  S. (2004). 
Translational control  by  MAPK signaling in long-term synaptic  plasticity and  memory. 
Cel 116, 467-479. 
Kertesz, M., Iovino, N., Unnerstal, U., Gaul, U., and Segal, E. (2007). The role of site 
accessibility in microRNA target recognition. Nature genetics 39, 1278-1284. 
Korte,  M.,  Carol,  P.,  Wolf,  E.,  Brem,  G.,  Thoenen,  H., and  Bonhoefer,  T. (1995). 
Hippocampal long-term  potentiation is impaired in  mice lacking  brain- derived 
neurotrophic factor. Proc Natl Acad Sci U S A 92, 8856-8860. 
Krol, J.,  Busskamp,  V.,  Markiewicz, I.,  Stadler,  M.B.,  Ribi,  S.,  Richter, J.,  Duebel, J., 
Bicker,  S.,  Fehling,  H.J.,  Schubeler,  D., et  al. (2010).  Characterizing light-regulated 
retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. 
Cel 141, 618-631. 
Kumar,  M.S.,  Erkeland,  S.J.,  Pester,  R.E.,  Chen,  C.Y.,  Ebert,  M.S.,  Sharp,  P.A., and 
Jacks,  T. (2008).  Suppression  of  non-smal cel lung tumor  development  by the let-7 
microRNA family. Proc Natl Acad Sci U S A 105, 3903-3908. 
Lee,  R.C.,  Feinbaum,  R.L., and  Ambros,  V. (1993).  The  C. elegans  heterochronic  gene 
lin-4 encodes smal RNAs with antisense complementarity to lin-14. Cel 75, 843-854. 
Letre,  G., Jackson,  A.U.,  Gieger,  C.,  Schumacher,  F.R.,  Berndt,  S.I.,  Sanna,  S., 
Eyheramendy, S., Voight, B.F., Butler, J.L., Guiducci, C., et al. (2008). Identification of 
ten loci associated  with  height  highlights  new  biological  pathways in  human  growth. 
Nature genetics 40, 584-591. 
 129	  
Levine,  E.S.,  Crozier,  R.A.,  Black, I.B., and  Plummer,  M.R. (1998).  Brain-derived 
neurotrophic factor  modulates  hippocampal synaptic transmission  by increasing  N-
methyl-D-aspartic acid receptor activity. Proc Natl Acad Sci U S A 95, 10235-10239. 
Levine, E.S., and Kolb, J.E. (2000). Brain-derived neurotrophic factor increases activity 
of  NR2B-containing  N-methyl-D-aspartate receptors in excised  patches from 
hippocampal neurons. Journal of neuroscience research 62, 357-362. 
Liao, L., Pilote, J., Xu, T., Wong, C.C., Edelman, G.M., Vanderklish, P., and Yates, J.R., 
3rd (2007).  BDNF induces  widespread changes in synaptic  protein content and  up-
regulates components  of the translation  machinery: an analysis  using  high-throughput 
proteomics. J Proteome Res 6, 1059-1071. 
Lin,  S.Y., Johnson,  S.M.,  Abraham,  M.,  Vela,  M.C.,  Pasquineli,  A.,  Gamberi,  C., 
Gotlieb, E., and Slack, F.J. (2003). The C elegans hunchback homolog, hbl-1, controls 
temporal paterning and is a probable microRNA target. Developmental cel 4, 639-650. 
Lin, S.Y., Wu, K., Levine, E.S., Mount, H.T., Suen, P.C., and Black, I.B. (1998). BDNF 
acutely increases tyrosine phosphorylation of the NMDA receptor subunit 2B in cortical 
and hippocampal postsynaptic densities. Brain research Molecular brain research 55, 20-
27. 
Liu, J.,  Rivas,  F.V.,  Wohlschlegel, J.,  Yates, J.R.,  3rd,  Parker,  R., and  Hannon,  G.J. 
(2005a). A role for the P-body component GW182 in microRNA function. Nat Cel Biol 
7, 1261-1266. 
Liu, J.,  Valencia-Sanchez,  M.A., Hannon,  G.J., and  Parker,  R. (2005b).  MicroRNA-
dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cel Biol 7, 719-
723. 
Lois,  C.,  Hong,  E.J.,  Pease,  S.,  Brown,  E.J., and  Baltimore,  D. (2002).  Germline 
transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. 
Science 295, 868-872. 
Lugli,  G.,  Torvik,  V.I.,  Larson, J., and  Smalheiser,  N.R. (2008).  Expression  of 
microRNAs and their  precursors in synaptic fractions  of adult  mouse forebrain. J 
Neurochem 106, 650-661. 
Mathonnet, G., Fabian, M.R., Svitkin, Y.V., Parsyan, A., Huck, L., Murata, T., Bifo, S., 
Merick,  W.C.,  Darzynkiewicz,  E.,  Pilai,  R.S., et  al. (2007).  MicroRNA inhibition  of 
translation initiation in  vitro  by targeting the cap-binding complex eIF4F. Science 317, 
1764-1767. 
Mefert,  M.K.,  Chang, J.M.,  Wiltgen,  B.J.,  Fanselow,  M.S., and  Baltimore,  D. (2003). 
NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci 6, 1072-1078. 
Melo, S.A., Ropero, S., Moutinho, C., Aaltonen, L.A., Yamamoto, H., Calin, G.A., Rossi, 
S.,  Fernandez,  A.F.,  Carneiro,  F.,  Oliveira,  C., et  al. (2009).  A  TARBP2  mutation in 
human cancer impairs microRNA processing and DICER1 function. Nat Genet 41, 365-
370. 
 130	  
Meng,  Y.,  Zhang,  Y.,  Tregoubov,  V., Janus,  C.,  Cruz,  L., Jackson,  M.,  Lu,  W.Y., 
MacDonald, J.F., Wang, J.Y., Fals, D.L., et al. (2002). Abnormal spine morphology and 
enhanced LTP in LIMK-1 knockout mice. Neuron 35, 121-133. 
Miyashiro,  K.Y.,  Beckel-Mitchener,  A.,  Purk,  T.P.,  Becker,  K.G.,  Baret,  T.,  Liu,  L., 
Carboneto,  S.,  Weiler, I.J.,  Greenough,  W.T., and  Eberwine, J. (2003).  RNA cargoes 
associating with FMRP reveal deficits in celular functioning in Fmr1 nul mice. Neuron 
37, 417-431. 
Moser, J.J., Chan, E.K., and Fritzler, M.J. (2009). Optimization of immunoprecipitation-
western  blot analysis in  detecting  GW182-associated components  of  GW/P  bodies.  Nat 
Protoc 4, 674-685. 
Moss, E.G., Lee, R.C., and Ambros, V. (1997). The cold shock domain protein LIN-28 
controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cel 88, 
637-646. 
Moss, E.G., and Tang, L. (2003). Conservation of the heterochronic regulator Lin-28, its 
developmental expression and microRNA complementary sites. Dev Biol 258, 432-442. 
Napoli, I., Mercaldo, V., Boyl, P.P., Eleuteri, B., Zalfa, F., De Rubeis, S., Di Marino, D., 
Mohr,  E.,  Massimi,  M.,  Falconi,  M., et  al. (2008).  The fragile  X syndrome  protein 
represses activity-dependent translation through CYFIP1, a new 4E-BP. Cel 134, 1042-
1054. 
Narayanan, U., Nalavadi, V., Nakamoto, M., Palas, D.C., Ceman, S., Bassel, G.J., and 
Waren,  S.T. (2007).  FMRP  phosphorylation reveals an immediate-early signaling 
pathway triggered  by  group I  mGluR and  mediated  by  PP2A. J  Neurosci 27,  14349-
14357. 
Narisawa-Saito, M., Carnahan, J., Araki, K., Yamaguchi, T., and Nawa, H. (1999). Brain-
derived  neurotrophic factor regulates the expression  of  AMPA receptor  proteins in 
neocortical neurons. Neuroscience 88, 1009-1014. 
Newman, M.A., Thomson, J.M., and Hammond, S.M. (2008). Lin-28 interaction with the 
Let-7 precursor loop mediates regulated microRNA processing. Rna 14, 1539-1549. 
Nielsen,  C.B.,  Shomron,  N.,  Sandberg,  R.,  Hornstein,  E.,  Kitzman, J., and  Burge,  C.B. 
(2007).  Determinants  of targeting  by endogenous and exogenous  microRNAs and 
siRNAs. RNA 13, 1894-1910. 
Ong, K.K., Elks, C.E., Li, S., Zhao, J.H., Luan, J., Andersen, L.B., Bingham, S.A., Brage, 
S.,  Smith,  G.D.,  Ekelund,  U., et al. (2009).  Genetic  variation in  LIN28B is associated 
with the timing of puberty. Nature genetics 41, 729-733. 
Pang, P.T., and  Lu,  B. (2004).  Regulation  of late-phase  LTP and long-term  memory in 
normal and aging  hippocampus: role  of secreted  proteins tPA and  BDNF.  Ageing  Res 
Rev 3, 407-430. 
Paroo,  Z.,  Ye,  X.,  Chen,  S., and  Liu,  Q. (2009).  Phosphorylation  of the  human 
microRNA-generating complex mediates MAPK/Erk signaling. Cel 139, 112-122. 
 131	  
Paterson, S.L., Abel, T., Deuel, T.A., Martin, K.C., Rose, J.C., and Kandel, E.R. (1996). 
Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP 
in BDNF knockout mice. Neuron 16, 1137-1145. 
Pery, J.R.,  Stolk,  L.,  Franceschini,  N.,  Luneta,  K.L.,  Zhai,  G.,  McArdle,  P.F.,  Smith, 
A.V.,  Aspelund,  T.,  Bandineli,  S.,  Boerwinkle,  E., et  al. (2009).  Meta-analysis  of 
genome-wide association  data identifies two loci influencing age at  menarche.  Nature 
genetics 41, 648-650. 
Petersen, C.P., Bordeleau, M.E., Peletier, J., and Sharp, P.A. (2006). Short RNAs repress 
translation after initiation in mammalian cels. Mol Cel 21, 533-542. 
Piskounova,  E.,  Polytarchou,  C., Thornton, J.E.,  LaPiere,  R.J.,  Pothoulakis,  C.,  Hagan, 
J.P., Iliopoulos,  D., and  Gregory,  R.I. (2011).  Lin28A and  Lin28B inhibit let-7 
microRNA biogenesis by distinct mechanisms. Cel 147, 1066-1079. 
Poo, M.M. (2001). Neurotrophins as synaptic modulators. Nat Rev Neurosci 2, 24-32. 
Raab-Graham,  K.F.,  Haddick,  P.C., Jan,  Y.N., and Jan,  L.Y. (2006).  Activity- and 
mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites. Science 
314, 144-148. 
Ramachandran, R., Fauset, B.V., and Goldman, D. (2010). Ascl1a regulates Muler glia 
dediferentiation and retinal regeneration through a  Lin-28-dependent, let-7  microRNA 
signaling pathway. Nature cel biology 12, 1101-1107. 
Rivera,  C.,  Li,  H.,  Thomas-Crusels, J.,  Lahtinen,  H.,  Vitanen,  T.,  Nanobashvili,  A., 
Kokaia,  Z.,  Airaksinen,  M.S.,  Voipio, J.,  Kaila,  K., et al. (2002).  BDNF-induced  TrkB 
activation  down-regulates the  K+-Cl- cotransporter  KCC2 and impairs  neuronal  Cl- 
extrusion. The Journal of cel biology 159, 747-752. 
Sampson, V.B., Rong, N.H., Han, J., Yang, Q., Aris, V., Soteropoulos, P., Petreli, N.J., 
Dunn, S.P., and Krueger, L.J. (2007). MicroRNA let-7a down-regulates MYC and reverts 
MYC-induced growth in Burkit lymphoma cels. Cancer research 67, 9762-9770. 
Sarmiere, P.D., and Bamburg, J.R. (2002). Head, neck, and spines: a role for LIMK-1 in 
the hippocampus. Neuron 35, 3-5. 
Schrat,  G.M.,  Nigh,  E.A.,  Chen,  W.G.,  Hu,  L., and  Greenberg,  M.E. (2004).  BDNF 
regulates the translation  of a select  group  of  mRNAs  by a  mammalian target  of 
rapamycin-phosphatidylinositol  3-kinase-dependent  pathway  during  neuronal 
development. J Neurosci 24, 7366-7377. 
Schrat,  G.M.,  Tuebing,  F.,  Nigh,  E.A.,  Kane,  C.G.,  Sabatini,  M.E.,  Kiebler,  M., and 
Greenberg,  M.E. (2006).  A  brain-specific  microRNA regulates  dendritic spine 
development. Nature 439, 283-289. 
Sempere, L.F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., and Ambros, V. 
(2004).  Expression  profiling  of  mammalian  microRNAs  uncovers a subset  of  brain-
expressed microRNAs with possible roles in murine and human neuronal diferentiation. 
Genome Biol 5, R13. 
 132	  
Sethi, P., and Lukiw, W.J. (2009). Micro-RNA abundance and stability in human brain: 
specific alterations in  Alzheimer's  disease temporal lobe  neocortex.  Neurosci  Let 459, 
100-104. 
Shan,  G.,  Li, Y.,  Zhang, J.,  Li,  W.,  Szulwach,  K.E.,  Duan,  R.,  Faghihi,  M.A.,  Khalil, 
A.M., Lu, L., Paroo, Z., et al. (2008). A smal molecule enhances RNA interference and 
promotes microRNA processing. Nat Biotechnol 26, 933-940. 
Shel, S., Park, S.M., Radjabi, A.R., Schickel, R., Kistner, E.O., Jewel, D.A., Feig, C., 
Lengyel, E., and Peter, M.E. (2007). Let-7 expression defines two diferentiation stages 
of cancer. Proc Natl Acad Sci U S A 104, 11400-11405. 
Shinohara, Y., Yahagi, K., Kawano, M., Nishiyori, H., Kawazu, C., Suzuki, N., Manabe, 
R., and  Hirase,  H. (2011).  miRNA  profiling  of  bilateral rat  hippocampal  CA3  by  deep 
sequencing. Biochemical and biophysical research communications 409, 293-298. 
Sulem, P., Gudbjartsson, D.F., Rafnar, T., Holm, H., Olafsdotir, E.J., Olafsdotir, G.H., 
Jonsson,  T.,  Alexandersen,  P.,  Feenstra,  B.,  Boyd,  H.A., et  al. (2009).  Genome-wide 
association study identifies sequence variants on 6q21 associated with age at menarche. 
Nature genetics 41, 734-738. 
Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, 
T.,  Yatabe,  Y.,  Nagino,  M.,  Nimura,  Y., et al. (2004).  Reduced expression  of the let-7 
microRNAs in human lung cancers in association with shortened postoperative survival. 
Cancer research 64, 3753-3756. 
Takei, N., Inamura, N., Kawamura, M., Namba, H., Hara, K., Yonezawa, K., and Nawa, 
H. (2004).  Brain-derived  neurotrophic factor induces  mammalian target  of rapamycin-
dependent local activation  of translation  machinery and  protein synthesis in  neuronal 
dendrites. J Neurosci 24, 9760-9769. 
Takei, N., Kawamura, M., Ishizuka, Y., Kakiya, N., Inamura, N., Namba, H., and Nawa, 
H. (2009). Brain-derived neurotrophic factor enhances the basal rate of protein synthesis 
by increasing active eukaryotic elongation factor  2 levels and  promoting translation 
elongation in cortical neurons. J Biol Chem 284, 26340-26348. 
Tanaka, J., Horike, Y., Matsuzaki, M., Miyazaki, T., Elis-Davies, G.C., and Kasai, H. 
(2008).  Protein synthesis and  neurotrophin-dependent structural  plasticity  of single 
dendritic spines. Science 319, 1683-1687. 
Teixeira,  D.,  Sheth,  U.,  Valencia-Sanchez,  M.A.,  Brengues,  M., and  Parker,  R. (2005). 
Processing bodies require RNA for assembly and contain nontranslating mRNAs. Rna 11, 
371-382. 
Thomson, J.M.,  Parker, J.,  Perou,  C.M., and  Hammond,  S.M. (2004).  A custom 
microaray platform for analysis of microRNA gene expression. Nature methods 1, 47-53. 
Tyler,  W.J.,  Alonso,  M.,  Bramham,  C.R., and  Pozzo-Miler,  L.D. (2002).  From 
acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in 
hippocampal-dependent learning. Learn Mem 9, 224-237. 
Vanderklish,  P.W., and  Edelman,  G.M. (2005).  Diferential translation and fragile  X 
syndrome. Genes, brain, and behavior 4, 360-384. 
 133	  
Viswanathan,  S.R.,  Daley,  G.Q., and  Gregory,  R.I. (2008).  Selective  blockade  of 
microRNA processing by Lin28. Science 320, 97-100. 
Viswanathan,  S.R.,  Powers, J.T.,  Einhorn,  W.,  Hoshida,  Y.,  Ng,  T.L.,  Tofanin,  S., 
O'Sulivan,  M.,  Lu, J.,  Philips,  L.A.,  Lockhart,  V.L., et  al. (2009).  Lin28  promotes 
transformation and is associated with advanced human malignancies. Nat Genet 41, 843-
848. 
Wang,  B.,  Love,  T.M.,  Cal,  M.E.,  Doench, J.G., and  Novina,  C.D. (2006). 
Recapitulation of short RNA-directed translational gene silencing in vitro. Mol Cel 22, 
553-560. 
Wang,  D.O.,  Kim,  S.M.,  Zhao,  Y.,  Hwang,  H.,  Miura,  S.K.,  Sossin,  W.S., and  Martin, 
K.C. (2009). Synapse- and stimulus-specific local translation during long-term neuronal 
plasticity. Science 324, 1536-1540. 
Wang, W., Zhu, J.Z., Chang, K.T., and Min, K.T. (2012). DSCR1 interacts with FMRP 
and is required for spine morphogenesis and local protein synthesis. The EMBO journal 
31, 3655-3666. 
Wardle,  R.A., and  Poo,  M.M. (2003).  Brain-derived  neurotrophic factor  modulation  of 
GABAergic synapses  by  postsynaptic regulation  of chloride transport. J  Neurosci 23, 
8722-8732. 
Wu, L., Wels, D., Tay, J., Mendis, D., Abbot, M.A., Barnit, A., Quinlan, E., Heynen, 
A.,  Falon, J.R., and  Richter, J.D. (1998).  CPEB-mediated cytoplasmic  polyadenylation 
and the regulation  of experience-dependent translation  of alpha-CaMKI  mRNA at 
synapses. Neuron 21, 1129-1139. 
Wulczyn,  F.G.,  Smirnova,  L.,  Rybak,  A.,  Brandt,  C.,  Kwidzinski,  E.,  Ninnemann,  O., 
Strehle,  M.,  Seiler,  A.,  Schumacher,  S., and  Nitsch,  R. (2007).  Post-transcriptional 
regulation  of the let-7  microRNA  during  neural cel specification.  FASEB journal : 
oficial publication of the Federation of American Societies for Experimental Biology 21, 
415-426. 
Yin, Y., Edelman, G.M., and Vanderklish, P.W. (2002). The brain-derived neurotrophic 
factor enhances synthesis  of  Arc in synaptoneurosomes.  Proc  Natl  Acad  Sci  U  S  A 99, 
2368-2373. 
Ying,  S.W.,  Futer,  M.,  Rosenblum,  K.,  Webber,  M.J.,  Hunt,  S.P.,  Bliss,  T.V., and 
Bramham, C.R. (2002). Brain-derived neurotrophic factor induces long-term potentiation 
in intact adult  hippocampus: requirement for  ERK activation coupled to  CREB and 
upregulation of Arc synthesis. J Neurosci 22, 1532-1540. 
Yu,  F.,  Yao,  H.,  Zhu,  P.,  Zhang,  X.,  Pan,  Q.,  Gong,  C.,  Huang,  Y.,  Hu,  X.,  Su,  F., 
Lieberman, J., et  al. (2007a). let-7 regulates self renewal and tumorigenicity  of  breast 
cancer cels. Cel 131, 1109-1123. 
Yu, J., Vodyanik, M.A., Smuga-Oto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., 
Nie, J., Jonsdotir, G.A., Ruoti, V., Stewart, R., et al. (2007b). Induced pluripotent stem 
cel lines derived from human somatic cels. Science 318, 1917-1920. 
 134	  
Yu, J.Y., Chung, K.H., Deo, M., Thompson, R.C., and Turner, D.L. (2008). MicroRNA 
miR-124 regulates  neurite  outgrowth  during  neuronal  diferentiation.  Experimental cel 
research 314, 2618-2633. 
Zalfa,  F.,  Achsel,  T., and  Bagni,  C. (2006).  mRNPs,  polysomes  or  granules:  FMRP in 
neuronal protein synthesis. Curent opinion in neurobiology 16, 265-269. 
Zhu,  H.,  Shah,  S.,  Shyh-Chang,  N.,  Shinoda,  G.,  Einhorn,  W.S.,  Viswanathan,  S.R., 
Takeuchi,  A.,  Grasemann,  C.,  Rinn, J.L.,  Lopez,  M.F., et al. (2010).  Lin28a transgenic 
mice  manifest size and  puberty  phenotypes identified in  human  genetic association 
studies. Nature genetics 42, 626-630. 
Zhu, H., Shyh-Chang, N., Segre, A.V., Shinoda, G., Shah, S.P., Einhorn, W.S., Takeuchi, 
A.,  Engreitz, J.M.,  Hagan, J.P.,  Kharas,  M.G., et  al. (2011).  The  Lin28/let-7 axis 








The Johns Hopkins University School of Medicine 
 





Ph.D. expected 2014 Neuroscience Program    Johns Hopkins School of  
    Medicine 
 
   Mentor: Molie Mefert M.D. Ph.D 
 




Other Professional Experience 
 
2009     Research Rotation Laboratory of Alfredo Quinones-Hinojosa M.D.  
     Johns Hopkins School of Medicine 
 
2008     Research Rotation Laboratory of Ted Dawson M.D. Ph.D. 
     Johns Hopkins School of Medicine 
 
2008     Research Rotation Laboratory of Seth Blackshaw Ph.D. 
     Johns Hopkins School of Medicine 
 
2008     Research Assistant Laboratory of David Morgan Ph.D.  
     Alzheimer’s Research Laboratory 
University of South Florida  
 
2007      Research Assistant Laboratory of Steven Shivers Ph.D. 
     Molecular Staging Laboratory  
     Lakeland Regional Cancer Center 
 
2005-2006  Research Assistant Laboratory of Philippe Rochat Ph.D. 
     Child Studies Center 
     Emory University  
 
 
Scholarships and Felowships 
 
2012-present Ruth L. Kirschstein National Research Service Grant Award (F31) NIMH 
 
 136	  





2013  Richard Goodman Scholars Award, Johns Hopkins Department of Neuroscience  
Awarded by the Neuroscience Steering Commitee to one student, selected from 
fourth year and above, who 'has made an outstanding discovery and exemplifies 
the characteristics that we hope to instil in our students’ 
 
2012  Biomedical Scholars Association (BSA) Milestone Achievement Award, Johns 
Hopkins  
 
2006  Dean’s List, Emory University  
 
2004  National Order of Omega, Greek Leadership Honor Society, Emory University 
 
2004  Nu Rho Psi, The National Honor Society in Neuroscience, Emory University  
 
 
Publications, Peer Reviewed 
 
Ruiz CR, Shi J, & Mefert MK. Transcript specificity in BDNF-induced regulated 
protein synthesis. Neuropharmacology (Invited Review. Special Issue: BDNF regulation 
of synaptic structure, function, and plasticity), 76; 657-63. January 2014. PMID 
23707639  
 
Lee DC, Ruiz CR, Lebson, L, Selenica ML, Rizer J, Hunt JB Jr, Rojiani R, Reid P, 
Kammath S, Nash K, Dickey CA, Gordon M, Morgan D. Aging enhances classical 
activation but mitigates alternative activation in the central nervous system. Neurobiology 
of Aging 34, 1610-1620, June 2013. PMID 23481567 
 
Huang Y-W A*, Ruiz CR*, Eyler ECH*, Lin K, & Mefert MK. Dual regulation of 
miRNA biogenesis generates target specificity in neurotrophin-induced protein synthesis. 





Ruiz CR*, Amen AM*, Shi J, & Mefert MK.  TRBP mediates diferential induction of 







Posters and Abstracts 
 
Ruiz CR, Huang Y-W A, Eyler ECH, Shi J, & Mefert MK. Dual regulation of miRNA 
biogenesis generates target specificity in neurotrophin-induced protein synthesis. 
Presented June 2012 at the Cel Biology of the Neuron Gordon Conference, Watervile 
Valey, New Hampshire (Poster)  
 
Huang Y-W A, Ruiz CR, Eyler ECH, Lin K, Mefert MK. Regulated microRNA 
biogenesis and P-body mRNA localization determine specificity of BDNF-induced 
protein synthesis. Presented November 2011 at the Society for Neuroscience Meeting, 
Washington D.C. (Poster)  
 
Guerero-Cazares, H., Niranjan, A., Ruiz, CR., Atri, D., Achanta, P., Garzon-Muvdi, T., 
Mohyeldin, A., Quinones-Hinojosa, A . Migration of human brain tumor stem cels in 
response to slit proteins. Presented September 2009 at the World Stem Cel Summit, 
Baltimore, Maryland (Poster) 
 
Lee, D.C., Ruiz CR, Lebson, L., Morgan, D., Gordon, M. Age-induced changes in 
classical and alternatively activated gene expression profiles folowing polarization of 
microglia in mouse CNS. Presented November 2008 at the Society for Neuroscience 
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2008-present Society for Neuroscience Member 
2008-present  American Association for the Advancement of Science 
 
 
Teaching and Mentoring Experience  
 
2013  Guided the rotation project of a Biological Chemistry Graduate Student 
2012   Teaching assistant, Neurobiology Course  
2012 Guided the rotation project of a Biochemistry, Celular, & Molecular 
Biology (BCMB) Graduate Student  
2011  Guided the rotation project of a Neuroscience Graduate Student  
2011  Guided the rotation project of a BCMB Graduate Student 
2010  Guided the rotation project of a Neuroscience Graduate Student  
2010-2014 Guided the research project of an Undergraduate Student (Curently a 




Service and Leadership 
 
2011-2013 Graduate Student Association (GSA) Neuroscience Representative  
2011-2013  Neuroscience Graduate Admissions Commitee Member  
2010   Neuroscience Department Green Team, Co-Chair 
2009-2011  Departmental Retreat Planning Commitee, Co-Chair 
2008-2013  Leadership Initiative for the Environment (LIFE), Co-Chair 
 
 
Talks and Seminars 
 
2012  Center for Cel Dynamics Seminar Live Cel Imaging Workshop  
2010  Center for Cel Dynamics Seminar Research Talk  
2009   Departmental Neuroscience Journal Club Research Talk 
2009   Department of Biological Chemistry Evening Research Discussion 
 
 
 
